Submitted URL: http://link.email.empr.com/a/1323/click/68826/2303653/5e8905b1fe7835fc5456362aa89e01246a3159da/6fe7119f58b2152a2ec9475bf11c...
Effective URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=ne...
Submission: On September 27 via api from US

Summary

This website contacted 46 IPs in 7 countries across 35 domains to perform 238 HTTP transactions. The main IP is 34.225.50.222, located in Ashburn, United States and belongs to AMAZON-AES - Amazon.com, Inc., US. The main domain is www.empr.com.
TLS certificate: Issued by RapidSSL RSA CA 2018 on January 16th 2019. Valid for: 2 years.
This is the only time www.empr.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

IP Address AS Autonomous System
1 2 35.238.92.4 15169 (GOOGLE)
36 34.225.50.222 14618 (AMAZON-AES)
24 94.31.29.64 33438 (HIGHWINDS2)
3 2a00:1450:400... 15169 (GOOGLE)
1 93.184.220.113 15133 (EDGECAST)
9 2a00:1450:400... 15169 (GOOGLE)
4 52.216.161.101 16509 (AMAZON-02)
1 2a00:1450:400... 15169 (GOOGLE)
1 2600:9000:20b... 16509 (AMAZON-02)
10 172.217.16.162 15169 (GOOGLE)
1 2606:4700::68... 13335 (CLOUDFLAR...)
1 6 2a00:1450:400... 15169 (GOOGLE)
1 4 2.19.43.224 20940 (AKAMAI-ASN1)
4 2a00:1450:400... 15169 (GOOGLE)
67 2606:4700:20:... 13335 (CLOUDFLAR...)
1 35.174.96.0 14618 (AMAZON-AES)
4 52.1.219.33 14618 (AMAZON-AES)
2 8 34.248.158.173 16509 (AMAZON-02)
1 1 2a00:1450:400... 15169 (GOOGLE)
1 4 2a00:1450:400... 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
1 143.204.214.38 16509 (AMAZON-02)
3 2a03:2880:f01... 32934 (FACEBOOK)
2 2 52.206.48.92 14618 (AMAZON-AES)
2 2 35.227.248.159 15169 (GOOGLE)
1 3.211.28.224 14618 (AMAZON-AES)
1 143.204.207.113 16509 (AMAZON-02)
3 2a03:2880:f11... 32934 (FACEBOOK)
1 34.202.10.50 14618 (AMAZON-AES)
1 1 104.111.241.32 16625 (AKAMAI-AS)
2 2 35.190.72.21 15169 (GOOGLE)
2 2 2.18.233.201 16625 (AKAMAI-AS)
2 3 18.200.54.67 16509 (AMAZON-02)
2 3 18.195.251.148 16509 (AMAZON-02)
1 143.204.214.122 16509 (AMAZON-02)
2 35.227.192.113 15169 (GOOGLE)
4 35.172.78.117 14618 (AMAZON-AES)
7 2a00:1450:400... 15169 (GOOGLE)
4 34.205.176.240 14618 (AMAZON-AES)
4 2600:9000:20b... 16509 (AMAZON-02)
2 143.204.214.7 16509 (AMAZON-02)
4 2600:1f14:e96... 16509 (AMAZON-02)
1 34.248.255.146 16509 (AMAZON-02)
1 3 2600:1f14:e96... 16509 (AMAZON-02)
1 3 2600:1f14:e96... 16509 (AMAZON-02)
1 3 2600:1f14:e96... 16509 (AMAZON-02)
1 3 2600:1f14:e96... 16509 (AMAZON-02)
1 54.203.125.28 16509 (AMAZON-02)
1 54.245.184.141 16509 (AMAZON-02)
1 35.166.13.162 16509 (AMAZON-02)
1 34.219.221.191 16509 (AMAZON-02)
238 46
Apex Domain
Subdomains
Transfer
69 lytics.io
c.lytics.io
api.lytics.io
81 KB
35 empr.com
link.email.empr.com
www.empr.com
3 MB
24 netdna-ssl.com
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
321 KB
20 b2c.com
api.b2c.com
api-54-203-125-28.b2c.com
api-54-245-184-141.b2c.com
api-35-166-13-162.b2c.com
api-34-219-221-191.b2c.com
27 KB
11 doubleclick.net
securepubads.g.doubleclick.net
stats.g.doubleclick.net
101 KB
9 googlesyndication.com
tpc.googlesyndication.com
pagead2.googlesyndication.com
168 KB
9 ml314.com
ml314.com
in.ml314.com
17 KB
9 haymarketmedia.com
accounts.haymarketmedia.com
subapi.haymarketmedia.com
adtrackapi.haymarketmedia.com
12 KB
6 spotible.com
ads.spotible.com
cdn1.spotible.com
218 KB
6 google-analytics.com
www.google-analytics.com
40 KB
5 google.com
adservice.google.com
www.google.com
972 B
5 googletagservices.com
www.googletagservices.com
130 KB
4 medtargetsystem.com
www.medtargetsystem.com
52 KB
4 gstatic.com
fonts.gstatic.com
50 KB
4 scorecardresearch.com
sb.scorecardresearch.com
3 KB
4 amazonaws.com
s3.amazonaws.com
2 MB
4 crwdcntrl.net
tags.crwdcntrl.net
sync.crwdcntrl.net
bcp.crwdcntrl.net
13 KB
3 eyeota.net
ps.eyeota.net
1 KB
3 facebook.com
www.facebook.com
325 B
3 sitomobile.com
mt.sitomobile.com
sp.sitomobile.com
2 KB
3 facebook.net
connect.facebook.net
120 KB
3 googleapis.com
fonts.googleapis.com
2 KB
2 mathtag.com
pixel.mathtag.com
1 KB
2 rlcdn.com
idsync.rlcdn.com
848 B
2 adsrvr.org
js.adsrvr.org
insight.adsrvr.org
2 KB
2 tapad.com
pixel.tapad.com
844 B
2 google.de
adservice.google.de
www.google.de
1007 B
2 maropost.com
content.maropost.com
mpct1.maropost.com
5 KB
1 pulmonologyadvisor.com
www.pulmonologyadvisor.com
97 KB
1 thecardiologyadvisor.com
www.thecardiologyadvisor.com
612 KB
1 alexametrics.com
certify.alexametrics.com
553 B
1 bluekai.com
tags.bluekai.com
856 B
1 cloudfront.net
d31qbv1cthcecs.cloudfront.net
2 KB
1 crazyegg.com
script.crazyegg.com
29 KB
1 googletagmanager.com
www.googletagmanager.com
35 KB
238 35
Domain Requested by
67 c.lytics.io 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
c.lytics.io
www.empr.com
34 www.empr.com www.empr.com
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
24 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com www.empr.com
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
10 securepubads.g.doubleclick.net www.googletagservices.com
securepubads.g.doubleclick.net
www.empr.com
8 ml314.com 2 redirects www.empr.com
ml314.com
7 tpc.googlesyndication.com securepubads.g.doubleclick.net
6 www.google-analytics.com 1 redirects www.googletagmanager.com
www.google-analytics.com
5 www.googletagservices.com www.empr.com
securepubads.g.doubleclick.net
4 api-34-219-221-191.b2c.com 1 redirects www.empr.com
4 api-35-166-13-162.b2c.com 1 redirects www.empr.com
4 api-54-245-184-141.b2c.com 1 redirects www.empr.com
4 api-54-203-125-28.b2c.com 1 redirects www.empr.com
4 api.b2c.com www.empr.com
securepubads.g.doubleclick.net
4 adtrackapi.haymarketmedia.com s3.amazonaws.com
4 ads.spotible.com www.empr.com
ads.spotible.com
4 subapi.haymarketmedia.com s3.amazonaws.com
4 www.google.com 1 redirects securepubads.g.doubleclick.net
4 www.medtargetsystem.com www.empr.com
www.medtargetsystem.com
4 fonts.gstatic.com www.empr.com
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
4 sb.scorecardresearch.com 1 redirects www.empr.com
www.googletagmanager.com
4 s3.amazonaws.com www.empr.com
3 ps.eyeota.net 2 redirects www.empr.com
3 www.facebook.com www.empr.com
connect.facebook.net
3 connect.facebook.net www.empr.com
connect.facebook.net
3 fonts.googleapis.com www.empr.com
s3.amazonaws.com
2 pagead2.googlesyndication.com
2 cdn1.spotible.com www.empr.com
2 api.lytics.io c.lytics.io
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
2 sync.crwdcntrl.net 2 redirects
2 pixel.mathtag.com 2 redirects
2 idsync.rlcdn.com 2 redirects
2 pixel.tapad.com 2 redirects
2 mt.sitomobile.com 2 redirects
1 insight.adsrvr.org js.adsrvr.org
1 bcp.crwdcntrl.net tags.crwdcntrl.net
1 www.pulmonologyadvisor.com www.empr.com
1 www.thecardiologyadvisor.com www.empr.com
1 certify.alexametrics.com www.empr.com
1 tags.bluekai.com 1 redirects
1 in.ml314.com ml314.com
1 js.adsrvr.org www.googletagmanager.com
1 sp.sitomobile.com www.empr.com
1 d31qbv1cthcecs.cloudfront.net www.empr.com
1 www.google.de www.empr.com
1 stats.g.doubleclick.net 1 redirects
1 accounts.haymarketmedia.com 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
1 mpct1.maropost.com content.maropost.com
1 script.crazyegg.com www.googletagmanager.com
1 adservice.google.com www.googletagservices.com
1 adservice.google.de www.googletagservices.com
1 content.maropost.com www.empr.com
1 www.googletagmanager.com www.empr.com
1 tags.crwdcntrl.net www.empr.com
1 link.email.empr.com 1 redirects
238 54
Subject Issuer Validity Valid
*.empr.com
RapidSSL RSA CA 2018
2019-01-16 -
2021-01-15
2 years crt.sh
*.netdna-ssl.com
Sectigo RSA Domain Validation Secure Server CA
2019-02-18 -
2020-02-27
a year crt.sh
*.googleapis.com
GTS CA 1O1
2019-09-05 -
2019-11-28
3 months crt.sh
tags.crwdcntrl.net
DigiCert SHA2 Secure Server CA
2019-03-15 -
2021-04-07
2 years crt.sh
*.g.doubleclick.net
GTS CA 1O1
2019-09-05 -
2019-11-28
3 months crt.sh
s3.amazonaws.com
DigiCert Baltimore CA-2 G2
2019-09-06 -
2020-12-02
a year crt.sh
*.google-analytics.com
GTS CA 1O1
2019-09-05 -
2019-11-28
3 months crt.sh
content.maropost.com
Amazon
2018-10-25 -
2019-11-25
a year crt.sh
*.google.com
GTS CA 1O1
2019-09-05 -
2019-11-28
3 months crt.sh
ssl945600.cloudflaressl.com
COMODO ECC Domain Validation Secure Server CA 2
2019-08-20 -
2020-02-26
6 months crt.sh
*.scorecardresearch.com
COMODO RSA Organization Validation Secure Server CA
2018-11-28 -
2019-12-26
a year crt.sh
*.maropost.com
Go Daddy Secure Certificate Authority - G2
2019-06-10 -
2021-08-09
2 years crt.sh
ssl379818.cloudflaressl.com
COMODO ECC Domain Validation Secure Server CA 2
2019-07-26 -
2020-02-01
6 months crt.sh
accounts.haymarketmedia.com
Amazon
2018-10-26 -
2019-11-26
a year crt.sh
medtargetsystem.com
Amazon
2018-11-23 -
2019-12-23
a year crt.sh
*.ml314.com
Amazon
2019-03-16 -
2020-04-16
a year crt.sh
www.google.de
GTS CA 1O1
2019-09-05 -
2019-11-28
3 months crt.sh
*.cloudfront.net
DigiCert Global CA G2
2019-07-17 -
2020-07-05
a year crt.sh
*.facebook.com
DigiCert SHA2 High Assurance Server CA
2019-08-24 -
2019-10-19
2 months crt.sh
*.sitomobile.com
RapidSSL RSA CA 2018
2018-01-22 -
2020-07-29
3 years crt.sh
*.adsrvr.org
Trustwave Organization Validation SHA256 CA, Level 1
2019-03-07 -
2021-04-19
2 years crt.sh
*.eyeota.net
Let's Encrypt Authority X3
2019-09-19 -
2019-12-18
3 months crt.sh
certify.alexametrics.com
Amazon
2019-07-26 -
2020-08-26
a year crt.sh
*.lytics.io
RapidSSL TLS RSA CA G1
2018-01-26 -
2020-01-06
2 years crt.sh
subapi.haymarketmedia.com
Amazon
2019-06-28 -
2020-07-28
a year crt.sh
*.thecardiologyadvisor.com
RapidSSL RSA CA 2018
2019-02-20 -
2020-02-20
a year crt.sh
*.pulmonologyadvisor.com
RapidSSL RSA CA 2018
2019-02-22 -
2020-02-22
a year crt.sh
tpc.googlesyndication.com
GTS CA 1O1
2019-09-05 -
2019-11-28
3 months crt.sh
*.spotible.com
Go Daddy Secure Certificate Authority - G2
2016-10-16 -
2019-11-06
3 years crt.sh
adtrackapi.haymarketmedia.com
Amazon
2019-03-27 -
2020-04-27
a year crt.sh
*.crwdcntrl.net
Go Daddy Secure Certificate Authority - G2
2019-06-13 -
2021-06-28
2 years crt.sh
*.b2c.com
Amazon
2019-03-24 -
2020-04-24
a year crt.sh
www.google.com
GTS CA 1O1
2019-09-05 -
2019-11-28
3 months crt.sh

This page contains 11 frames:

Primary Page: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Frame ID: 0AD6BDA124C0A8E809E65CEDC14A7D7C
Requests: 206 HTTP requests in this frame

Frame: https://api.lytics.io/api/me/iframe/43bffbce6f25564c8e2145a11836ff9f/_uid/eba40efa5985b991eb795147de5cdecd?segments=true&mergestate=true&ts=1569558930678
Frame ID: 0C7A0DD5996C8160E2111947A262507D
Requests: 1 HTTP requests in this frame

Frame: https://www.medtargetsystem.com/beacon/portal/?_url=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F&_sid=48a98256-b793-404a-a267-b663edb51788&_vid=42d335cf-097c-487f-b86f-d16df8e6a46c&_ak=35-212-8F62AC13&_flash=false&_th=1569558930|1569558930|1
Frame ID: 5076CCD4F84C5E0D9BEDD4D4B35297D1
Requests: 1 HTTP requests in this frame

Frame: https://www.facebook.com/tr/
Frame ID: 9E869181DA7AA79FC10B27C716FD5A01
Requests: 1 HTTP requests in this frame

Frame: https://www.facebook.com/tr/
Frame ID: 60272A29E44B2BD9970CD70DE048BD2F
Requests: 1 HTTP requests in this frame

Frame: https://ads.spotible.com/tag/universal-tag.js
Frame ID: 18C900E14767148203C4061BF9473D38
Requests: 2 HTTP requests in this frame

Frame: https://bcp.crwdcntrl.net/5/c=14413/rand=714902447/pv=y/ver=1.4/int=%23OpR%2396858%23Total%20Site%20Traffic%20%3A%20www.empr.com/int=%23OpR%2396859%23www.empr.com%20%3A%20Site%20Section%20%3A%20home/int=%23OpR%2396860%23www.empr.com%20%3A%20Site%20Section%20%3A%20home%20%20%3A%20news/int=%23OpR%2397492%23www.empr.com%20%3A%20Site%20Section%20%3A%20home%20%3A%20news%20%3A%20atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/med=%23OpR%2397539%23Article%20Tags%20%3A%20Oncology%2CRespiratory%20and%20Thoracic%20Cancers/rb=%7B%22url%22%3A%22https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653%22%7D/rt=ifr
Frame ID: 2D6386BA6ACFBF4B95E2AC09C3136675
Requests: 1 HTTP requests in this frame

Frame: https://insight.adsrvr.org/track/up?adv=wxli9bh&ref=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&upid=7fhq4wn&upv=1.1.0
Frame ID: BEC1F14515E05A0B096FA9FDEE2F8756
Requests: 1 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjst5oHdsyxWdeAImnpRdEUAx9Q82VCfkEUQlnmUWYdbAfjkDxhz4PM8UoyY9XA5bHvp0uOp5Tn3m-_0Xk1rRr9Q7vSurg7waojIx16ZfVUucEkrEy93-kd0HiNn7zX6lMyTElUb433ccfuueMDbqOx6kRB9jWvweTgpZHMZxGoUjDLjAoYR8VYgAZhrPHTr8EuLhdYhcxev2gx9BPVRRuZBt5n_1mo5p3cH81K77KsDDAKF5lwEAFjoLSNYCEOrzfJiZuegNy0mA-rIkbnrAux_9RTA&sig=Cg0ArKJSzKuaOvEJRTf4EAE&adurl=
Frame ID: 209CB51EFC7E1A880C158D0DFD801C59
Requests: 11 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsto6BuMHOcfML0MxscZnlae9FCkEZNtZCVINwl8s6hp_xb2FfAeI7L2zWb6b-537nCijmgn78try3dyuyNserPYwKpai1mHB1lRebgi8dxtSGJesLBHm5zcwFlf8nbbvo_a1_Kk-gu2kCnF7tgpwnxM24SZ1OcYWNiKZ-8lp5xn45CYhNqLFGr901n5W4FhkYN_aEUGwPp4Lyc2scEn7MGX8-1Ct-WESYOd8TVFyoQBtzjA7X-8ATiV_0uSJVV6pMt2Xs2ecbHz&sig=Cg0ArKJSzIhyrQN-mFThEAE&adurl=
Frame ID: C36C0D7268AE1971AE96D699DC430365
Requests: 11 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsv9JYOTnuL2Z4_-OEx9uPzKPQyZ8OkNbTXTkk0mRQQGNJjZo2zDk_5iZzGjz5VFv64HBBYerDR1IWIhxwm7-e101qSkHhFPVB--ge--E0dgyYnhxTHLAxpKMrLfh8O345qFABEwLF_YR4CiTLpnUCJoP0YRsHIIawR-tw9EMTawctZX-YZXgMoy-gHe87S0Fs_r-CJPS8e8o6xQsbLCPiRQ--zHXTobUKohDdF3Cwq011foa-g8sRxIeUaLNJqCU9tkzB2IfYQC&sig=Cg0ArKJSzPLcfP3ijgOwEAE&adurl=
Frame ID: 3F23D3814D7C990C77B7E56CA782DD77
Requests: 10 HTTP requests in this frame

Screenshot


Page URL History Show full URLs

  1. http://link.email.empr.com/a/1323/click/68826/2303653/5e8905b1fe7835fc5456362aa89e01246a3159da/6fe7119f... HTTP 302
    https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-... Page URL

Detected technologies

Overall confidence: 100%
Detected patterns
  • headers link /rel="https:\/\/api\.w\.org\/"/i

Overall confidence: 100%
Detected patterns
  • headers link /rel="https:\/\/api\.w\.org\/"/i

Overall confidence: 100%
Detected patterns
  • headers link /rel="https:\/\/api\.w\.org\/"/i

Overall confidence: 100%
Detected patterns
  • headers server /nginx(?:\/([\d.]+))?/i

Overall confidence: 100%
Detected patterns
  • script /script\.crazyegg\.com\/pages\/scripts\/\d+\/\d+\.js/i

Overall confidence: 100%
Detected patterns
  • script /\/\/connect\.facebook\.net\/[^\/]*\/[a-z]*\.js/i

Overall confidence: 100%
Detected patterns
  • script /google-analytics\.com\/(?:ga|urchin|analytics)\.js/i

Overall confidence: 100%
Detected patterns
  • html /googletagmanager\.com\/ns\.html[^>]+><\/iframe>/i
  • html /<!-- (?:End )?Google Tag Manager -->/i

Page Statistics

238
Requests

100 %
HTTPS

39 %
IPv6

35
Domains

54
Subdomains

46
IPs

7
Countries

6920 kB
Transfer

9276 kB
Size

37
Cookies

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

  1. http://link.email.empr.com/a/1323/click/68826/2303653/5e8905b1fe7835fc5456362aa89e01246a3159da/6fe7119f58b2152a2ec9475bf11c05168b614aa0&amp HTTP 302
    https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653 Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 39
  • https://sb.scorecardresearch.com/b?c1=2&c2=21948019&ns__t=1569558930130&ns_c=UTF-8&c8=Atezolizumab%20May%20Improve%20Survival%20for%20Some%20With%20Advanced%20Squamous%20NSCLC%20-%20MPR&c7=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&c9= HTTP 302
  • https://sb.scorecardresearch.com/b2?c1=2&c2=21948019&ns__t=1569558930130&ns_c=UTF-8&c8=Atezolizumab%20May%20Improve%20Survival%20for%20Some%20With%20Advanced%20Squamous%20NSCLC%20-%20MPR&c7=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&c9=
Request Chain 56
  • https://www.google-analytics.com/r/collect?v=1&_v=j79&a=503328978&t=pageview&_s=1&dl=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&ul=en-us&de=UTF-8&dt=Atezolizumab%20May%20Improve%20Survival%20for%20Some%20With%20Advanced%20Squamous%20NSCLC%20-%20MPR&sd=24-bit&sr=1600x1200&vp=1585x1200&je=0&_u=aGDAAAAjQ~&jid=1236394914&gjid=1684262429&cid=1601973801.1569558930&tid=UA-1290429-2&_gid=697230513.1569558930&_r=1&gtm=2wg9i15XFK9V6&cd1=124119%3A0&cd2=oncology%2Crespiratory%20and%20thoracic%20cancers&cd3=&cd4=&cd5=post&cd6=&cd7=home&cd8=news&cd9=atezolizumab%20may%20improve%20survival%20for%20some%20with%20advanced%20squamous%20nsclc&cd11=omn&cd12=13&cd14=false&cd15=&cd16=false&cd17=&cd18=0&cd19=&cd31=&cd32=&cd33=&cd34=Brian%20Park%2C%20PharmD&cd35=MPR%20Drug%20News&cd36=&cd37=undefined&cd38=undefined&cd39=undefined&cd40=&cd41=&cd42=&cd43=&cd46=&cd48=&cd50=&cd52=&cd53=home&cd54=&cd55=&cd56=9&cd57=&cd58=&cd62=false&cd63=2019-09-18&cd64=341&cd67=&cd68=undef&cd71=false&cd78=false&cd79=false&cd80=false&cd93=news&cd94=placeholder&z=396987685 HTTP 302
  • https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-1290429-2&cid=1601973801.1569558930&jid=1236394914&_gid=697230513.1569558930&gjid=1684262429&_v=j79&z=396987685 HTTP 302
  • https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1601973801.1569558930&jid=1236394914&_v=j79&z=396987685 HTTP 302
  • https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1601973801.1569558930&jid=1236394914&_v=j79&z=396987685&slf_rd=1&random=4114984652
Request Chain 62
  • https://mt.sitomobile.com/sync/ta?aid=136&sid=hmm&val=12 HTTP 302
  • https://pixel.tapad.com/idsync/ex/push?partner_id=2822&partner_url=https%3A%2F%2Fmt.sitomobile.com%2Fsync%2Ftacb%3Fexid%3D%24%7BTA_DEVICE_ID%7D%26aid%3D136%26sid%3Dhmm%26val%3D12 HTTP 302
  • https://pixel.tapad.com/idsync/ex/push/check?partner_id=2822&partner_url=https%3A%2F%2Fmt.sitomobile.com%2Fsync%2Ftacb%3Fexid%3D%24%7BTA_DEVICE_ID%7D%26aid%3D136%26sid%3Dhmm%26val%3D12 HTTP 302
  • https://mt.sitomobile.com/sync/tacb?exid=3cdeeed0-e0e0-11e9-8dcb-52c7686934ad&aid=136&sid=hmm&val=12 HTTP 302
  • https://sp.sitomobile.com/i?tna=sito&p=mob&e=ue&ue_px=eyJzY2hlbWEiOiJpZ2x1OmNvbS5zbm93cGxvd2FuYWx5dGljcy5zbm93cGxvdy91bnN0cnVjdF9ldmVudC9qc29uc2NoZW1hLzEtMC0wIiwiZGF0YSI6eyJzY2hlbWEiOiJpZ2x1OmNvbS5zaXRvbW9iaWxlLnNub3dwbG93L2Nvb2tpZV9zeW5jL2pzb25zY2hlbWEvMS0wLTAiLCJkYXRhIjp7InBhcnRuZXJJZCI6InRhcGFkIn19fQ%3D%3D&cx=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
Request Chain 69
  • https://tags.bluekai.com/site/20486?limit=0&id=5978151501699125277&redir=https://ml314.com/csync.ashx%3Ffp=$_BK_UUID%26person_id=5978151501699125277%26eid=50056 HTTP 302
  • https://ml314.com/csync.ashx?fp=x2nuvx9999YDyRN5&person_id=5978151501699125277&eid=50056
Request Chain 70
  • https://idsync.rlcdn.com/395886.gif?partner_uid=5978151501699125277 HTTP 307
  • https://idsync.rlcdn.com/1000.gif?memo=CO6UGBIeChoIARCuXxoTNTk3ODE1MTUwMTY5OTEyNTI3NxAAGg0IkqO27AUSBQjoBxAAQgBKAA HTTP 307
  • https://ml314.com/csync.ashx?fp=35740769d112c5d6bd6e7a26462ff0aee2f000220c5a7bde91265996da677d4df4cb09cee1a4f8eb&person_id=5978151501699125277&eid=50082
Request Chain 71
  • https://pixel.mathtag.com/sync/img?redir=https://ml314.com/csync.ashx%3Ffp=[MM_UUID]%26person_id=5978151501699125277%26eid=50220 HTTP 302
  • https://pixel.mathtag.com/sync/img?redir=https://ml314.com/csync.ashx%3Ffp=[MM_UUID]%26person_id=5978151501699125277%26eid=50220&mm_bnc&mm_bct&UUID=ef445d8d-8cf5-4700-a308-9a86ad0111e6 HTTP 302
  • https://ml314.com/csync.ashx?fp=ef445d8d-8cf5-4700-a308-9a86ad0111e6&person_id=5978151501699125277&eid=50220
Request Chain 72
  • https://sync.crwdcntrl.net/map/c=6985/tp=BOMB?https://ml314.com/csync.ashx%3Ffp%3D%24%7Bprofile_id%7D%26eid%3D50146%26person_id%3D5978151501699125277 HTTP 302
  • https://sync.crwdcntrl.net/map/ct=y/c=6985/tp=BOMB?https://ml314.com/csync.ashx%3Ffp%3D%24%7Bprofile_id%7D%26eid%3D50146%26person_id%3D5978151501699125277 HTTP 302
  • https://ml314.com/csync.ashx?fp=90eac7e3b74cfa126cc5d7b163f6f80c&eid=50146&person_id=5978151501699125277
Request Chain 73
  • https://ps.eyeota.net/pixel?pid=r8hrb20&t=gif HTTP 302
  • https://ps.eyeota.net/pixel/bounce/?pid=r8hrb20&t=gif HTTP 302
  • https://ml314.com/utsync.ashx?eid=50052&et=0&fp=2jOsM7JJVaDSQjGrpEUYipXQYcL5CzLDr2nccJu51NCw&gdpr=1&gdpr_consent=&return=https%3A%2F%2Fps.eyeota.net%2Fmatch%3Fbid%3Dr8hrb20%26uid%3Dnil HTTP 302
  • https://ml314.com/csync.ashx?fp=2jOsM7JJVaDSQjGrpEUYipXQYcL5CzLDr2nccJu51NCw&person_id=5978151501699125277&eid=50052&return=https%3a%2f%2fps.eyeota.net%2fmatch%3fbid%3dr8hrb20%26uid%3dnil HTTP 302
  • https://ps.eyeota.net/match?bid=r8hrb20&uid=nil
Request Chain 232
  • https://api-54-203-125-28.b2c.com/api/x?lTqdDOoZhzUwKMFp$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 HTTP 302
  • https://api-54-203-125-28.b2c.com:444/api/4?lTqdDOoZhzUwKMFp
Request Chain 234
  • https://api-54-245-184-141.b2c.com/api/x?nmvGW6zwFAyOY7Gj$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 HTTP 302
  • https://api-54-245-184-141.b2c.com:444/api/4?nmvGW6zwFAyOY7Gj
Request Chain 235
  • https://api-35-166-13-162.b2c.com/api/x?cAdUZQMT5wFwWu5Y$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 HTTP 302
  • https://api-35-166-13-162.b2c.com:444/api/4?cAdUZQMT5wFwWu5Y
Request Chain 236
  • https://api-34-219-221-191.b2c.com/api/x?xX0Lj6s33Hw3Bheo$dXJsJDAkaHR0cHM6Ly93d3cuZW1wci5jb20vaG9tZS9uZXdzL2F0ZXpvbGl6dW1hYi1tYXktaW1wcm92ZS1zdXJ2aXZhbC1mb3Itc29tZS13aXRoLWFkdmFuY2VkLXNxdWFtb3VzLW5zY2xjLz91dG1fc291cmNlPW5ld3NsZXR0ZXImdXRtX21lZGl1bT1lbWFpbCZ1dG1fY2FtcGFpZ249bXByLXNwb3RsaWdodC1oYXktMjAxOTA5MjcmY3BuPXBjcF9tZCxmcF9tZCxwY3BfYWxsLGhhcnZvbml0YmcsZXBjbHVzYWxpc3RiX2phbjIwMTksZXBjbHVzYV9hcHJpbF8yMDE5JmhtU3ViSWQ9JmhtRW1haWw9OHQ4NU9hTW5BdGRzZVlsMUtzSFZXcGVWcDF3MTQ4dGJQY016QXVVY2s1RTEmTklEPTE2MTk5MDk5NzUmY19pZD0mZW1haWxfaGFzaD0xM2ZjZjgwYjgwOTdlZWQxODZlMDdkYjE5ZmQzYzJjNiZkbD0wJm1wd2ViPTEzMjMtNjg4MjYtMjMwMzY1MyIsInJlZmVycmVyJDAkIiwiYW5jZXN0b3JPcmlnaW5zJDAkaHR0cHM6Ly93d3cuZW1wci5jb20iLCJ2aWRlbyQwJDE2MDB4MTIwMHgyNCIsImZyYW1lJDAkMSIsImhpZGRlbiQwJDAiLCJ2aXNpYmlsaXR5U3RhdGUkMCR2aXNpYmxlIiwiaGFzRm9jdXMkMCQwIiwid2luZG93JDAkMzAweDI1MCIsImlubmVyJDAkMzAweDI1MCIsIm91dGVyJDAkMTYwMHgxMjAwIiwibG9jYWxTdG9yYWdlJDAkRXJyb3I6IFR5cGVFcnJvcjogQ2Fubm90IHJlYWQgcHJvcGVydHkgJ3NldEl0ZW0nIG9mIG51bGwiLCJzZXNzaW9uU3RvcmFnZSQwJDEiLCJhcHBDb2RlTmFtZSQwJE1vemlsbGEiLCJhcHBOYW1lJDAkTmV0c2NhcGUiLCJhcHBWZXJzaW9uJDAkNS4wIChNYWNpbnRvc2g7IEludGVsIE1hYyBPUyBYIDEwXzE0XzUpIEFwcGxlV2ViS2l0LzUzNy4zNiAoS0hUTUwsIGxpa2UgR2Vja28pIENocm9tZS83NC4wLjM3MjkuMTY5IFNhZmFyaS81MzcuMzYiLCJjb29raWVFbmFibGVkJDAkdHJ1ZSIsImRvTm90VHJhY2skMCQiLCJoYXJkd2FyZUNvbmN1cnJlbmN5JDAkMTYiLCJsYW5ndWFnZSQwJGVuLVVTIiwicGxhdGZvcm0kMCRMaW51eCB4ODZfNjQiLCJwcm9kdWN0JDAkR2Vja28iLCJwcm9kdWN0U3ViJDAkMjAwMzAxMDciLCJzZW5kQmVhY29uJDAkMSIsInVzZXJBZ2VudCQwJE1vemlsbGEvNS4wIChNYWNpbnRvc2g7IEludGVsIE1hYyBPUyBYIDEwXzE0XzUpIEFwcGxlV2ViS2l0LzUzNy4zNiAoS0hUTUwsIGxpa2UgR2Vja28pIENocm9tZS83NC4wLjM3MjkuMTY5IFNhZmFyaS81MzcuMzYiLCJ2ZW5kb3IkMCRHb29nbGUgSW5jLiIsInZlbmRvclN1YiQwJCIsImZvbnRyZW5kZXIkMSQxIiwid2ViZ2wkMiRuL2EiLCJ3ZWJnbDIkMiQwIiwidGltZSQyJDE1Njk1NTg5MzMxMzYiLCJ0aW1lem9uZSQyJC0xMjAiLCJwbHVnaW5zJDIkTm9uZSIsIm1lbS10b3RhbEpTSGVhcFNpemUkMiQ0Mi4wOTc2MzUiLCJtZW0tdXNlZEpTSGVhcFNpemUkMiQzNC41Mjk3NzkiLCJtZW0tanNIZWFwU2l6ZUxpbWl0JDIkNDM0NS4yOTg5NDQiLCJuYXZpZ2F0aW9uLXJlZGlyZWN0Q291bnQkMiQwIiwibmF2aWdhdGlvbi10eXBlJDIkbmF2aWdhdGUiLCJnbG9iYWxzLXRpbWUkNSQwLjQzIiwiZ2xvYmFscyQ1JDFiZjlhOWZiIiwiZG9jdW1lbnQtdGltZSQ3JDAuNjA1IiwiZG9jdW1lbnQkOCQ4YmI3MWFkMiIsImNvbm5lY3Rpb24kOCQiLCJkb3dubGlua01heCQ4JCIsImdldFVzZXJNZWRpYSQ4JDIiLCJjbG9jayQxMSQ0NTUwIiwiYmF0dGVyeSQxNCQxIDEgMCBJbmZpbml0eSIsImludGVyc2VjdGlvbi1zaXplJDUxJDE1ODV4MTIwMCIsImludGVyc2VjdGlvbi1lbnRlciQ1MSQwLjV4MCAzMDB4MCIsImludGVyc2VjdGlvbiQ1MSQxMDAiLCJhdWRpb2NvbnRleHQkNTEkZGM2NmE2MjgiLCJzb3J0JDc1JDEwLjg2NSIsImZyYW1lcmF0ZSQxMjUkNzA HTTP 302
  • https://api-34-219-221-191.b2c.com:444/api/4?xX0Lj6s33Hw3Bheo

238 HTTP transactions

Resource
Path
Size
x-fer
Type
MIME-Type
Primary Request /
www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/
Redirect Chain
  • http://link.email.empr.com/a/1323/click/68826/2303653/5e8905b1fe7835fc5456362aa89e01246a3159da/6fe7119f58b2152a2ec9475bf11c05168b614aa0&amp
  • https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_...
103 KB
23 KB
Document
General
Full URL
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
34.225.50.222 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-225-50-222.compute-1.amazonaws.com
Software
nginx /
Resource Hash
3831ce65c84a69356a031077168510933920dd685df14ca4b8c14e9579b54afc

Request headers

:method
GET
:authority
www.empr.com
:scheme
https
:path
/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
none
accept-encoding
gzip, deflate, br
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
200
server
nginx
date
Fri, 27 Sep 2019 04:35:29 GMT
content-type
text/html; charset=UTF-8
vary
Accept-Encoding Accept-Encoding Accept-Encoding,Cookie,X-WPENGINE-SEGMENT
x-distributor
yes
x-pingback
https://www.empr.com/xmlrpc.php
link
<https://www.empr.com/wp-json/>; rel="https://api.w.org/" <https://www.empr.com/?p=124119>; rel=shortlink
x-cacheable
SHORT
cache-control
max-age=600, must-revalidate
x-cache
MISS
x-pass-why
x-cache-group
normal
x-wpengine-segment
NONHT
content-encoding
gzip

Redirect headers

Content-Type
text/html; charset=utf-8
Transfer-Encoding
chunked
Connection
keep-alive
Status
302 Found
Cache-Control
no-cache
X-XSS-Protection
1; mode=block
X-Request-Id
db651e52-40e2-488e-ab14-bb6dd34928ce
Location
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
X-Runtime
0.037767
X-Frame-Options
SAMEORIGIN
X-Content-Type-Options
nosniff
Date
Fri, 27 Sep 2019 04:35:29 GMT
Set-Cookie
_session_id=62ca90176378a9b541100fe2d593108e; path=/; expires=Fri, 27 Sep 2019 16:35:29 -0000; HttpOnly
X-Powered-By
Phusion Passenger 5.3.4
Server
nginx/1.14.0 + Phusion Passenger 5.3.4
style.min.css
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/css/dist/block-library/
29 KB
5 KB
Stylesheet
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/css/dist/block-library/style.min.css?ver=5.2.3
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
4b8fe5c3d0e5ef7a6582185cbf5c535b5d369c8df1da98c03ed69833e55f474d

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:29 GMT
content-encoding
gzip
last-modified
Mon, 22 Apr 2019 12:40:04 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5cbdb624-726f"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=31536000
shared-style.min.css
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/
48 KB
7 KB
Stylesheet
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/shared-style.min.css?ver=1553589230
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
33fe4fe8214760f15a5fdd753b5c396ee5b916e5d6f66f79d4765ed260706723

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:29 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5c99e3ee-c05a"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=31536000
style.min.css
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/
240 KB
32 KB
Stylesheet
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/style.min.css?ver=1567085297
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
f1e3884dae2f0ddd32795c0c1ac83e9f9a8c7dce35dbd784bdc3c9872196bb1c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:29 GMT
content-encoding
gzip
last-modified
Thu, 29 Aug 2019 13:28:17 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d67d2f1-3bfb4"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=31536000
css
fonts.googleapis.com/
8 KB
1 KB
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i|Roboto+Slab:400,400i,700,700i
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:817::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
ESF /
Resource Hash
bb4c48e63332f312f4d1945747e9e319247d26592eec54e38fe75eff833eb130
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
br
last-modified
Fri, 27 Sep 2019 04:35:29 GMT
server
ESF
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
status
200
date
Fri, 27 Sep 2019 04:35:29 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
x-xss-protection
0
expires
Fri, 27 Sep 2019 04:35:29 GMT
lytics.min.css
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/
39 KB
3 KB
Stylesheet
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/lytics.min.css?ver=1567085297
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
6944e75951f2e7bf00121eea502e7d952a833e811e13a1f28fb077df6af721f3

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:29 GMT
content-encoding
gzip
last-modified
Thu, 29 Aug 2019 13:28:17 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d67d2f1-9de9"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=31536000
css
fonts.googleapis.com/
825 B
409 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Bree+Serif&ver=0.1.1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:817::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
ESF /
Resource Hash
19aa6c614f72f6bb67cb17a6169ca551686c2bab5475293c95880f5f32cd830e
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
br
last-modified
Fri, 27 Sep 2019 04:35:29 GMT
server
ESF
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
status
200
date
Fri, 27 Sep 2019 04:35:29 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
x-xss-protection
0
expires
Fri, 27 Sep 2019 04:35:29 GMT
autosuggest.min.css
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/elasticpress/dist/css/
766 B
581 B
Stylesheet
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/elasticpress/dist/css/autosuggest.min.css?ver=3.1.4
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
8689484e31c0c85e3e074f0b59348974f5de4b2eec412e388e2ea32924a41478

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:29 GMT
content-encoding
gzip
last-modified
Wed, 10 Jul 2019 08:59:26 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d25a8ee-2fe"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=31536000
jquery.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/jquery/
95 KB
34 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/jquery/jquery.js?ver=1.12.4-wp
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
1db21d816296e6939ba1f42962496e4134ae2b0081e26970864c40c6d02bb1df

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:29 GMT
content-encoding
gzip
last-modified
Fri, 17 May 2019 17:08:53 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5cdeeaa5-17a69"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
jquery-migrate.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/jquery/
10 KB
4 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/jquery/jquery-migrate.min.js?ver=1.4.1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
48eb8b500ae6a38617b5738d2b3faec481922a7782246e31d2755c034a45cd5d

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:29 GMT
content-encoding
gzip
last-modified
Fri, 20 May 2016 06:11:28 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"573eaa90-2748"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
cookie.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/mu-plugins/cookie-controller/js/
2 KB
1 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/mu-plugins/cookie-controller/js/cookie.min.js?ver=1.2
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
e828282e92509efc0f7bc57888382c5816bd403e0abbb685eda5c4372cc7daa5

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:29 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5c99e3ee-834"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
cc.js
tags.crwdcntrl.net/c/14413/
39 KB
11 KB
Script
General
Full URL
https://tags.crwdcntrl.net/c/14413/cc.js?ver=1.4&ns=_cc14413
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
93.184.220.113 London, United Kingdom, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
ECS (lcy/1D5D) /
Resource Hash
207775987f53f3b91160546806345706ec562f294cb076637004e36d81ef221b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:29 GMT
content-encoding
gzip
last-modified
Thu, 12 Sep 2019 01:01:17 GMT
server
ECS (lcy/1D5D)
etag
"5d7998dd-9b68+gzip"
vary
Accept-Encoding
x-cache
HIT
content-type
application/javascript
status
200
cache-control
max-age=86400
content-length
11493
expires
Sat, 28 Sep 2019 04:35:29 GMT
digest.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/hm-npi-manager/js/
16 KB
5 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/hm-npi-manager/js/digest.min.js?ver=2.1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
b3c617e4ee00489d6fb85a53bd88cb1e1f5e71ae5244c54a7fea6b6e7d9921ad

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:29 GMT
content-encoding
gzip
last-modified
Wed, 22 May 2019 09:37:40 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5ce51864-3fc1"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
UtilityMove-custom.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/vendor/
2 KB
1 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/vendor/UtilityMove-custom.min.js?ver=1553589230
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
cffef365e4b53f1a6e9d33a7d42c0d1542b573360f774069589240f75f0e84f1

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:29 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5c99e3ee-751"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
polyfill.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/js/frontend/
102 KB
35 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/js/frontend/polyfill.min.js?ver=1553589230
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
59173f786dd1f3802f7ab26fd339aac4099dc10c6cb54a6a92213e6af277592a

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:29 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5c99e3ee-19873"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
gpt.js
www.googletagservices.com/tag/js/
44 KB
14 KB
Script
General
Full URL
https://www.googletagservices.com/tag/js/gpt.js
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:816::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
ce647423705101407941c5ea90afc23dff9181046d16b62b2b1433d048144bfa
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:29 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"291 / 37 of 1000 / last-modified: 1569527018"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
14238
x-xss-protection
0
expires
Fri, 27 Sep 2019 04:35:29 GMT
adtracking.js
s3.amazonaws.com/haymarket-adtracking-js/prod/
19 KB
19 KB
Script
General
Full URL
https://s3.amazonaws.com/haymarket-adtracking-js/prod/adtracking.js
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.216.161.101 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
s3-1.amazonaws.com
Software
AmazonS3 /
Resource Hash
822847109c3aaf484affe599900514bcf4167ceda17fcca7a97b691d780dae25

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:35:31 GMT
Last-Modified
Tue, 15 Jan 2019 22:54:19 GMT
Server
AmazonS3
x-amz-request-id
15556560EE184C22
ETag
"dc289fc811d6d3a62b068bfcda1f8f30"
Content-Type
application/javascript
x-amz-version-id
MlU6AsBGwcOjZYgQIgNYntESpQyo9BbN
Accept-Ranges
bytes
Content-Length
19158
x-amz-id-2
4Hj2YnJ2moh4mgC4Por29TjebkTd3Sfm0OXYfL1PYnizxU/0pUJthEitwsWDE1Ss1SqgvRa9kWo=
head.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/
44 KB
13 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/head.min.js?ver=1569414182
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
3463d937369067ba4b7700dd056500a6d9d28fed29addce4e3bce87a0970a348

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:29 GMT
content-encoding
gzip
last-modified
Wed, 25 Sep 2019 12:23:02 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d8b5c26-aebf"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
MPR-logo_website.png
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2018/12/
16 KB
16 KB
Image
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2018/12/MPR-logo_website.png
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
9c9401c3de840fa118289641c41b6125ca5825612d110a20584d2ba32036a1cf
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:29 GMT
etag
"452a9f099947d43a38734d72a92e9193"
last-modified
Wed, 20 Mar 2019 21:55:07 GMT
server
NetDNA-cache/2.2
x-amz-server-side-encryption
AES256
x-frame-options
SAMEORIGIN
x-cache
HIT
content-type
image/png
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
16492
expires
Sat, 19 Oct 2019 17:46:01 GMT
gtm.js
www.googletagmanager.com/
139 KB
35 KB
Script
General
Full URL
https://www.googletagmanager.com/gtm.js?id=GTM-5XFK9V6
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:814::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
b92a2e8779df445c71f7253608ef7526db31a5cfda1130a0df33c5e2f554f344
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:30 GMT
content-encoding
br
last-modified
Fri, 27 Sep 2019 03:00:00 GMT
server
Google Tag Manager
access-control-allow-headers
Cache-Control
status
200
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
http://www.googletagmanager.com
cache-control
private, max-age=900
access-control-allow-credentials
true
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
35074
x-xss-protection
0
expires
Fri, 27 Sep 2019 04:35:30 GMT
Park_Brian-150x150.jpg
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2019/05/
15 KB
15 KB
Image
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2019/05/Park_Brian-150x150.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
de709acbe98dba4f2f3fc3204a09a5add553a366b33501d54f78b5f263775785
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:30 GMT
etag
"5c39283ae49b2ce7914cb7d8d198c8a8"
last-modified
Tue, 20 Aug 2019 07:11:14 GMT
server
NetDNA-cache/2.2
x-amz-server-side-encryption
AES256
x-frame-options
SAMEORIGIN
x-cache
HIT
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
14921
expires
Sun, 20 Oct 2019 05:03:02 GMT
NSCLC.jpg
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2019/09/
83 KB
84 KB
Image
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2019/09/NSCLC.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
138ea615cc7a69000251588011c04ded37150346b21476ad46c16913b9bba80c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:30 GMT
last-modified
Wed, 18 Sep 2019 20:23:53 GMT
server
NetDNA-cache/2.2
status
200
etag
"5d829259-14cca"
vary
Accept-Encoding
x-cache
MISS
content-type
image/jpeg
access-control-allow-origin
*
cache-control
max-age=2592000, public, max-age=31536000
accept-ranges
bytes
content-length
85194
expires
Sun, 27 Oct 2019 04:35:30 GMT
300x100mprsub-300x105.gif
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2019/01/
13 KB
14 KB
Image
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2019/01/300x100mprsub-300x105.gif
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
f0341fe392815f4fedec6d94398334b176ce2fb0eafebc391a82afcb3cc5fef0
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:30 GMT
etag
"fb86d90a5bcf340b8bd64802ec39a7a5"
last-modified
Wed, 20 Mar 2019 09:05:43 GMT
server
NetDNA-cache/2.2
x-amz-server-side-encryption
AES256
x-frame-options
SAMEORIGIN
x-cache
HIT
content-type
image/gif
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
13667
expires
Sat, 19 Oct 2019 17:46:23 GMT
spinner.svg
www.empr.com/wp-content/themes/haymarket/assets/svg/src/
694 B
631 B
Image
General
Full URL
https://www.empr.com/wp-content/themes/haymarket/assets/svg/src/spinner.svg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
34.225.50.222 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-225-50-222.compute-1.amazonaws.com
Software
nginx /
Resource Hash
abb1dd7905b3797711e15609800d43cabead4c0358dc0030a1932a20e82a37d7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:30 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
nginx
status
200
etag
W/"5c99e3ee-2b6"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
image/svg+xml
access-control-allow-origin
*
cache-control
public, max-age=31536000
96ac8580a54c3864c4ba15ff4a38efdcb7084985-v2.js
content.maropost.com/uploads/1323/websites/5/
3 KB
3 KB
Script
General
Full URL
https://content.maropost.com/uploads/1323/websites/5/96ac8580a54c3864c4ba15ff4a38efdcb7084985-v2.js?ver=1.1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:20bb:7a00:1b:fadc:b780:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
3b8eec5229515f9e95a68b635aba1d27d7d91f2e1b726302c53124fe18cefd20

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 23 Sep 2019 19:08:41 GMT
via
1.1 a84a4d90dd581e1a1c18e1bf5992b931.cloudfront.net (CloudFront)
last-modified
Thu, 27 Sep 2018 21:48:02 GMT
server
AmazonS3
age
31218
etag
"ff4375eccda3ca6bc54ed96c5d77d9bb"
x-cache
Hit from cloudfront
status
200
x-amz-cf-pop
FRA56
accept-ranges
bytes
content-length
2622
x-amz-cf-id
Q4oTbSU8wrYcSVVaIeNX2ceD0W5g77XVSCPKJ5BHgwlsJ-uD5_s9gg==
blocks.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/
7 KB
3 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/blocks.min.js?ver=1567085297
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
3ed3de3fd0fabc795d8b96ada205998944ff3157366f20b70d5d10b099b63120

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:29 GMT
content-encoding
gzip
last-modified
Thu, 29 Aug 2019 13:28:17 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d67d2f1-1b42"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
local-storage-lib.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/hm-npi-manager/js/
1 KB
918 B
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/hm-npi-manager/js/local-storage-lib.js?ver=2.1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
693d39f8b27d78f2a570672b862512cb8e3dee72e8f641cf95ada2d81bac720b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:30 GMT
content-encoding
gzip
last-modified
Wed, 17 Jul 2019 13:03:16 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d2f1c94-591"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
npi-manager.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/hm-npi-manager/js/
3 KB
1 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/hm-npi-manager/js/npi-manager.js?ver=2.1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
43a5ba666207ae3718ce7fe6b4015c58043b4ac4dfdacae285d5d8574d80fdf6

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:30 GMT
content-encoding
gzip
last-modified
Thu, 29 Aug 2019 13:28:17 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d67d2f1-b3b"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
hmi-registration-ui.manifest.js
s3.amazonaws.com/haymarket-reg-js/develop/production/
799 B
1 KB
Script
General
Full URL
https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.manifest.js?ver=0.1.1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.216.161.101 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
s3-1.amazonaws.com
Software
AmazonS3 /
Resource Hash
4d3e9dbf75d761b4fc344b3be601971eb517ce533c7ce46e093539e03349616e

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:35:31 GMT
Last-Modified
Thu, 29 Aug 2019 20:10:10 GMT
Server
AmazonS3
x-amz-request-id
A706855035B2B30E
ETag
"6878a8fbe72bde4a3f8ecf5b16523972"
Content-Type
application/javascript
x-amz-version-id
csLBKnYjTffo31CifRF6x383B2E_amuJ
Accept-Ranges
bytes
Content-Length
799
x-amz-id-2
z2AQlOUcrt0AUslydC/jrmogwnP86zkUqtrBZ1SqJmbU68p1OSJJENkBHADDBcIrbaj4J4Euk5U=
hmi-registration-ui.vendor.js
s3.amazonaws.com/haymarket-reg-js/develop/production/
357 KB
357 KB
Script
General
Full URL
https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.vendor.js?ver=0.1.1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.216.161.101 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
s3-1.amazonaws.com
Software
AmazonS3 /
Resource Hash
2673f6b0416b9a9f7488ee96f384f5badfa04acb14499c92ae52e394b7572f1f

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:35:31 GMT
Last-Modified
Thu, 29 Aug 2019 20:10:10 GMT
Server
AmazonS3
x-amz-request-id
C72EB9FD4A34452A
ETag
"dfdfd93abc9eec4ff346a12a61df7c41"
Content-Type
application/javascript
x-amz-version-id
6ACuZZ4Fakkhaw3IL9mD952B0XZGZK4Q
Accept-Ranges
bytes
Content-Length
365119
x-amz-id-2
yk7PvW2vgBEfcPh439G1xq0LkRcREQo3C+kDNw7/9JgKh1Mlm15Lm4M+6z9zJMWcRdbMYun023c=
hmi-registration-ui.bundle.js
s3.amazonaws.com/haymarket-reg-js/develop/production/
1 MB
1 MB
Script
General
Full URL
https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.bundle.js?ver=0.1.1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.216.161.101 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
s3-1.amazonaws.com
Software
AmazonS3 /
Resource Hash
4eef9cbbcb01ac2538e54c45514c0560e686abf17070adfba489fd1b3b86455a

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:35:31 GMT
Last-Modified
Thu, 29 Aug 2019 20:10:10 GMT
Server
AmazonS3
x-amz-request-id
9B91E22D75EFD6DC
ETag
"8f47379688c3f5980d42b891fcaea0eb"
Content-Type
application/javascript
x-amz-version-id
1g9qbXhjK6v_p1EyiVTzg_c7stFBXUFD
Accept-Ranges
bytes
Content-Length
1225121
x-amz-id-2
CvEtZoLvOrjZ+TjKrGOuC8/Gzl+F6XinMCZyCHgrDUR0pI17+LWASYeoC1+/J2PilWdO/7R56Z0=
autosuggest.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/elasticpress/dist/js/
17 KB
5 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/elasticpress/dist/js/autosuggest.min.js?ver=3.1.4
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
6258dbe6dbce7a7de872ad56d9ceea8354f5d37626e66201ec29b2717a95e949

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:30 GMT
content-encoding
gzip
last-modified
Thu, 12 Sep 2019 09:51:52 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d7a1538-4361"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
frontend.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/
147 KB
39 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1568281912
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
be6beaacd90961241ca111e54c0953bc476a844a264e5afade4792a75c78c540

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:30 GMT
content-encoding
gzip
last-modified
Thu, 12 Sep 2019 09:51:52 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d7a1538-24c66"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
iab.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/
8 KB
2 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1567085297
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
6463301e10c71f76fc14bb977dfa9097b5633ed4a3ee4119abccf2ead9aa9e29

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:30 GMT
content-encoding
gzip
last-modified
Thu, 29 Aug 2019 13:28:17 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d67d2f1-1ecd"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
wp-embed.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/
1 KB
1004 B
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/wp-embed.min.js?ver=5.2.3
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
2152557cac69e2bd7d6debef5037a9f554f9209cc305b8141b3329acb10c42b7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:30 GMT
content-encoding
gzip
last-modified
Thu, 30 Aug 2018 12:40:26 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5b87e5ba-57b"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
integrator.js
adservice.google.de/adsid/
109 B
594 B
Script
General
Full URL
https://adservice.google.de/adsid/integrator.js?domain=www.empr.com
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:816::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 27 Sep 2019 04:35:30 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status
200
cache-control
private, no-cache, no-store
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
104
x-xss-protection
0
integrator.js
adservice.google.com/adsid/
109 B
594 B
Script
General
Full URL
https://adservice.google.com/adsid/integrator.js?domain=www.empr.com
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:816::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 27 Sep 2019 04:35:30 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status
200
cache-control
private, no-cache, no-store
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
104
x-xss-protection
0
pubads_impl_2019091901.js
securepubads.g.doubleclick.net/gpt/
156 KB
58 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019091901.js
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.162 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s11-in-f2.1e100.net
Software
sffe /
Resource Hash
c77635c1d346c5471d294f59d0c4ef11f71c21f94e82087cbd99984c9aaa3cda
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:30 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Thu, 19 Sep 2019 13:07:51 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
58568
x-xss-protection
0
expires
Fri, 27 Sep 2019 04:35:30 GMT
7341.js
script.crazyegg.com/pages/scripts/0034/
88 KB
29 KB
Script
General
Full URL
https://script.crazyegg.com/pages/scripts/0034/7341.js?435988
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5XFK9V6
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6813:9408 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
8617f3b621a7fe14ab36ef607fda9909163c458e72f24f0836fb0158a5e31f83

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:30 GMT
via
1.1 04ce5a607a98db6d08257633417b84d7.cloudfront.net (CloudFront)
cf-cache-status
HIT
age
2201
cf-polished
origSize=89761
x-cache
Hit from cloudfront
status
200
content-encoding
gzip
last-modified
Wed, 25 Sep 2019 17:06:18 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/x-javascript
cache-control
private, max-age=300
x-amz-cf-pop
FRA2-C2
cf-ray
51cac5732854cbb0-VIE
x-amz-cf-id
bgSABxQQehjngADKxBsDyOjIDQya34o6WaHTLGcNWBLISn9j59kvLw==
cf-bgj
minify
analytics.js
www.google-analytics.com/
43 KB
18 KB
Script
General
Full URL
https://www.google-analytics.com/analytics.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5XFK9V6
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
dbb67c620eaabf6679a314db18d3ae43037aef71ab27422e6feec08ee987cc0a
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=10886400; includeSubDomains; preload
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Mon, 19 Aug 2019 17:22:41 GMT
server
Golfe2
age
572
date
Fri, 27 Sep 2019 04:25:58 GMT
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
public, max-age=7200
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
17803
expires
Fri, 27 Sep 2019 06:25:58 GMT
b2
sb.scorecardresearch.com/
Redirect Chain
  • https://sb.scorecardresearch.com/b?c1=2&c2=21948019&ns__t=1569558930130&ns_c=UTF-8&c8=Atezolizumab%20May%20Improve%20Survival%20for%20Some%20With%20Advanced%20Squamous%20NSCLC%20-%20MPR&c7=https%3A...
  • https://sb.scorecardresearch.com/b2?c1=2&c2=21948019&ns__t=1569558930130&ns_c=UTF-8&c8=Atezolizumab%20May%20Improve%20Survival%20for%20Some%20With%20Advanced%20Squamous%20NSCLC%20-%20MPR&c7=https%3...
0
248 B
Image
General
Full URL
https://sb.scorecardresearch.com/b2?c1=2&c2=21948019&ns__t=1569558930130&ns_c=UTF-8&c8=Atezolizumab%20May%20Improve%20Survival%20for%20Some%20With%20Advanced%20Squamous%20NSCLC%20-%20MPR&c7=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&c9=
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.19.43.224 , Ascension Island, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a2-19-43-224.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 27 Sep 2019 04:35:30 GMT
Cache-Control
private, no-cache, no-cache=Set-Cookie, no-store, proxy-revalidate
Connection
keep-alive
Content-Length
0
Expires
Mon, 01 Jan 1990 00:00:00 GMT

Redirect headers

Location
https://sb.scorecardresearch.com/b2?c1=2&c2=21948019&ns__t=1569558930130&ns_c=UTF-8&c8=Atezolizumab%20May%20Improve%20Survival%20for%20Some%20With%20Advanced%20Squamous%20NSCLC%20-%20MPR&c7=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&c9=
Pragma
no-cache
Date
Fri, 27 Sep 2019 04:35:30 GMT
Cache-Control
private, no-cache, no-cache=Set-Cookie, no-store, proxy-revalidate
Connection
keep-alive
Content-Length
0
Expires
Mon, 01 Jan 1990 00:00:00 GMT
src.svg
www.empr.com/wp-content/themes/haymarket/assets/svg/
33 KB
10 KB
Other
General
Full URL
https://www.empr.com/wp-content/themes/haymarket/assets/svg/src.svg?ver=1553589230
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
34.225.50.222 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-225-50-222.compute-1.amazonaws.com
Software
nginx /
Resource Hash
866e74600600f8647c979414828f3538d646101dc8504de84c2ed00e30460811

Request headers

Sec-Fetch-Mode
same-origin
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:30 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
nginx
status
200
etag
W/"5c99e3ee-8317"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
image/svg+xml
access-control-allow-origin
*
cache-control
public, max-age=31536000
S6uyw4BMUTPHjx4wXiWtFCc.woff2
fonts.gstatic.com/s/lato/v16/
14 KB
14 KB
Font
General
Full URL
https://fonts.gstatic.com/s/lato/v16/S6uyw4BMUTPHjx4wXiWtFCc.woff2
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
036d841b132c14046e26d8f2da1bc634c6ad34885ed1295660694a91c98933a6
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i|Roboto+Slab:400,400i,700,700i
Origin
https://www.empr.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 13:36:09 GMT
x-content-type-options
nosniff
last-modified
Tue, 23 Jul 2019 03:45:55 GMT
server
sffe
age
2732361
status
200
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
14044
x-xss-protection
0
expires
Tue, 25 Aug 2020 13:36:09 GMT
chevron-right-white.svg
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/svg/src/
190 B
400 B
Image
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/svg/src/chevron-right-white.svg
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/vendor/UtilityMove-custom.min.js?ver=1553589230
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
8e0da2e2d764c1a202d33dd39287784df8ac6bc20c7401ea14f2d62001292856

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/style.min.css?ver=1567085297
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:30 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5c99e3ee-be"
vary
Accept-Encoding
x-cache
HIT
content-type
image/svg+xml
access-control-allow-origin
*
cache-control
public, max-age=31536000
BngRUXZYTXPIvIBgJJSb6u92w7CGwR2oefDo.woff2
fonts.gstatic.com/s/robotoslab/v9/
11 KB
11 KB
Font
General
Full URL
https://fonts.gstatic.com/s/robotoslab/v9/BngRUXZYTXPIvIBgJJSb6u92w7CGwR2oefDo.woff2
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/vendor/UtilityMove-custom.min.js?ver=1553589230
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
4901c9453014d8e210b2f62189f68c2d7964543517e1fc8447924de7d542058a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i|Roboto+Slab:400,400i,700,700i
Origin
https://www.empr.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 13:27:01 GMT
x-content-type-options
nosniff
last-modified
Mon, 22 Jul 2019 19:27:03 GMT
server
sffe
age
2732909
status
200
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
11388
x-xss-protection
0
expires
Tue, 25 Aug 2020 13:27:01 GMT
BngMUXZYTXPIvIBgJJSb6ufN5qWr4xCC.woff2
fonts.gstatic.com/s/robotoslab/v9/
11 KB
11 KB
Font
General
Full URL
https://fonts.gstatic.com/s/robotoslab/v9/BngMUXZYTXPIvIBgJJSb6ufN5qWr4xCC.woff2
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/vendor/UtilityMove-custom.min.js?ver=1553589230
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
c68d891f07355e5d0807b4a4f18ac8f16f6e9088277be3134c7efa570022ab2d
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i|Roboto+Slab:400,400i,700,700i
Origin
https://www.empr.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 02 Sep 2019 15:53:22 GMT
x-content-type-options
nosniff
last-modified
Mon, 22 Jul 2019 19:19:23 GMT
server
sffe
age
2119328
status
200
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
11272
x-xss-protection
0
expires
Tue, 01 Sep 2020 15:53:22 GMT
S6u9w4BMUTPHh6UVSwiPGQ3q5d0.woff2
fonts.gstatic.com/s/lato/v16/
14 KB
14 KB
Font
General
Full URL
https://fonts.gstatic.com/s/lato/v16/S6u9w4BMUTPHh6UVSwiPGQ3q5d0.woff2
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
9baad10e85c5be8d5697086479983b6b477197103bf8f0f11817b1bdfb9a7451
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i|Roboto+Slab:400,400i,700,700i
Origin
https://www.empr.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Wed, 21 Aug 2019 21:19:20 GMT
x-content-type-options
nosniff
last-modified
Tue, 23 Jul 2019 03:45:54 GMT
server
sffe
age
3136570
status
200
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
14176
x-xss-protection
0
expires
Thu, 20 Aug 2020 21:19:20 GMT
js
www.google-analytics.com/gtm/
56 KB
21 KB
Script
General
Full URL
https://www.google-analytics.com/gtm/js?id=GTM-T8P2ZZ9&t=gtm1&cid=1601973801.1569558930
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
2b9d553068a82437949fb7f332ecf746c87fb1a8abedf7dc231a6026030f5c38
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:30 GMT
content-encoding
br
last-modified
Fri, 27 Sep 2019 03:00:00 GMT
server
Google Tag Manager
access-control-allow-headers
Cache-Control
status
200
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
http://www.googletagmanager.com
cache-control
private, max-age=900
access-control-allow-credentials
true
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
21298
x-xss-protection
0
expires
Fri, 27 Sep 2019 04:35:30 GMT
96ac8580a54c3864c4ba15ff4a38efdcb7084985.js
mpct1.maropost.com/accounts/1323/websites/5/track/
4 KB
3 KB
Script
General
Full URL
https://mpct1.maropost.com/accounts/1323/websites/5/track/96ac8580a54c3864c4ba15ff4a38efdcb7084985.js?contact_id=2303653&campaign_id=68826&title=Atezolizumab%20May%20Improve%20Survival%20for%20Some%20With%20Advanced%20Squamous%20NSCLC%20-%20MPR&url=https%3A%2F%2Fempr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F&parent_url=&version=2&&&&funnel[0][name]=&funnel[0][status]=started&funnel[0][time_out]=40&
Requested by
Host: content.maropost.com
URL: https://content.maropost.com/uploads/1323/websites/5/96ac8580a54c3864c4ba15ff4a38efdcb7084985-v2.js?ver=1.1
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.238.92.4 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
4.92.238.35.bc.googleusercontent.com
Software
nginx/1.14.0 + Phusion Passenger 5.3.4 / Phusion Passenger 5.3.4
Resource Hash
b98f9a9b49eef5d104e6d3d91907fa226b8b04b7d60364e6a32fbecf50bfaceb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:35:30 GMT
Content-Encoding
gzip
X-Content-Type-Options
nosniff
X-Powered-By
Phusion Passenger 5.3.4
Transfer-Encoding
chunked
Status
200 OK
Connection
keep-alive
Vary
Accept-Encoding
X-XSS-Protection
1; mode=block
X-Request-Id
d213f356-3ec2-4c27-a9d4-3a3d27179cb7
X-Runtime
0.035735
Server
nginx/1.14.0 + Phusion Passenger 5.3.4
ETag
W/"5210d94975ce464a0f90cf71e28fb267"
X-Frame-Options
SAMEORIGIN
Content-Type
text/javascript; charset=utf-8
Cache-Control
max-age=0, private, must-revalidate
lio.js
c.lytics.io/api/tag/43bffbce6f25564c8e2145a11836ff9f/
45 KB
11 KB
Script
General
Full URL
https://c.lytics.io/api/tag/43bffbce6f25564c8e2145a11836ff9f/lio.js
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1568281912
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
803e3ba42413340bcc0c185e1b5f40bfcc115ed3a52832ffcdf7827cbf239be0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

cf-ray
51cac5739de759b2-VIE
date
Fri, 27 Sep 2019 04:35:30 GMT
via
1.1 google
cf-cache-status
HIT
server
cloudflare
age
102
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=7200
content-encoding
br
expires
Fri, 27 Sep 2019 06:35:30 GMT
most-widget
www.empr.com/wp-json/haymarket/v1/
4 KB
2 KB
XHR
General
Full URL
https://www.empr.com/wp-json/haymarket/v1/most-widget?id=most-5
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1568281912
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
34.225.50.222 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-225-50-222.compute-1.amazonaws.com
Software
nginx /
Resource Hash
169b598c2a86576823e1068924ba6325c973d3250c9464ff3ea0e0fcbd73cf01
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:30 GMT
content-encoding
gzip
x-content-type-options
nosniff
x-cacheable
SHORT
x-cache
HIT: 8
status
200
x-wpengine-segment
NONHT
x-cache-group
normal
access-control-allow-headers
Authorization, Content-Type
allow
GET
server
nginx
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding,Cookie
content-type
application/json; charset=UTF-8
access-control-expose-headers
X-WP-Total, X-WP-TotalPages
cache-control
max-age=600, must-revalidate
x-distributor
yes
x-robots-tag
noindex
link
<https://www.empr.com/wp-json/>; rel="https://api.w.org/"
x-pass-why
124119
www.empr.com/wp-json/haymarket/v1/infinite-scroll/
11 KB
3 KB
XHR
General
Full URL
https://www.empr.com/wp-json/haymarket/v1/infinite-scroll/124119
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1568281912
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
34.225.50.222 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-225-50-222.compute-1.amazonaws.com
Software
nginx /
Resource Hash
15153958bd4482bc5c553cf705694509d008fe238f00bb1a92a347d4dabbadc5
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:30 GMT
content-encoding
gzip
x-content-type-options
nosniff
x-cacheable
SHORT
x-cache
MISS
status
200
x-wpengine-segment
NONHT
x-cache-group
normal
access-control-allow-headers
Authorization, Content-Type
allow
GET
server
nginx
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding,Cookie
content-type
application/json; charset=UTF-8
access-control-expose-headers
X-WP-Total, X-WP-TotalPages
cache-control
max-age=600, must-revalidate
x-distributor
yes
x-robots-tag
noindex
link
<https://www.empr.com/wp-json/>; rel="https://api.w.org/"
x-pass-why
partial-login
www.empr.com/wp-json/haymarket/v1/
634 B
839 B
XHR
General
Full URL
https://www.empr.com/wp-json/haymarket/v1/partial-login?subid=&subemail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1568281912
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
34.225.50.222 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-225-50-222.compute-1.amazonaws.com
Software
nginx /
Resource Hash
ad16911f49d3e72d789bfe438841576129e86d69f42bcaddf489d3523ed69951
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:30 GMT
content-encoding
gzip
x-content-type-options
nosniff
x-cacheable
SHORT
x-cache
HIT: 1
status
200
x-wpengine-segment
NONHT
x-cache-group
normal
access-control-allow-headers
Authorization, Content-Type
allow
GET
server
nginx
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding,Cookie
content-type
application/json; charset=UTF-8
access-control-expose-headers
X-WP-Total, X-WP-TotalPages
cache-control
max-age=600, must-revalidate
x-distributor
yes
x-robots-tag
noindex
link
<https://www.empr.com/wp-json/>; rel="https://api.w.org/"
x-pass-why
/
accounts.haymarketmedia.com/sso/check/
45 B
443 B
XHR
General
Full URL
https://accounts.haymarketmedia.com/sso/check/?gn=101
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1568281912
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.174.96.0 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-35-174-96-0.compute-1.amazonaws.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
916b46685de3064525220ba828d946e60ab332f5e65c62d7df5fe9877f9c54b2

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:30 GMT
x-aspnetmvc-version
4.0
server
Microsoft-IIS/8.5
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET
status
200
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.empr.com
cache-control
private
access-control-allow-credentials
true
content-length
45
beacon.js
www.medtargetsystem.com/javascript/
177 KB
52 KB
Script
General
Full URL
https://www.medtargetsystem.com/javascript/beacon.js?v2.5.12
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.1.219.33 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-1-219-33.compute-1.amazonaws.com
Software
Apache/2.4.7 (Ubuntu) /
Resource Hash
7bb8bc9d113519cbd812363c3376a39d24f1dba2d12b48ad2fd8a833e5287f31

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:35:30 GMT
Content-Encoding
gzip
Last-Modified
Fri, 06 Sep 2019 19:15:11 GMT
Server
Apache/2.4.7 (Ubuntu)
ETag
"2c4ec-591e741cd4dc0-gzip"
Vary
X-Forwarded-Proto,Accept-Encoding
Content-Type
application/javascript
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
52843
linkid.js
www.google-analytics.com/plugins/ua/
2 KB
995 B
Script
General
Full URL
https://www.google-analytics.com/plugins/ua/linkid.js
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
92fca55833f48b4289ac8f1cedd48752b580fce4ec4b5d81670b8193d6e51b54
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 03:40:29 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Thu, 21 Apr 2016 03:17:22 GMT
server
sffe
age
3301
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
public, max-age=3600
accept-ranges
bytes
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
856
x-xss-protection
0
expires
Fri, 27 Sep 2019 04:40:29 GMT
tag.aspx
ml314.com/
26 KB
12 KB
Script
General
Full URL
https://ml314.com/tag.aspx?2782019
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.248.158.173 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-34-248-158-173.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
7d655e8cd62ba58d86b3bc9c8e1e04a76506a4dfc852c3b3813deb0aef284548

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:35:30 GMT
Content-Encoding
gzip
Last-Modified
Thu, 26 Sep 2019 05:39:48 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
Content-Type
application/javascript; charset=utf-8
Cache-Control
public, max-age=3857
Connection
keep-alive
Content-Length
11933
Expires
Fri, 27 Sep 2019 05:39:48 GMT
ga-audiences
www.google.de/ads/
Redirect Chain
  • https://www.google-analytics.com/r/collect?v=1&_v=j79&a=503328978&t=pageview&_s=1&dl=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsc...
  • https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-1290429-2&cid=1601973801.1569558930&jid=1236394914&_gid=697230513.1569558930&gjid=1684262429&_v=j79&z=396987685
  • https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1601973801.1569558930&jid=1236394914&_v=j79&z=396987685
  • https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1601973801.1569558930&jid=1236394914&_v=j79&z=396987685&slf_rd=1&random=4114984652
42 B
413 B
Image
General
Full URL
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1601973801.1569558930&jid=1236394914&_v=j79&z=396987685&slf_rd=1&random=4114984652
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:30 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
cache-control
no-cache, no-store, must-revalidate
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:30 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
302
content-type
text/html; charset=UTF-8
location
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1601973801.1569558930&jid=1236394914&_v=j79&z=396987685&slf_rd=1&random=4114984652
cache-control
no-cache, no-store, must-revalidate
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
io.min.js
c.lytics.io/static/v2/
13 KB
6 KB
Script
General
Full URL
https://c.lytics.io/static/v2/io.min.js
Requested by
Host: c.lytics.io
URL: https://c.lytics.io/api/tag/43bffbce6f25564c8e2145a11836ff9f/lio.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
1c0e0ca6ba3ee267ba14d39184efb68c958717fc6e58b528b700502c0aea5170

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

cf-ray
51cac573bdf759b2-VIE
date
Fri, 27 Sep 2019 04:35:30 GMT
via
1.1 google
cf-cache-status
HIT
last-modified
Fri, 13 Sep 2019 19:02:47 GMT
server
cloudflare
age
6684
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=7200
content-encoding
br
expires
Fri, 27 Sep 2019 06:35:30 GMT
4
c.lytics.io/cid/
77 B
332 B
Script
General
Full URL
https://c.lytics.io/cid/4?callback=jQuery112401534175573294485_1569558930023&_=1569558930024
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/jquery/jquery.js?ver=1.12.4-wp
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
1e5207491267777bd65a4bd10fc7289e9b2dc5eee7deec16e5893db15a3ce353

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

cf-ray
51cac573ee0359b2-VIE
pragma
no-cache
date
Fri, 27 Sep 2019 04:35:30 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
text/javascript
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
content-encoding
br
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
expires
0
atrk.js
d31qbv1cthcecs.cloudfront.net/
4 KB
2 KB
Script
General
Full URL
https://d31qbv1cthcecs.cloudfront.net/atrk.js
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.214.38 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-214-38.fra53.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
90451ba3e82cd9db02f0ca76bd45d0ab5ef7e90a49da4215903cb7f08471e2e7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 04 Jun 2019 00:38:41 GMT
Content-Encoding
gzip
Connection
keep-alive
Last-Modified
Sat, 16 Mar 2019 16:01:33 GMT
Server
AmazonS3
Age
9950210
Vary
Accept-Encoding
X-Cache
Hit from cloudfront
Content-Type
text/javascript
Via
1.1 a3c2566f9e36ad3cdf79fc6307fcf567.cloudfront.net (CloudFront)
Cache-Control
max-age=26920000
Transfer-Encoding
chunked
X-Amz-Cf-Pop
FRA53-C1
X-Amz-Cf-Id
7ZM0YCBdYaoiVcZI2GGCGzW0Cb4v4h9O98RNs6TWh5qzC4OAS6zXWQ==
gg.js
sb.scorecardresearch.com/rs/pt/
2 KB
1 KB
Script
General
Full URL
https://sb.scorecardresearch.com/rs/pt/gg.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5XFK9V6
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.19.43.224 , Ascension Island, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a2-19-43-224.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
d0e90581c7b707bcad9f78f9b066371e6b1377d993ff03cbdee7193d6068ac78

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:35:30 GMT
Content-Encoding
gzip
Connection
keep-alive
X-N
S
Content-Length
1246
Vary
Accept-Encoding
Content-Type
application/x-javascript
fbevents.js
connect.facebook.net/en_US/
121 KB
32 KB
Script
General
Full URL
https://connect.facebook.net/en_US/fbevents.js
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f01c:8012:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
/
Resource Hash
14d88b3a27f0e6de034f86ad42d6411081e9467daf754147f2f16bcb20782177
Security Headers
Name Value
Content-Security-Policy default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self';
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; preload; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
status
200
content-length
31604
x-xss-protection
0
pragma
public
x-fb-debug
Dw14h4pXG7zLzJuoCovGMDTXgTrHT2Ny2NKKk4kL2Gbly48s1WFeUi18NsgEGsq82qo9S2gWlNkiImjmhZk5tA==
x-fb-trip-id
194532234
x-frame-options
DENY
date
Fri, 27 Sep 2019 04:35:30 GMT
vary
Origin, Accept-Encoding
access-control-allow-methods
OPTIONS
content-type
application/x-javascript; charset=utf-8
access-control-allow-origin
https://connect.facebook.net
access-control-expose-headers
X-FB-Debug, X-Loader-Length
cache-control
public, max-age=1200
access-control-allow-credentials
true
content-security-policy
default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self';
expires
Sat, 01 Jan 2000 00:00:00 GMT
i
sp.sitomobile.com/
Redirect Chain
  • https://mt.sitomobile.com/sync/ta?aid=136&sid=hmm&val=12
  • https://pixel.tapad.com/idsync/ex/push?partner_id=2822&partner_url=https%3A%2F%2Fmt.sitomobile.com%2Fsync%2Ftacb%3Fexid%3D%24%7BTA_DEVICE_ID%7D%26aid%3D136%26sid%3Dhmm%26val%3D12
  • https://pixel.tapad.com/idsync/ex/push/check?partner_id=2822&partner_url=https%3A%2F%2Fmt.sitomobile.com%2Fsync%2Ftacb%3Fexid%3D%24%7BTA_DEVICE_ID%7D%26aid%3D136%26sid%3Dhmm%26val%3D12
  • https://mt.sitomobile.com/sync/tacb?exid=3cdeeed0-e0e0-11e9-8dcb-52c7686934ad&aid=136&sid=hmm&val=12
  • https://sp.sitomobile.com/i?tna=sito&p=mob&e=ue&ue_px=eyJzY2hlbWEiOiJpZ2x1OmNvbS5zbm93cGxvd2FuYWx5dGljcy5zbm93cGxvdy91bnN0cnVjdF9ldmVudC9qc29uc2NoZW1hLzEtMC0wIiwiZGF0YSI6eyJzY2hlbWEiOiJpZ2x1OmNvbS5...
43 B
388 B
Script
General
Full URL
https://sp.sitomobile.com/i?tna=sito&p=mob&e=ue&ue_px=eyJzY2hlbWEiOiJpZ2x1OmNvbS5zbm93cGxvd2FuYWx5dGljcy5zbm93cGxvdy91bnN0cnVjdF9ldmVudC9qc29uc2NoZW1hLzEtMC0wIiwiZGF0YSI6eyJzY2hlbWEiOiJpZ2x1OmNvbS5zaXRvbW9iaWxlLnNub3dwbG93L2Nvb2tpZV9zeW5jL2pzb25zY2hlbWEvMS0wLTAiLCJkYXRhIjp7InBhcnRuZXJJZCI6InRhcGFkIn19fQ%3D%3D&cx=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
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.211.28.224 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-211-28-224.compute-1.amazonaws.com
Software
Apache-Coyote/1.1 /
Resource Hash
f4eef8263281c0b26486637831251059757bc3fdc4c3a48045a8ef8646b36e8f

Request headers

Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:35:30 GMT
Server
Apache-Coyote/1.1
Connection
keep-alive
P3P
policyref="/w3c/p3p.xml", CP="NOI DSP COR NID PSA OUR IND COM NAV STA"
Content-Length
43
Content-Type
image/gif

Redirect headers

Date
Fri, 27 Sep 2019 04:35:31 GMT
Server
nginx/1.12.1
X-Powered-By
Express
Vary
Accept
Content-Type
text/plain; charset=utf-8
Location
https://sp.sitomobile.com/i?tna=sito&p=mob&e=ue&ue_px=eyJzY2hlbWEiOiJpZ2x1OmNvbS5zbm93cGxvd2FuYWx5dGljcy5zbm93cGxvdy91bnN0cnVjdF9ldmVudC9qc29uc2NoZW1hLzEtMC0wIiwiZGF0YSI6eyJzY2hlbWEiOiJpZ2x1OmNvbS5zaXRvbW9iaWxlLnNub3dwbG93L2Nvb2tpZV9zeW5jL2pzb25zY2hlbWEvMS0wLTAiLCJkYXRhIjp7InBhcnRuZXJJZCI6InRhcGFkIn19fQ%3D%3D&cx=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
Connection
keep-alive
Content-Length
972
up_loader.1.1.0.js
js.adsrvr.org/
6 KB
2 KB
Script
General
Full URL
https://js.adsrvr.org/up_loader.1.1.0.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5XFK9V6
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.207.113 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-207-113.fra53.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
7e98e381189d908e1981b6e535bcdd7f3edceafdb0e7095f3e04292e8aac6a0c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Thu, 26 Sep 2019 19:04:24 GMT
Content-Encoding
gzip
Last-Modified
Wed, 17 Jul 2019 18:26:10 GMT
Server
AmazonS3
Age
34338
Vary
Accept-Encoding
X-Cache
Hit from cloudfront
Content-Type
application/x-javascript
Via
1.1 e7377cc861b31102786678df3616bf69.cloudfront.net (CloudFront)
Connection
keep-alive
Transfer-Encoding
chunked
X-Amz-Cf-Pop
FRA53-C1
X-Amz-Cf-Id
ZNQJTvA54ibkDMxIcNn-M6y3HQgP2IdPjysDxGqQcUs6NT0IiyNR5Q==
1073716492693685
connect.facebook.net/signals/config/
307 KB
78 KB
Script
General
Full URL
https://connect.facebook.net/signals/config/1073716492693685?v=2.9.4&r=stable
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f01c:8012:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
/
Resource Hash
93c4a8cc5d4782ed85c9a7661ce68d1e7e7e6d4a91a57219f649f77564617460
Security Headers
Name Value
Content-Security-Policy default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; preload; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
status
200
content-length
79754
x-xss-protection
0
pragma
public
x-fb-debug
Ku771L1PPOlMX6ACX8Ai+wlgNEMQ+OmItIGFAKU6CFe38MrnRjvfOgU2juYJdkG+V+Y+jdyn+OK3seTRBNmzBA==
x-fb-trip-id
194532234
x-frame-options
DENY
date
Fri, 27 Sep 2019 04:35:30 GMT
vary
Origin, Accept-Encoding
access-control-allow-methods
OPTIONS
content-type
application/x-javascript; charset=utf-8
access-control-allow-origin
https://connect.facebook.net
access-control-expose-headers
X-FB-Debug, X-Loader-Length
cache-control
public, max-age=1200
access-control-allow-credentials
true
content-security-policy
default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
expires
Sat, 01 Jan 2000 00:00:00 GMT
inferredEvents.js
connect.facebook.net/signals/plugins/
35 KB
10 KB
Script
General
Full URL
https://connect.facebook.net/signals/plugins/inferredEvents.js?v=2.9.4
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f01c:8012:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
/
Resource Hash
b4e9e9bef19c34422f55a7fdb9d10c4db5e39cff24b8c98a0be0e09b2ee6ac2b
Security Headers
Name Value
Content-Security-Policy default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; preload; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
status
200
content-length
10218
x-xss-protection
0
pragma
public
x-fb-debug
XD+jPKOTQiEcQqY+fZ4lH21OPCoB0kuuo/T8KNiAJxnmL+wH2Q4rOxl9tT8hhgxzejAekplxC2FiCYKXtlMmCQ==
x-fb-trip-id
194532234
x-frame-options
DENY
date
Fri, 27 Sep 2019 04:35:30 GMT
vary
Origin, Accept-Encoding
access-control-allow-methods
OPTIONS
content-type
application/x-javascript; charset=utf-8
access-control-allow-origin
https://connect.facebook.net
access-control-expose-headers
X-FB-Debug, X-Loader-Length
cache-control
public, max-age=1200
access-control-allow-credentials
true
content-security-policy
default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
expires
Sat, 01 Jan 2000 00:00:00 GMT
/
www.facebook.com/tr/
44 B
325 B
Image
General
Full URL
https://www.facebook.com/tr/?id=1073716492693685&ev=PageView&dl=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&rl=&if=false&ts=1569558930610&sw=1600&sh=1200&v=2.9.4&r=stable&ec=0&o=30&fbp=fb.1.1569558930609.1359657798&it=1569558930563&coo=false&rqm=GET
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f11c:8083:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
10d8d42d73a02ddb877101e72fbfa15a0ec820224d97cedee4cf92d571be5caa
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:30 GMT
last-modified
Fri, 21 Dec 2012 00:00:01 GMT
server
proxygen-bolt
strict-transport-security
max-age=31536000; includeSubDomains
content-type
image/gif
status
200
cache-control
no-cache, must-revalidate, max-age=0
content-length
44
expires
Fri, 27 Sep 2019 04:35:30 GMT
utsync.ashx
ml314.com/
793 B
2 KB
Script
General
Full URL
https://ml314.com/utsync.ashx?pub=&adv=&et=0&eid=740&ct=js&pi=&fp=&clid=&if=0&ps=&cl=&mlt=&data=&&cp=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&pv=1569558930614_jmolk9dk9&bl=en-us&cb=4244912&return=&ht=&d=&dc=&si=1569558930614_jmolk9dk9&cid=&s=1600x1200&rp=
Requested by
Host: ml314.com
URL: https://ml314.com/tag.aspx?2782019
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.248.158.173 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-34-248-158-173.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
5b2ad74d53081be605e9eccddb55b222611a4cd93a283651d43fa299c0e9c670

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 27 Sep 2019 04:35:30 GMT
Content-Encoding
gzip
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
p3P
CP="NON DSP COR ADMo PSAo DEVo BUS COM UNI NAV DEM STA"
Cache-Control
private
Connection
keep-alive
Content-Type
application/javascript; charset=utf-8
Content-Length
485
Expires
0
ud.ashx
in.ml314.com/
20 B
698 B
Script
General
Full URL
https://in.ml314.com/ud.ashx?topiclimit=&cb=2782019
Requested by
Host: ml314.com
URL: https://ml314.com/tag.aspx?2782019
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.202.10.50 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-202-10-50.compute-1.amazonaws.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
d0e4a6372d6fb5ffe9505dbe9e94aee8f1b9b96ec8e5e20684cce8b4c5a88fa7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:35:30 GMT
Content-Encoding
gzip
Server
Microsoft-IIS/8.5
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
Content-Type
application/javascript; charset=utf-8
Cache-Control
public, no-cache="set-cookie"
Connection
keep-alive
Content-Length
138
Expires
Sat, 28 Sep 2019 04:35:30 GMT
csync.ashx
ml314.com/
Redirect Chain
  • https://tags.bluekai.com/site/20486?limit=0&id=5978151501699125277&redir=https://ml314.com/csync.ashx%3Ffp=$_BK_UUID%26person_id=5978151501699125277%26eid=50056
  • https://ml314.com/csync.ashx?fp=x2nuvx9999YDyRN5&person_id=5978151501699125277&eid=50056
43 B
312 B
Image
General
Full URL
https://ml314.com/csync.ashx?fp=x2nuvx9999YDyRN5&person_id=5978151501699125277&eid=50056
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.248.158.173 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-34-248-158-173.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:35:30 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Content-Type
image/gif
Cache-Control
private
Connection
keep-alive
Content-Length
43
Expires
Sat, 28 Sep 2019 00:35:30 GMT

Redirect headers

Location
https://ml314.com/csync.ashx?fp=x2nuvx9999YDyRN5&person_id=5978151501699125277&eid=50056
Date
Fri, 27 Sep 2019 04:35:30 GMT
Connection
keep-alive
Content-Length
0
BK-Server
b42d
P3P
CP="NOI DSP COR CUR ADMo DEVo PSAo PSDo OUR SAMo BUS UNI NAV", policyref="http://tags.bluekai.com/w3c/p3p.xml"
csync.ashx
ml314.com/
Redirect Chain
  • https://idsync.rlcdn.com/395886.gif?partner_uid=5978151501699125277
  • https://idsync.rlcdn.com/1000.gif?memo=CO6UGBIeChoIARCuXxoTNTk3ODE1MTUwMTY5OTEyNTI3NxAAGg0IkqO27AUSBQjoBxAAQgBKAA
  • https://ml314.com/csync.ashx?fp=35740769d112c5d6bd6e7a26462ff0aee2f000220c5a7bde91265996da677d4df4cb09cee1a4f8eb&person_id=5978151501699125277&eid=50082
43 B
312 B
Image
General
Full URL
https://ml314.com/csync.ashx?fp=35740769d112c5d6bd6e7a26462ff0aee2f000220c5a7bde91265996da677d4df4cb09cee1a4f8eb&person_id=5978151501699125277&eid=50082
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.248.158.173 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-34-248-158-173.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:35:30 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Content-Type
image/gif
Cache-Control
private
Connection
keep-alive
Content-Length
43
Expires
Sat, 28 Sep 2019 00:35:30 GMT

Redirect headers

date
Fri, 27 Sep 2019 04:35:30 GMT
via
1.1 google
status
307
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
location
https://ml314.com/csync.ashx?fp=35740769d112c5d6bd6e7a26462ff0aee2f000220c5a7bde91265996da677d4df4cb09cee1a4f8eb&person_id=5978151501699125277&eid=50082
cache-control
no-cache, no-store
timing-allow-origin
*
alt-svc
clear
content-length
0
csync.ashx
ml314.com/
Redirect Chain
  • https://pixel.mathtag.com/sync/img?redir=https://ml314.com/csync.ashx%3Ffp=[MM_UUID]%26person_id=5978151501699125277%26eid=50220
  • https://pixel.mathtag.com/sync/img?redir=https://ml314.com/csync.ashx%3Ffp=[MM_UUID]%26person_id=5978151501699125277%26eid=50220&mm_bnc&mm_bct&UUID=ef445d8d-8cf5-4700-a308-9a86ad0111e6
  • https://ml314.com/csync.ashx?fp=ef445d8d-8cf5-4700-a308-9a86ad0111e6&person_id=5978151501699125277&eid=50220
43 B
312 B
Image
General
Full URL
https://ml314.com/csync.ashx?fp=ef445d8d-8cf5-4700-a308-9a86ad0111e6&person_id=5978151501699125277&eid=50220
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.248.158.173 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-34-248-158-173.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:35:30 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Content-Type
image/gif
Cache-Control
private
Connection
keep-alive
Content-Length
43
Expires
Sat, 28 Sep 2019 00:35:30 GMT

Redirect headers

Date
Fri, 27 Sep 2019 04:35:30 GMT
Server
MT3 1734 ed2a032 master zrh-pixel-x18
P3P
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
Location
https://ml314.com/csync.ashx?fp=ef445d8d-8cf5-4700-a308-9a86ad0111e6&person_id=5978151501699125277&eid=50220
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
0
Expires
Fri, 27 Sep 2019 04:35:29 GMT
csync.ashx
ml314.com/
Redirect Chain
  • https://sync.crwdcntrl.net/map/c=6985/tp=BOMB?https://ml314.com/csync.ashx%3Ffp%3D%24%7Bprofile_id%7D%26eid%3D50146%26person_id%3D5978151501699125277
  • https://sync.crwdcntrl.net/map/ct=y/c=6985/tp=BOMB?https://ml314.com/csync.ashx%3Ffp%3D%24%7Bprofile_id%7D%26eid%3D50146%26person_id%3D5978151501699125277
  • https://ml314.com/csync.ashx?fp=90eac7e3b74cfa126cc5d7b163f6f80c&eid=50146&person_id=5978151501699125277
43 B
312 B
Image
General
Full URL
https://ml314.com/csync.ashx?fp=90eac7e3b74cfa126cc5d7b163f6f80c&eid=50146&person_id=5978151501699125277
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.248.158.173 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-34-248-158-173.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:35:29 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Content-Type
image/gif
Cache-Control
private
Connection
keep-alive
Content-Length
43
Expires
Sat, 28 Sep 2019 00:35:30 GMT

Redirect headers

Pragma
no-cache
Date
Fri, 27 Sep 2019 04:35:30 GMT
P3P
CP=NOI DSP COR NID PSAa PSDa OUR UNI COM NAV
Location
https://ml314.com/csync.ashx?fp=90eac7e3b74cfa126cc5d7b163f6f80c&eid=50146&person_id=5978151501699125277
Cache-Control
no-cache
X-Server
10.45.17.138
Connection
keep-alive
Content-Length
0
Expires
0
match
ps.eyeota.net/
Redirect Chain
  • https://ps.eyeota.net/pixel?pid=r8hrb20&t=gif
  • https://ps.eyeota.net/pixel/bounce/?pid=r8hrb20&t=gif
  • https://ml314.com/utsync.ashx?eid=50052&et=0&fp=2jOsM7JJVaDSQjGrpEUYipXQYcL5CzLDr2nccJu51NCw&gdpr=1&gdpr_consent=&return=https%3A%2F%2Fps.eyeota.net%2Fmatch%3Fbid%3Dr8hrb20%26uid%3Dnil
  • https://ml314.com/csync.ashx?fp=2jOsM7JJVaDSQjGrpEUYipXQYcL5CzLDr2nccJu51NCw&person_id=5978151501699125277&eid=50052&return=https%3a%2f%2fps.eyeota.net%2fmatch%3fbid%3dr8hrb20%26uid%3dnil
  • https://ps.eyeota.net/match?bid=r8hrb20&uid=nil
70 B
171 B
Image
General
Full URL
https://ps.eyeota.net/match?bid=r8hrb20&uid=nil
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
18.195.251.148 Frankfurt am Main, Germany, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-18-195-251-148.eu-central-1.compute.amazonaws.com
Software
/
Resource Hash
de9d3fd0eb948bd294477d0eda60a73b85caff1794803530d0463193a113da98

Request headers

Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:35:31 GMT
Content-Length
70
Content-Type
image/gif

Redirect headers

Date
Fri, 27 Sep 2019 04:35:30 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Content-Type
text/html; charset=utf-8
Location
https://ps.eyeota.net/match?bid=r8hrb20&uid=nil
Cache-Control
private
Connection
keep-alive
Content-Length
168
Expires
Sat, 28 Sep 2019 00:35:31 GMT
atrk.gif
certify.alexametrics.com/
43 B
553 B
Image
General
Full URL
https://certify.alexametrics.com/atrk.gif?frame_height=1200&frame_width=1600&iframe=0&title=Atezolizumab%20May%20Improve%20Survival%20for%20Some%20With%20Advanced%20Squamous%20NSCLC%20-%20MPR&time=1569558930659&time_zone_offset=-120&screen_params=1600x1200x24&java_enabled=0&cookie_enabled=1&ref_url=&host_url=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&random_number=17780547432&sess_cookie=7ffcae4d16d7100a4e3c57557a2&sess_cookie_flag=1&user_cookie=7ffcae4d16d7100a4e3c57557a2&user_cookie_flag=1&dynamic=true&domain=empr.com&account=gujPp1NErb205V&jsv=20130128&user_lang=en-US
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.214.122 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-214-122.fra53.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
89fe0ee6020314794fc2cfeacf3d10c31050cfe56f8ebddf1ed0a33fbe941fa7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Thu, 26 Sep 2019 04:49:41 GMT
Via
1.1 48391c4ed2c51e95dcabcb70cf613127.cloudfront.net (CloudFront)
Last-Modified
Mon, 17 Jan 2011 20:41:40 GMT
Server
AmazonS3
Age
113846
ETag
"221d8352905f2c38b3cb2bd191d630b0"
X-Cache
Hit from cloudfront
Content-Type
image/gif
Connection
keep-alive
Accept-Ranges
bytes
X-Amz-Cf-Pop
FRA53-C1
x-amz-meta-alexa-last-modified
20110117123941
Content-Length
43
X-Amz-Cf-Id
Xgb35Izm2rz09dDsU3CeicFcRVFEvbh-Xk3xBI8CFVJETHTulFfodQ==
eba40efa5985b991eb795147de5cdecd
api.lytics.io/api/me/iframe/43bffbce6f25564c8e2145a11836ff9f/_uid/ Frame 0C7A
0
0
Document
General
Full URL
https://api.lytics.io/api/me/iframe/43bffbce6f25564c8e2145a11836ff9f/_uid/eba40efa5985b991eb795147de5cdecd?segments=true&mergestate=true&ts=1569558930678
Requested by
Host: c.lytics.io
URL: https://c.lytics.io/api/tag/43bffbce6f25564c8e2145a11836ff9f/lio.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.227.192.113 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
113.192.227.35.bc.googleusercontent.com
Software
lytics.io afbca1b0bd5468a6f7b9c99405e0c6c063368ebf /
Resource Hash

Request headers

:method
GET
:authority
api.lytics.io
:scheme
https
:path
/api/me/iframe/43bffbce6f25564c8e2145a11836ff9f/_uid/eba40efa5985b991eb795147de5cdecd?segments=true&mergestate=true&ts=1569558930678
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
accept-encoding
gzip, deflate, br
cookie
__cfduid=de32db4a184c77bd99bdcb9f83b402ba91569558930; seerid=eba40efa5985b991eb795147de5cdecd
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653

Response headers

status
200
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Authorization, Cookie, *
access-control-allow-methods
GET
access-control-allow-origin
content-encoding
gzip
content-type
text/html
server
lytics.io afbca1b0bd5468a6f7b9c99405e0c6c063368ebf
date
Fri, 27 Sep 2019 04:35:30 GMT
content-length
294
via
1.1 google
alt-svc
clear
Cookie set /
www.medtargetsystem.com/beacon/portal/ Frame 5076
0
0
Document
General
Full URL
https://www.medtargetsystem.com/beacon/portal/?_url=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F&_sid=48a98256-b793-404a-a267-b663edb51788&_vid=42d335cf-097c-487f-b86f-d16df8e6a46c&_ak=35-212-8F62AC13&_flash=false&_th=1569558930|1569558930|1
Requested by
Host: www.medtargetsystem.com
URL: https://www.medtargetsystem.com/javascript/beacon.js?v2.5.12
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.1.219.33 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-1-219-33.compute-1.amazonaws.com
Software
Apache/2.4.7 (Ubuntu) / PHP/7.0.19-1+deb.sury.org~trusty+2
Resource Hash

Request headers

Host
www.medtargetsystem.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
Sec-Fetch-Site
cross-site
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Accept-Encoding
gzip, deflate, br
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653

Response headers

Cache-Control
no-store, no-cache, must-revalidate
Content-Encoding
gzip
Content-Type
text/html; charset=UTF-8
Date
Fri, 27 Sep 2019 04:35:31 GMT
Expires
Thu, 19 Nov 1981 08:52:00 GMT
P3P
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
Pragma
no-cache
Server
Apache/2.4.7 (Ubuntu)
Set-Cookie
DMDSESSID=9ba74aem1dmpubvj1klbsjb4b6; path=/; HttpOnly
Vary
X-Forwarded-Proto,Accept-Encoding
X-Powered-By
PHP/7.0.19-1+deb.sury.org~trusty+2
Content-Length
6989
Connection
keep-alive
collect.gif
www.medtargetsystem.com/analytics/
0
313 B
Image
General
Full URL
https://www.medtargetsystem.com/analytics/collect.gif?e=1&aid=&vid=42d335cf-097c-487f-b86f-d16df8e6a46c&sid=48a98256-b793-404a-a267-b663edb51788&vh=1&vt=1569558930&pt=1569558930&u=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&r=&t=Atezolizumab%20May%20Improve%20Survival%20for%20Some%20With%20Advanced%20Squamous%20NSCLC%20-%20MPR&p=2168.12&pm=&ab=&ak=35-212-8F62AC13
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.1.219.33 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-1-219-33.compute-1.amazonaws.com
Software
Apache/2.4.7 (Ubuntu) / PHP/7.0.19-1+deb.sury.org~trusty+2
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:35:31 GMT
Server
Apache/2.4.7 (Ubuntu)
Connection
keep-alive
X-Powered-By
PHP/7.0.19-1+deb.sury.org~trusty+2
Content-Length
0
Vary
X-Forwarded-Proto
Content-Type
text/html; charset=UTF-8
/
www.facebook.com/tr/ Frame 9E86
0
0
Document
General
Full URL
https://www.facebook.com/tr/
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f11c:8083:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

:method
POST
:authority
www.facebook.com
:scheme
https
:path
/tr/
content-length
3940
pragma
no-cache
cache-control
no-cache
origin
https://www.empr.com
upgrade-insecure-requests
1
content-type
application/x-www-form-urlencoded
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
accept-encoding
gzip, deflate, br
cookie
fr=0U16ML3vt0Z6EfxKp..BdjZGS...1.0.BdjZGS.
Origin
https://www.empr.com
Upgrade-Insecure-Requests
1
Content-Type
application/x-www-form-urlencoded
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653

Response headers

status
200
content-type
text/plain
access-control-allow-origin
https://www.empr.com
access-control-allow-credentials
true
strict-transport-security
max-age=31536000; includeSubDomains
content-length
0
server
proxygen-bolt
date
Fri, 27 Sep 2019 04:35:31 GMT
pathfora.min.js
c.lytics.io/static/
98 KB
20 KB
Script
General
Full URL
https://c.lytics.io/static/pathfora.min.js
Requested by
Host: c.lytics.io
URL: https://c.lytics.io/api/tag/43bffbce6f25564c8e2145a11836ff9f/lio.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
4215e6200c04a4874f3d23c78af23fcd22b5bc3bc916237fd95c108aaae38735

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

cf-ray
51cac5775f1059b2-VIE
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
cf-cache-status
HIT
last-modified
Wed, 03 Jul 2019 23:03:58 GMT
server
cloudflare
age
5766
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=7200
content-encoding
br
expires
Fri, 27 Sep 2019 06:35:31 GMT
43bffbce6f25564c8e2145a11836ff9f
c.lytics.io/c/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f?_ts=1569558931056&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_e=pv&utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&_sesstart=1&_tz=2&_ul=en-US&_sz=1600x1200&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5775f1159b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
43bffbce6f25564c8e2145a11836ff9f
c.lytics.io/c/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f?publicationId=13&channel=home&pagetype=post&tags=oncology%2Crespiratory%20and%20thoracic%20cancers&categories=news&pagename=Atezolizumab%20May%20Improve%20Survival%20for%20Some%20With%20Advanced%20Squamous%20NSCLC&author=Brian%20Park%2C%20PharmD&section=home%3Anews%3Aatezolizumab%20may%20improve%20survival%20for%20some%20with%20advanced%20squamous%20nsclc&email=nguyentt%40sutterhealth.org&user_id=0&cpn=pcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019&login=nguyentt%40sutterhealth.org&userstate=CA&userspecialty=&userprofession=Physician&_ts=1569558931057&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5775f1259b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?gtm.start=1569558929885&event=gtm.js&gtm.uniqueEventId=15&_ts=1569558931057&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5775f1359b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
104 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.AdBlocking=&_ts=1569558931057&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5775f1459b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.NHTFlag=false&_ts=1569558931058&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5775f1659b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.ArticleId=124119%3A0&_ts=1569558931058&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5775f1759b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.ArticleType=MPR%20Drug%20News&_ts=1569558931058&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5775f1859b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.MetaData=&_ts=1569558931058&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5775f1959b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Type=post&_ts=1569558931059&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5775f1b59b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.ScrollDepth=&_ts=1569558931059&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5775f1c59b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.cmeActivityId=&_ts=1569558931059&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5775f1d59b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.PrintSource=&_ts=1569558931059&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f2159b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.SEOScore=&_ts=1569558931060&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f2259b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Site.Prefix=omn&_ts=1569558931060&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f2359b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Site.PublicationId=13&_ts=1569558931060&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f2459b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.Author=Brian%20Park%2C%20PharmD&_ts=1569558931060&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f2559b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Novo.PremiumMonograph=&_ts=1569558931060&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f2659b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Novo.Geolocation=&_ts=1569558931061&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f2759b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Activity.Name=&_ts=1569558931061&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f2859b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.GenericEvents=&_ts=1569558931061&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f2959b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?eComm.CurrencyCode=&_ts=1569558931061&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f2a59b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?eComm.OrderId=&_ts=1569558931062&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f2b59b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Drug.CompanyName=&_ts=1569558931062&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f2c59b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Novo.IsPremiumMonograph=false&_ts=1569558931062&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f2e59b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
94 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.GatingType=post%3Anone&_ts=1569558931062&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f2f59b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.Company=&_ts=1569558931062&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f3059b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
94 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.Discipline=&_ts=1569558931063&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f3159b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.Asset=&_ts=1569558931063&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f3259b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.PublishDate=2019-09-18&_ts=1569558931063&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f3359b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
95 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.Curation=false&_ts=1569558931063&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f3459b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
101 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.WordCount=341&_ts=1569558931063&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f3559b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?MyCME.CreditType=&_ts=1569558931064&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f3659b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
94 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?MyCME.ActivityResult=&_ts=1569558931064&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f3859b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.NumberofAdCalls=9&_ts=1569558931064&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f3959b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?eComm.ProductsInCart=&_ts=1569558931064&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f3a59b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
101 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Section1=home&_ts=1569558931064&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f3b59b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
166 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Section2=home%3Anews&_ts=1569558931065&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f3c59b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Section3=home%3Anews%3Aatezolizumab%20may%20improve%20survival%20for%20some%20with%20advanced%20squamous%20nsclc&_ts=1569558931065&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f3d59b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
94 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Section4=&_ts=1569558931065&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f3e59b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Tags=oncology%2Crespiratory%20and%20thoracic%20cancers&_ts=1569558931065&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f3f59b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Categories=news&_ts=1569558931065&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f4059b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
94 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.LoggedIn=false&_ts=1569558931066&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f4159b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
94 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.Login=&_ts=1569558931066&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f4259b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.SocSSN=&_ts=1569558931066&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f4359b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.SSO=3&_ts=1569558931066&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f4459b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.SubscriberId=0&_ts=1569558931066&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f4559b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
95 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.Source=&_ts=1569558931066&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f4659b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
96 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.Profession=Physician&_ts=1569558931067&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f4759b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
94 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.Specialty=&_ts=1569558931067&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f4859b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.SubProfession=&_ts=1569558931067&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f4959b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
116 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.SubSpecialty=&_ts=1569558931067&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f4a59b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
231 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.JobTitle=&_ts=1569558931067&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f4b59b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.CampaignCodes=pcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019&_ts=1569558931067&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f4c59b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
95 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.Country=&_ts=1569558931068&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f4d59b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
94 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.Company=&_ts=1569558931068&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f4e59b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.CompanySize=&_ts=1569558931068&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f4f59b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.IsHaymarket=false&_ts=1569558931068&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f5059b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
95 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.IsTracked=true&_ts=1569558931068&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f5159b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
104 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.IsFromAim=false&_ts=1569558931068&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f5259b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
94 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.NpiNumber=1619909975&_ts=1569558931069&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f5359b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?gtm.start=1569558930436&event=gtm.js&gtm.uniqueEventId=3&_ts=1569558931069&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=eba40efa5985b991eb795147de5cdecd&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac5776f5459b2-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
eba40efa5985b991eb795147de5cdecd
api.lytics.io/api/content/recommend/43bffbce6f25564c8e2145a11836ff9f/user/_uid/
167 KB
28 KB
XHR
General
Full URL
https://api.lytics.io/api/content/recommend/43bffbce6f25564c8e2145a11836ff9f/user/_uid/eba40efa5985b991eb795147de5cdecd?limit=30&contentsegment=ee9fe9a51cf2f1774e42f33abc9ca99c&shuffle=true
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1568281912
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.227.192.113 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
113.192.227.35.bc.googleusercontent.com
Software
lytics.io afbca1b0bd5468a6f7b9c99405e0c6c063368ebf /
Resource Hash
128ac90fcfc2f8612b7d97447b302b0c8a5e8187bab2eba836c7fe609de5057b

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:31 GMT
content-encoding
gzip
server
lytics.io afbca1b0bd5468a6f7b9c99405e0c6c063368ebf
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Authorization, Cookie, *
status
200
access-control-allow-methods
GET
content-type
application/json
access-control-allow-origin
https://www.empr.com
alt-svc
clear
via
1.1 google
pathfora.min.css
c.lytics.io/static/
20 KB
3 KB
Stylesheet
General
Full URL
https://c.lytics.io/static/pathfora.min.css
Requested by
Host: c.lytics.io
URL: https://c.lytics.io/static/pathfora.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
58aa5964d6f5dc68b2180e943ea63b6031c0ba83e44d9815e724b10f2f615f9f

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

cf-ray
51cac5777f5659b2-VIE
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
cf-cache-status
HIT
last-modified
Wed, 03 Jul 2019 23:03:58 GMT
server
cloudflare
age
6602
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/css; charset=utf-8
status
200
cache-control
public, max-age=7200
content-encoding
br
expires
Fri, 27 Sep 2019 06:35:31 GMT
config.js
c.lytics.io/api/program/campaign/config/43bffbce6f25564c8e2145a11836ff9f/
54 KB
7 KB
Script
General
Full URL
https://c.lytics.io/api/program/campaign/config/43bffbce6f25564c8e2145a11836ff9f/config.js
Requested by
Host: c.lytics.io
URL: https://c.lytics.io/api/tag/43bffbce6f25564c8e2145a11836ff9f/lio.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
4b3c190f1fd1a6c15ba3202a789424a7fbfb9e6b3fc0a96af1e712d456fc9fd4

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

cf-ray
51cac5777f5759b2-VIE
date
Fri, 27 Sep 2019 04:35:31 GMT
via
1.1 google
cf-cache-status
HIT
server
cloudflare
age
100
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=7200
content-encoding
br
expires
Fri, 27 Sep 2019 06:35:31 GMT
/
www.facebook.com/tr/ Frame 6027
0
0
Document
General
Full URL
https://www.facebook.com/tr/
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f11c:8083:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

:method
POST
:authority
www.facebook.com
:scheme
https
:path
/tr/
content-length
11738
pragma
no-cache
cache-control
no-cache
origin
https://www.empr.com
upgrade-insecure-requests
1
content-type
application/x-www-form-urlencoded
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
accept-encoding
gzip, deflate, br
cookie
fr=0U16ML3vt0Z6EfxKp..BdjZGS...1.0.BdjZGS.
Origin
https://www.empr.com
Upgrade-Insecure-Requests
1
Content-Type
application/x-www-form-urlencoded
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653

Response headers

status
200
content-type
text/plain
access-control-allow-origin
https://www.empr.com
access-control-allow-credentials
true
strict-transport-security
max-age=31536000; includeSubDomains
content-length
0
server
proxygen-bolt
date
Fri, 27 Sep 2019 04:35:31 GMT
css
fonts.googleapis.com/
1 KB
477 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Lato:400,900
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.bundle.js?ver=0.1.1
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:817::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
ESF /
Resource Hash
4bd7ab38b940371c161b19f0cf34bdfdeaac480eda86b13c29591ed01ed67c36
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
br
last-modified
Fri, 27 Sep 2019 04:35:31 GMT
server
ESF
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
status
200
date
Fri, 27 Sep 2019 04:35:31 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
x-xss-protection
0
expires
Fri, 27 Sep 2019 04:35:31 GMT
truncated
/
5 KB
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
d9593473fc4d73446eac1a620bb1bbe590fc80d61d8909484dfee64ae522b787

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
13
subapi.haymarketmedia.com/newsletter/
3 KB
4 KB
XHR
General
Full URL
https://subapi.haymarketmedia.com/newsletter/13
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.vendor.js?ver=0.1.1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.172.78.117 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-35-172-78-117.compute-1.amazonaws.com
Software
/ Express
Resource Hash
dc33184388cdcf8d8744da89db61d1633ff8219cc2a82f5c16758ff51a6ef531

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

date
Fri, 27 Sep 2019 04:35:31 GMT
x-powered-by
Express
etag
W/"d3e-V8fKzUWOVMxpQEouMHWsycPY5EQ"
status
200
access-control-allow-methods
GET, POST, OPTIONS
content-type
text/html; charset=utf-8
access-control-allow-origin
*
access-control-allow-credentials
true
access-control-allow-headers
Content-Type, Connection, Keep-Alive, Content-Length
content-length
3390
13
subapi.haymarketmedia.com/newsletter/
3 KB
4 KB
XHR
General
Full URL
https://subapi.haymarketmedia.com/newsletter/13
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.vendor.js?ver=0.1.1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.172.78.117 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-35-172-78-117.compute-1.amazonaws.com
Software
/ Express
Resource Hash
dc33184388cdcf8d8744da89db61d1633ff8219cc2a82f5c16758ff51a6ef531

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

date
Fri, 27 Sep 2019 04:35:31 GMT
x-powered-by
Express
etag
W/"d3e-V8fKzUWOVMxpQEouMHWsycPY5EQ"
status
200
access-control-allow-methods
GET, POST, OPTIONS
content-type
text/html; charset=utf-8
access-control-allow-origin
*
access-control-allow-credentials
true
access-control-allow-headers
Content-Type, Connection, Keep-Alive, Content-Length
content-length
3390
truncated
/
24 KB
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
65f72bc49f7e243cf332df6eb265d987e4c6e997e7aecd813ceace591f805071

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/gif
collect.gif
www.medtargetsystem.com/analytics/
0
245 B
Image
General
Full URL
https://www.medtargetsystem.com/analytics/collect.gif?e=1&aid=&vid=42d335cf-097c-487f-b86f-d16df8e6a46c&sid=48a98256-b793-404a-a267-b663edb51788&vh=2&vt=1569558930&pt=1569558931&u=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&r=&t=Atezolizumab%20May%20Improve%20Survival%20for%20Some%20With%20Advanced%20Squamous%20NSCLC%20-%20MPR&p=2391.94&pm=&ab=&ak=35-212-8F62AC13
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.1.219.33 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-1-219-33.compute-1.amazonaws.com
Software
Apache/2.4.7 (Ubuntu) / PHP/7.0.19-1+deb.sury.org~trusty+2
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:35:31 GMT
Server
Apache/2.4.7 (Ubuntu)
Connection
keep-alive
X-Powered-By
PHP/7.0.19-1+deb.sury.org~trusty+2
Content-Length
0
Vary
X-Forwarded-Proto
Content-Type
text/html; charset=UTF-8
truncated
/
82 KB
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
ad9d820f1802abd0f80d4e260c43cd6c92d643c926732a00296821182ae3f9c7

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/svg+xml
handdriphospitalg760270983_1435994.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
19 KB
19 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/handdriphospitalg760270983_1435994.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
34.225.50.222 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-225-50-222.compute-1.amazonaws.com
Software
nginx /
Resource Hash
2fb1365733c0309e4d51b57b5c7aacdf0a028d1b59f8ccfe7bffa405bb5c491b
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:35:31 GMT
last-modified
Wed, 20 Mar 2019 19:56:31 GMT
server
nginx
etag
"32295763acf7dc98848706af47718994"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
19054
expires
Sun, 27 Oct 2019 04:35:31 GMT
newborng661949105_1455686.jpg
www.empr.com/wp-content/uploads/sites/7/2019/01/
11 KB
11 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2019/01/newborng661949105_1455686.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
34.225.50.222 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-225-50-222.compute-1.amazonaws.com
Software
nginx /
Resource Hash
734fd0ea8fd9ef5774133ec8229454a33210c6a4b6eb70ab2d3cdc85426ab1d3
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:35:31 GMT
last-modified
Wed, 20 Mar 2019 09:05:36 GMT
server
nginx
etag
"534d95a101b459f52fe05227a4d7ac69"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
11060
expires
Sun, 27 Oct 2019 04:35:31 GMT
hivinfectioncd4cellsss468_1159086.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
122 KB
123 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/hivinfectioncd4cellsss468_1159086.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
34.225.50.222 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-225-50-222.compute-1.amazonaws.com
Software
nginx /
Resource Hash
47bc305eb82af2bd196db29a335a223c0ab8cf72534dd5378460bfb59d104116
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:35:31 GMT
last-modified
Wed, 20 Mar 2019 21:51:52 GMT
server
nginx
etag
"8ab57440d1581d97b40de60be8e01c1a"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
125365
expires
Sun, 27 Oct 2019 04:35:31 GMT
headachemigraineillustration_1290665.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
22 KB
23 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/headachemigraineillustration_1290665.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
34.225.50.222 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-225-50-222.compute-1.amazonaws.com
Software
nginx /
Resource Hash
635994bacaaafcf5296ca204df7739d714b94ad861f7156c0d3e98d5353de747
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:35:31 GMT
last-modified
Wed, 20 Mar 2019 22:03:06 GMT
server
nginx
etag
"2f2ca0ad618d7044e38fea32bab1994d"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
22898
expires
Sun, 27 Oct 2019 04:35:31 GMT
ezallor_capsule_artwork_contact-sheet_resized.jpg
www.thecardiologyadvisor.com/wp-content/uploads/sites/17/2019/07/
611 KB
612 KB
Image
General
Full URL
https://www.thecardiologyadvisor.com/wp-content/uploads/sites/17/2019/07/ezallor_capsule_artwork_contact-sheet_resized.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
34.225.50.222 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-225-50-222.compute-1.amazonaws.com
Software
nginx /
Resource Hash
2e497e5231e532fad481d8b7874822e1808d2ba6432a2f8436e57ccfdcdc2685
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:35:31 GMT
last-modified
Mon, 29 Jul 2019 07:11:15 GMT
server
nginx
etag
"429337dd1993d8a13e28c0a6834e6a8a"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
625396
expires
Sun, 27 Oct 2019 04:35:31 GMT
vaccinecloseupns_947985.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
82 KB
82 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/vaccinecloseupns_947985.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
34.225.50.222 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-225-50-222.compute-1.amazonaws.com
Software
nginx /
Resource Hash
7df3d9fe132da0dc751d222fd597ad501748a6f6a6e30ae9f9f510515ded1887
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:35:31 GMT
last-modified
Thu, 21 Mar 2019 02:13:41 GMT
server
nginx
etag
"0abab3f78b278eb643633789ba68fca3"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
83918
expires
Sun, 27 Oct 2019 04:35:31 GMT
viaskinpeanutpatch_1080585.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
87 KB
87 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/viaskinpeanutpatch_1080585.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
34.225.50.222 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-225-50-222.compute-1.amazonaws.com
Software
nginx /
Resource Hash
de21751600a5bbe5eede21f33cc022383a3583c34c2d72384fe95fd771e8a8b5
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:35:31 GMT
last-modified
Wed, 20 Mar 2019 19:37:44 GMT
server
nginx
etag
"0b6e576241bc8a39ae49a5dc1557ca99"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
88985
expires
Sun, 27 Oct 2019 04:35:31 GMT
Adhansia-XR.jpg
www.empr.com/wp-content/uploads/sites/7/2019/06/
19 KB
19 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2019/06/Adhansia-XR.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
34.225.50.222 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-225-50-222.compute-1.amazonaws.com
Software
nginx /
Resource Hash
206a40b0d9084415064c358a1a381b3a05b27de806b4e62ffefb1b7be2da3bd0
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:35:31 GMT
last-modified
Sun, 30 Jun 2019 07:14:35 GMT
server
nginx
etag
"91429c817978b489984fb6a33fe6c53a"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
19328
expires
Sun, 27 Oct 2019 04:35:31 GMT
psilocybecubensisg868014788_1488553.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
25 KB
25 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/psilocybecubensisg868014788_1488553.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
34.225.50.222 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-225-50-222.compute-1.amazonaws.com
Software
nginx /
Resource Hash
8744ced6470d0961297be478b4f7e25cbb8a1638af4724a7b288ed9e9d79281a
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:35:31 GMT
last-modified
Wed, 20 Mar 2019 21:35:10 GMT
server
nginx
etag
"d27793312d362e7c469a592603df6968"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
25366
expires
Sun, 27 Oct 2019 04:35:31 GMT
drugdiscontinuedv3_1064038.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
115 KB
115 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/drugdiscontinuedv3_1064038.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
34.225.50.222 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-225-50-222.compute-1.amazonaws.com
Software
nginx /
Resource Hash
33fb5a762c31a731746d28a872769d3ef5ea3a2702ec4d0b7e0a7f9c9147bcc3
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:35:31 GMT
last-modified
Wed, 20 Mar 2019 19:40:26 GMT
server
nginx
etag
"f6a0f19c10cfeb68f9e7b6151f2c6acb"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
117644
expires
Sun, 27 Oct 2019 04:35:31 GMT
imfinzi_1215044.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
396 KB
396 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/imfinzi_1215044.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
34.225.50.222 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-225-50-222.compute-1.amazonaws.com
Software
nginx /
Resource Hash
397486cc51c9de9801c4edd9fb26b4ff81b25b770528ef43cd5ebebb6c541b13
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:35:31 GMT
last-modified
Wed, 20 Mar 2019 21:40:53 GMT
server
nginx
etag
"bcc532d51fe6cfece965d6933a3fb75f"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
405197
expires
Sun, 27 Oct 2019 04:35:31 GMT
diabeteswordstethoscopess4_1161209.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
198 KB
198 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/diabeteswordstethoscopess4_1161209.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
34.225.50.222 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-225-50-222.compute-1.amazonaws.com
Software
nginx /
Resource Hash
2a3c8fc442100be71fa62aecfe6c6db82d0074d9b5b982940fb96dc402afb703
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:35:31 GMT
last-modified
Thu, 21 Mar 2019 02:16:44 GMT
server
nginx
etag
"5f22abd2a5ef67a3b2900b245acc55bf"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
202699
expires
Sun, 27 Oct 2019 04:35:31 GMT
ptsddictionaryns_980920.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
94 KB
94 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/ptsddictionaryns_980920.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
34.225.50.222 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-225-50-222.compute-1.amazonaws.com
Software
nginx /
Resource Hash
d4bcb251006ecf5b401b479c59b7c07234d028ebf9e5d1d8ed4614eee91b3d72
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:35:31 GMT
last-modified
Thu, 21 Mar 2019 01:57:32 GMT
server
nginx
etag
"d49a4f6766779788d9c31427aa2de1c8"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
95751
expires
Sun, 27 Oct 2019 04:35:31 GMT
Vitamin-D-G-966728568.jpg
www.empr.com/wp-content/uploads/sites/7/2019/08/
15 KB
15 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2019/08/Vitamin-D-G-966728568.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
34.225.50.222 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-225-50-222.compute-1.amazonaws.com
Software
nginx /
Resource Hash
a54d3bff6a0eee0fd36bfdb96e571636fca0fde8e8524daf3ea38fcbe3a834c8
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:35:31 GMT
last-modified
Tue, 20 Aug 2019 07:11:10 GMT
server
nginx
etag
"d48c32930511e22f7ebc5af253ad08e7"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
15163
expires
Sun, 27 Oct 2019 04:35:31 GMT
vaccine-elder-G-697574085.jpg
www.empr.com/wp-content/uploads/sites/7/2019/08/
29 KB
30 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2019/08/vaccine-elder-G-697574085.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
34.225.50.222 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-225-50-222.compute-1.amazonaws.com
Software
nginx /
Resource Hash
04fd413245ae05c0ec3f793814266315a74f2107767c3614b34ed89764663795
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:35:31 GMT
last-modified
Wed, 28 Aug 2019 07:11:39 GMT
server
nginx
etag
"9d14a07273387f773bcbcf4546473573"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
30073
expires
Sun, 27 Oct 2019 04:35:31 GMT
hpvhumanpapillomavirusss51_1198880.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
174 KB
174 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/hpvhumanpapillomavirusss51_1198880.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
34.225.50.222 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-225-50-222.compute-1.amazonaws.com
Software
nginx /
Resource Hash
8461c8b27e1ab73d3b920835dc71668152c013ee563c97fbbc53ee8c32b09038
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:35:31 GMT
last-modified
Wed, 20 Mar 2019 21:53:50 GMT
server
nginx
etag
"9806f7b5f298b316797015d1ba8e41f2"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
177790
expires
Sun, 27 Oct 2019 04:35:31 GMT
trivisc_1524557.jpg
www.empr.com/wp-content/uploads/sites/7/2019/02/
15 KB
16 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2019/02/trivisc_1524557.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
34.225.50.222 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-225-50-222.compute-1.amazonaws.com
Software
nginx /
Resource Hash
6bc323bb55caf9db36461181e8ecdc648456d6d1f28bce914c6d716cee9835ce
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:35:31 GMT
last-modified
Wed, 20 Mar 2019 09:12:50 GMT
server
nginx
etag
"e6ee37f5fe43b2fffdd30fe6033c0c64"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
15632
expires
Sun, 27 Oct 2019 04:35:31 GMT
tourettesyndromess547721980_1314936.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
28 KB
28 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/tourettesyndromess547721980_1314936.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
34.225.50.222 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-225-50-222.compute-1.amazonaws.com
Software
nginx /
Resource Hash
cb391edd0de3ef3afb6e8960e8609017ccd3f39fd009219154d79dd9bae6b7cb
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:35:31 GMT
last-modified
Thu, 21 Mar 2019 01:42:12 GMT
server
nginx
etag
"d69aa343cd6d5b97b01a18591d7c31a7"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
28203
expires
Sun, 27 Oct 2019 04:35:31 GMT
proairdigihaler_1518132.jpg
www.empr.com/wp-content/uploads/sites/7/2019/01/
85 KB
85 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2019/01/proairdigihaler_1518132.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
34.225.50.222 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-225-50-222.compute-1.amazonaws.com
Software
nginx /
Resource Hash
aab6776d26273b51bcb25e1058f3ef503b39ac1e5219dbaa6f20927c140669c0
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:35:31 GMT
last-modified
Wed, 20 Mar 2019 09:05:39 GMT
server
nginx
etag
"df9960e2bc2fde003ca96940cae19bbb"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
86852
expires
Sun, 27 Oct 2019 04:35:31 GMT
painmanagementipad_1123350.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
222 KB
223 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/painmanagementipad_1123350.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
34.225.50.222 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-225-50-222.compute-1.amazonaws.com
Software
nginx /
Resource Hash
6003829935cc8575fbf4e925dace1c877be37ef8a64db4e4d36ba9cccb81ced8
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:35:31 GMT
last-modified
Wed, 20 Mar 2019 21:52:16 GMT
server
nginx
etag
"e10544aaa8142aad98c8f792023e6f75"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
227393
expires
Sun, 27 Oct 2019 04:35:31 GMT
pediatricinfluenzag525444523_1408391.jpg
www.pulmonologyadvisor.com/wp-content/uploads/sites/21/2019/01/
96 KB
97 KB
Image
General
Full URL
https://www.pulmonologyadvisor.com/wp-content/uploads/sites/21/2019/01/pediatricinfluenzag525444523_1408391.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
34.225.50.222 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-225-50-222.compute-1.amazonaws.com
Software
nginx /
Resource Hash
4e501c17d8c5779bf86d7be7f64a8743c9286dc9ec478fbf0acebb84632f26a2
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:35:31 GMT
last-modified
Sun, 24 Mar 2019 01:06:04 GMT
server
nginx
etag
"4ddafc55d5516fb2ceb6168e454ba7a1"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
98499
expires
Sun, 27 Oct 2019 04:35:31 GMT
drugshortage_1054458.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
120 KB
121 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/drugshortage_1054458.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
34.225.50.222 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-225-50-222.compute-1.amazonaws.com
Software
nginx /
Resource Hash
acc5e3a4ec186ddd04bf3dc78cc2b00b5664aca1214c6c9460285400cce759f6
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:35:31 GMT
last-modified
Wed, 20 Mar 2019 19:53:41 GMT
server
nginx
etag
"49cfba416ab2d7120d74f1e1f629e21f"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
123016
expires
Sun, 27 Oct 2019 04:35:31 GMT
imfinzidurvalumabns_1376023.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
30 KB
30 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/imfinzidurvalumabns_1376023.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
34.225.50.222 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-225-50-222.compute-1.amazonaws.com
Software
nginx /
Resource Hash
cb02a588c74d4f4d1220ad2c949acad7308a47b5d81420d649cc4a189ea44b1d
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:35:31 GMT
last-modified
Thu, 21 Mar 2019 00:04:15 GMT
server
nginx
etag
"d5875e6571d077f3d9ae4a8d58ca2c79"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
30829
expires
Sun, 27 Oct 2019 04:35:31 GMT
a58b0e37cbad321631b80bb5fdfe6522_clientImage_xlarge_original_1.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
32 KB
33 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/a58b0e37cbad321631b80bb5fdfe6522_clientImage_xlarge_original_1.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
34.225.50.222 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-225-50-222.compute-1.amazonaws.com
Software
nginx /
Resource Hash
ef4b924da9d8dd8119518323f50bcb8f0a3953228b9995ea6398e4e56209aefe
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:35:31 GMT
last-modified
Wed, 20 Mar 2019 19:42:18 GMT
server
nginx
etag
"de2f1f3c9fd0f5520fe8e57a136ace0f"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
33127
expires
Sun, 27 Oct 2019 04:35:31 GMT
Image-1.jpg
www.empr.com/wp-content/uploads/sites/7/2019/06/
580 KB
580 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2019/06/Image-1.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
34.225.50.222 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-225-50-222.compute-1.amazonaws.com
Software
nginx /
Resource Hash
5a546cfcdf18d9f64acea85800d8ce7348338fa4ccaaed237041bdc4bb12737e
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:35:31 GMT
last-modified
Wed, 03 Jul 2019 07:14:48 GMT
server
nginx
etag
"f6b543ac50a13e6fe67fe41962772498"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
593486
expires
Sun, 27 Oct 2019 04:35:31 GMT
genericpillsg92964678_1248233.jpg
www.empr.com/wp-content/uploads/sites/7/2019/01/
133 KB
134 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2019/01/genericpillsg92964678_1248233.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
34.225.50.222 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-225-50-222.compute-1.amazonaws.com
Software
nginx /
Resource Hash
719a7e9a6d7b5858bb3e6f52044f7e3314d8e831a50558e7fde876c23b41abd7
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:35:31 GMT
last-modified
Wed, 20 Mar 2019 09:10:04 GMT
server
nginx
etag
"18b3d88a0fc76fd4c9d4ca87bd066f99"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
136647
expires
Sun, 27 Oct 2019 04:35:31 GMT
FDA-logo-FI-1-1.png
www.empr.com/wp-content/uploads/sites/7/2019/04/
426 KB
427 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2019/04/FDA-logo-FI-1-1.png
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
34.225.50.222 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-225-50-222.compute-1.amazonaws.com
Software
nginx /
Resource Hash
92f43f03582b5fa6ab35f37ba18f5e9b532fe6105c262a7ad0879bd1b3a565c7
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:35:31 GMT
last-modified
Wed, 24 Apr 2019 07:11:37 GMT
server
nginx
etag
"ebd14b1e1b6d11a26972094f1799ed78"
x-frame-options
SAMEORIGIN
content-type
image/png
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
436575
expires
Sun, 27 Oct 2019 04:35:31 GMT
wavecreststimulator_1501071.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
18 KB
18 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/wavecreststimulator_1501071.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
34.225.50.222 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-225-50-222.compute-1.amazonaws.com
Software
nginx /
Resource Hash
6f288f48917269872aabf9f5f79383b1fff2974f0ae1fbf30bd65636489e69ad
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:35:31 GMT
last-modified
Wed, 20 Mar 2019 21:56:01 GMT
server
nginx
etag
"7d236e7220ba4b2c25b9da61117846ac"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
18115
expires
Sun, 27 Oct 2019 04:35:31 GMT
passwordg973902638_1523532.jpg
www.empr.com/wp-content/uploads/sites/7/2019/01/
24 KB
25 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2019/01/passwordg973902638_1523532.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
34.225.50.222 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-225-50-222.compute-1.amazonaws.com
Software
nginx /
Resource Hash
2d407ec30530520d2ba4a86a5bf4c00d8060ceb0fea21b796ab71b12e1016fd8
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:35:31 GMT
last-modified
Wed, 20 Mar 2019 09:09:32 GMT
server
nginx
etag
"f8aa6327e76cf710ec74960caf2480e1"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
24960
expires
Sun, 27 Oct 2019 04:35:31 GMT
blood-pressure-monitoring-gaug_755889.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
42 KB
42 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/blood-pressure-monitoring-gaug_755889.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
34.225.50.222 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-225-50-222.compute-1.amazonaws.com
Software
nginx /
Resource Hash
5fbf2db66ae1d2af5ac41e878a9fe20ed5574bd073ada8c03ef2b2f7f9efea5d
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:35:31 GMT
last-modified
Wed, 20 Mar 2019 21:51:56 GMT
server
nginx
etag
"ab4da90a63e54226c2854b46fcca3c97"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
42649
expires
Sun, 27 Oct 2019 04:35:31 GMT
ads
securepubads.g.doubleclick.net/gampad/
4 KB
2 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=3816467843477988&correlator=3548141125121021&output=ldjh&impl=fif&adsid=NT&eid=21064387%2C21064592&vrg=2019091901&guci=1.2.0.0.2.2.0.0&plat=1%3A32776%2C2%3A16809992%2C8%3A134250504&sc=1&sfv=1-0-35&ecs=20190927&iu=%2F5745%2Fmpr_us%2Fhome%2Fnews%2FOOP_prestitial&sz=1x1&ists=1&scp=pos%3DOOP_prestitial&eri=1&cust_params=pagetype%3Dpost%26sponsor%3D%26comp%3D%26author%3DSteve%2520Duffy%26postID%3D124119%26env%3Dlive%26sid%3DNews%26styleid%3D%26cat%3DOncology%252CRespiratory_and_Thoracic_Cancers%26atype%3DMPR_Drug_News%26block%3DHMN_Abilify_Reserve_107385%252CHMN_Nasal_Glucagon_2019%252CHMN_Rexulti_2019%252CHMN_Sanofi_2019%252CHMN_Tecfidera_2019%252Cmpr_basaglar042616%252CTest%26isnht%3Dfalse%26browser%3DChrome%252074%26subid%3D0%26usrc%3Dhaymarket%26eid%3D4765f0213a10614f6c52b4556676d479ec4f181705feaedbccdcef78c850b74a%26amid%3D7ae510fe18e7431582eb749cfc8567497d75868fa53d079af4ef35f92eebbf33%26spr%3D448%26ssp%3D%26cpn%3Dpcp_md%252Cfp_md%252Cpcp_all%252Charvonitbg%252Cepclusalistb_jan2019%252Cepclusa_april_2019%26LyticsSegments%3Dga_med_nomycme%252Cga_med_nht_false%252Cmycme_rheum_survey_audience%252Cmycme_4638_audience%252Conc_town_wall_audience%252Con_town_wall_audience_use_this%252Con_town_wall_audience_use_this_no_gastro%252C3_day_visitors_neuro_ca_empr%252Cblackfriday_notunknown%252Cactivity_5126_audience%252Cmycme_endofyearsale_noanonymous_nosdc%252Caudience_for_mlk_sale%252Cnot_unknown_5770%252Cmycme_activity_5762%252Call%252Csmt_new%252Cly_reporting_from_email%252Cly_reporting_has_visited_web%252Cly_reporting_multi_session_visitor%252Cly_reporting_last_visit_within_day%252Cly_reporting_last_visit_within_week%252Cly_reporting_last_visit_within_month%252Cly_reporting_last_visit_within_3_months%252Cly_known_email%252Cly_repeat_visitor%252Cly_international_visitor%252Cly_uses_desktop%252Cly_from_email%252Cknown%252Call_time_visitors%252Cmycme_allergy_all_except_4797_completes%252Cmycme_hiv_all_except_4670_completes%252Cmycme_internal_med_all_except_4670_completes%252Cmycme_allergy_all_except_4744_completes%252Cmycme_psychiatry_all_except_4812_completes%252Cmycme_cardiology_all_except_cardiology_pas%252Cmycme_dermatology_all_except_4831_completes%252Cmycme_pediatrics_all_except_4354_completes%252Cmycme_acc_next_activity_promo_no_4523%252Cmycme_acc_next_activity_promo_no_4524%252Cmycme_acc_next_activity_promo_no_4525%252Cmycme_acc_next_activity_promo_no_4526%252Cmycme_acc_next_activity_promo_no_4593%252Cmycme_acc_next_activity_promo_no_4595%252Cmycme_acc_next_activity_promo_no_4710%252Cmycme_acc_next_activity_promo_no_4804%252Cmycme_acc_next_activity_promo_no_4834%252Cmycme_acc_next_activity_promo_no_4800%252Cmycme_acc_next_activity_promo_no_4792%252Cmycme_acc_next_activity_promo_no_4511%252Cmycme_acc_next_activity_promo_no_4529%252Cmycme_acc_next_activity_promo_no_4558%252Cmycme_acc_next_activity_promo_no_4634%252Cmycme_impact_next_activity_promo_no_4740%252Cmycme_impact_next_activity_promo_no_4757%252Cmycme_impact_next_activity_promo_no_4842%252Cmycme_impact_next_activity_promo_no_4816%252Cmycme_impact_next_activity_promo_no_4897%252Cmycme_impact_next_activity_promo_no_4727%252Cmycme_impact_next_activity_promo_no_4755%252Cmycme_impact_next_activity_promo_no_4791%252Cmycme_impact_next_activity_promo_no_47911%252Cmycme_impact_next_activity_promo_no_4826%252Cmycme_impact_next_activity_promo_no_4815%252Cce_excluding_mpr_print_subscribers%252Cce_excluding_ca_print_subscribers%252Cga_med_known%252Cnace_conversations_in_onc_ona%252Cmycme_homepage_ibs_town_wall_%252Cmycme_ddw_nash%252Cmycme_cll_may_16%252Cemailops060619%252Cmycme_activity_5841_2%252Cmycme_pediatrics_activity_5591&cookie_enabled=1&bc=31&abxe=1&lmt=1569558931&dt=1569558931592&dlt=1569558929880&idt=697&frm=20&biw=1585&bih=1200&oid=3&adx=0&ady=4069&adk=1518026067&uci=1&ifi=1&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&dssz=78&icsg=38070590111748&mso=67108864&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=1585x4070&msz=1585x1&ga_vid=1601973801.1569558930&ga_sid=1569558932&ga_hid=503328978&fws=4&ohw=1585
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019091901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.162 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s11-in-f2.1e100.net
Software
cafe /
Resource Hash
538eeb4c52038047bc8e54debcaf7891fbf3422f735fd0f483fd7b4d3c84f3d5
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:31 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
1978
x-xss-protection
0
google-lineitem-id
132788185
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138287632758
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.empr.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
pubads_impl_rendering_2019091901.js
securepubads.g.doubleclick.net/gpt/
62 KB
24 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091901.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019091901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.162 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s11-in-f2.1e100.net
Software
sffe /
Resource Hash
a29b20518a3bb583278ebb330cba43e072795b7009b39f3479819d00f0833064
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:31 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Thu, 19 Sep 2019 13:07:51 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
24151
x-xss-protection
0
expires
Fri, 27 Sep 2019 04:35:31 GMT
container.html
tpc.googlesyndication.com/safeframe/1-0-35/html/
0
0
Other
General
Full URL
https://tpc.googlesyndication.com/safeframe/1-0-35/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019091901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81e::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
/
Resource Hash

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

registration-profession
subapi.haymarketmedia.com/
589 B
876 B
XHR
General
Full URL
https://subapi.haymarketmedia.com/registration-profession?countryCode=US
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.vendor.js?ver=0.1.1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.172.78.117 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-35-172-78-117.compute-1.amazonaws.com
Software
/ Express
Resource Hash
808e5dda9ebf9cae0ae42a7f53c8c335e6f2951724c8a58c15658d0fdd49b61f

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

date
Fri, 27 Sep 2019 04:35:31 GMT
x-powered-by
Express
etag
W/"24d-pNT5lZLPsLHhX4AYX72K6qXLTk4"
status
200
access-control-allow-methods
GET, POST, OPTIONS
content-type
application/json; charset=utf-8
access-control-allow-origin
*
access-control-allow-credentials
true
access-control-allow-headers
Content-Type, Connection, Keep-Alive, Content-Length
content-length
589
registration-specialty
subapi.haymarketmedia.com/
2 KB
2 KB
XHR
General
Full URL
https://subapi.haymarketmedia.com/registration-specialty?countryCode=US
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.vendor.js?ver=0.1.1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.172.78.117 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-35-172-78-117.compute-1.amazonaws.com
Software
/ Express
Resource Hash
2ccc2d6a6ce64b8e30228624183547c2456f8d9597ca456d147f47e95f4fe443

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

date
Fri, 27 Sep 2019 04:35:31 GMT
x-powered-by
Express
etag
W/"686-ZUbw46JA9hG3Fv9uXg61Vkj0+q0"
status
200
access-control-allow-methods
GET, POST, OPTIONS
content-type
application/json; charset=utf-8
access-control-allow-origin
*
access-control-allow-credentials
true
access-control-allow-headers
Content-Type, Connection, Keep-Alive, Content-Length
content-length
1670
truncated
/
88 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
65af014c9562d3ef38dbb4638bef464aa19d2c5899e1872b6ec96da9046168e5

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/svg+xml;charset=utf-8
universal-tag.js
ads.spotible.com/tag/ Frame 18C9
4 KB
2 KB
Script
General
Full URL
https://ads.spotible.com/tag/universal-tag.js
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.205.176.240 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-205-176-240.compute-1.amazonaws.com
Software
/
Resource Hash
8a846df9c01f4d8d8b6e82c6e505069104280430b3b05d94a13a5b99d7c854aa

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:35:31 GMT
Content-Encoding
gzip
ETag
"5c736e518f66ceaaee6badc00016e1a5"
Vary
Accept-Encoding
Content-Type
application/javascript
Cache-Control
public, max-age=3600
Connection
keep-alive
Content-Length
1767
truncated
/ Frame 18C9
216 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
2fb7e78ece3fe64f8f94c1dda266f0aa6708ef5c01e787440f8f96f54344945c

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
osd.js
www.googletagservices.com/activeview/js/current/
77 KB
29 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd.js?cb=%2Fr20100101
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019091901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:816::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
218087ed3854e672a6627b47c86b3a97e1dad722daa9f509fe522b33b01302a2
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:31 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1569237451959804"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
29169
x-xss-protection
0
expires
Fri, 27 Sep 2019 04:35:31 GMT
/
adtrackapi.haymarketmedia.com/adverttracking/
2 B
364 B
XHR
General
Full URL
https://adtrackapi.haymarketmedia.com/adverttracking/
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-adtracking-js/prod/adtracking.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:20bb:5400:16:bc48:4dc0:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-type
application/json

Response headers

date
Fri, 27 Sep 2019 04:35:32 GMT
via
1.1 63db28734e1b9429c04087abd41a1692.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA56
x-amzn-requestid
d7254e39-c888-4334-ae24-d0335f109e9c
status
200
x-cache
Miss from cloudfront
content-type
application/json
access-control-allow-origin
*
x-amzn-trace-id
Root=1-5d8d9194-3c6f4da51901afc94b538810;Sampled=0
x-amz-apigw-id
AqOvLFRTIAMF8Xw=
content-length
2
x-amz-cf-id
w2t5zA1u0Bg11fFORHIMrUogyhqO-ojd9iVFE2C2wbuMIroi_z8Ktw==
creative-delivery.js
ads.spotible.com/creative/aiv6/
58 KB
20 KB
Script
General
Full URL
https://ads.spotible.com/creative/aiv6/creative-delivery.js
Requested by
Host: ads.spotible.com
URL: https://ads.spotible.com/tag/universal-tag.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.205.176.240 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-205-176-240.compute-1.amazonaws.com
Software
/
Resource Hash
8bb87b6a883fd75428afe9c39a568eea8415cb06565b55f77483dcfedf440290

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:35:31 GMT
Content-Encoding
gzip
ETag
"c009dc01c1c99388f07743f6b22a012f"
Vary
Accept-Encoding
Content-Type
application/javascript
Cache-Control
no-cache
transfer-encoding
chunked
Connection
keep-alive
MPR-lightbox_640x480_Sept_1_.png
cdn1.spotible.com/hashed/65b04db536233c88899551573fc5aa10/
193 KB
194 KB
Image
General
Full URL
https://cdn1.spotible.com/hashed/65b04db536233c88899551573fc5aa10/MPR-lightbox_640x480_Sept_1_.png
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.214.7 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-214-7.fra53.r.cloudfront.net
Software
/
Resource Hash
7a1eaf913cf2579fc6b89d3a474cc9def653fa4d36702569d75b54fce2502519

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Wed, 18 Sep 2019 11:41:09 GMT
via
1.1 80d90c7955dda88e3912960ead8e99d6.cloudfront.net (CloudFront)
age
145202
etag
"65b04db536233c88899551573fc5aa10"
x-cache
Hit from cloudfront
status
200
cache-control
public, max-age=604800
x-amz-cf-pop
FRA53-C1
accept-ranges
bytes
content-length
197880
x-amz-cf-id
DRleGxM1gjNlsY0cRgVcB0AtpDpQupsI681Zc8f_yYfWiIqzVAU5Bg==
ads
securepubads.g.doubleclick.net/gampad/
20 KB
6 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=3816467843477988&correlator=3548141125121021&output=ldjh&impl=fif&adsid=NT&eid=21064387%2C21064592&vrg=2019091901&guci=1.2.0.0.2.2.0.0&plat=1%3A32776%2C2%3A16809992%2C8%3A134250504&sc=1&sfv=1-0-35&ecs=20190927&iu=%2F5745%2Fmpr_us%2Fhome%2Fnews%2Fleaderboard_top&sz=728x90&scp=pos%3Dleaderboard_top%26amid%3D7ae510fe18e7431582eb749cfc8567497d75868fa53d079af4ef35f92eebbf33%26atype%3DMPR_Drug_News%26author%3DSteve%2520Duffy%26block%3DHMN_Abilify_Reserve_107385%2CHMN_Nasal_Glucagon_2019%2CHMN_Rexulti_2019%2CHMN_Sanofi_2019%2CHMN_Tecfidera_2019%2Cmpr_basaglar042616%2CTest%26browser%3DChrome%252074%26cat%3DOncology%2CRespiratory_and_Thoracic_Cancers%26comp%3D%26eid%3D4765f0213a10614f6c52b4556676d479ec4f181705feaedbccdcef78c850b74a%26env%3Dlive%26isnht%3Dfalse%26pagetype%3Dpost%26postID%3D124119%26sid%3DNews%26sponsor%3D%26spr%3D448%26ssp%3D%26styleid%3D%26subid%3D0%26usrc%3Dhaymarket&eri=1&cust_params=pagetype%3Dpost%26sponsor%3D%26comp%3D%26author%3DSteve%2520Duffy%26postID%3D124119%26env%3Dlive%26sid%3DNews%26styleid%3D%26cat%3DOncology%252CRespiratory_and_Thoracic_Cancers%26atype%3DMPR_Drug_News%26block%3DHMN_Abilify_Reserve_107385%252CHMN_Nasal_Glucagon_2019%252CHMN_Rexulti_2019%252CHMN_Sanofi_2019%252CHMN_Tecfidera_2019%252Cmpr_basaglar042616%252CTest%26isnht%3Dfalse%26browser%3DChrome%252074%26subid%3D0%26usrc%3Dhaymarket%26eid%3D4765f0213a10614f6c52b4556676d479ec4f181705feaedbccdcef78c850b74a%26amid%3D7ae510fe18e7431582eb749cfc8567497d75868fa53d079af4ef35f92eebbf33%26spr%3D448%26ssp%3D%26cpn%3Dpcp_md%252Cfp_md%252Cpcp_all%252Charvonitbg%252Cepclusalistb_jan2019%252Cepclusa_april_2019%26LyticsSegments%3Dga_med_nomycme%252Cga_med_nht_false%252Cmycme_rheum_survey_audience%252Cmycme_4638_audience%252Conc_town_wall_audience%252Con_town_wall_audience_use_this%252Con_town_wall_audience_use_this_no_gastro%252C3_day_visitors_neuro_ca_empr%252Cblackfriday_notunknown%252Cactivity_5126_audience%252Cmycme_endofyearsale_noanonymous_nosdc%252Caudience_for_mlk_sale%252Cnot_unknown_5770%252Cmycme_activity_5762%252Call%252Csmt_new%252Cly_reporting_from_email%252Cly_reporting_has_visited_web%252Cly_reporting_multi_session_visitor%252Cly_reporting_last_visit_within_day%252Cly_reporting_last_visit_within_week%252Cly_reporting_last_visit_within_month%252Cly_reporting_last_visit_within_3_months%252Cly_known_email%252Cly_repeat_visitor%252Cly_international_visitor%252Cly_uses_desktop%252Cly_from_email%252Cknown%252Call_time_visitors%252Cmycme_allergy_all_except_4797_completes%252Cmycme_hiv_all_except_4670_completes%252Cmycme_internal_med_all_except_4670_completes%252Cmycme_allergy_all_except_4744_completes%252Cmycme_psychiatry_all_except_4812_completes%252Cmycme_cardiology_all_except_cardiology_pas%252Cmycme_dermatology_all_except_4831_completes%252Cmycme_pediatrics_all_except_4354_completes%252Cmycme_acc_next_activity_promo_no_4523%252Cmycme_acc_next_activity_promo_no_4524%252Cmycme_acc_next_activity_promo_no_4525%252Cmycme_acc_next_activity_promo_no_4526%252Cmycme_acc_next_activity_promo_no_4593%252Cmycme_acc_next_activity_promo_no_4595%252Cmycme_acc_next_activity_promo_no_4710%252Cmycme_acc_next_activity_promo_no_4804%252Cmycme_acc_next_activity_promo_no_4834%252Cmycme_acc_next_activity_promo_no_4800%252Cmycme_acc_next_activity_promo_no_4792%252Cmycme_acc_next_activity_promo_no_4511%252Cmycme_acc_next_activity_promo_no_4529%252Cmycme_acc_next_activity_promo_no_4558%252Cmycme_acc_next_activity_promo_no_4634%252Cmycme_impact_next_activity_promo_no_4740%252Cmycme_impact_next_activity_promo_no_4757%252Cmycme_impact_next_activity_promo_no_4842%252Cmycme_impact_next_activity_promo_no_4816%252Cmycme_impact_next_activity_promo_no_4897%252Cmycme_impact_next_activity_promo_no_4727%252Cmycme_impact_next_activity_promo_no_4755%252Cmycme_impact_next_activity_promo_no_4791%252Cmycme_impact_next_activity_promo_no_47911%252Cmycme_impact_next_activity_promo_no_4826%252Cmycme_impact_next_activity_promo_no_4815%252Cce_excluding_mpr_print_subscribers%252Cce_excluding_ca_print_subscribers%252Cga_med_known%252Cnace_conversations_in_onc_ona%252Cmycme_homepage_ibs_town_wall_%252Cmycme_ddw_nash%252Cmycme_cll_may_16%252Cemailops060619%252Cmycme_activity_5841_2%252Cmycme_pediatrics_activity_5591&cookie=ID%3D8ef9adabcaf64527%3AT%3D1569558931%3AS%3DALNI_MaQyj8MLoiFlNqv9mhW5yXDAnK6zA&cookie_enabled=1&bc=31&abxe=1&lmt=1569558932&dt=1569558932257&dlt=1569558929880&idt=697&frm=20&biw=1585&bih=1200&oid=3&adx=193&ady=140&adk=2785330797&uci=2&ifi=2&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&dssz=80&icsg=152282360446980&mso=67108864&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=1200x-1&msz=1200x-1&psts=Ci8I2d-oP-gB9qLXlIMEggIVsbmAD9G59iGBw_Yh8e3PNLfIz49R0QKSwJJcgI7Tjg&ga_vid=1601973801.1569558930&ga_sid=1569558932&ga_hid=503328978&fws=516&ohw=1585
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019091901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.162 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s11-in-f2.1e100.net
Software
cafe /
Resource Hash
a46294826b4b30760616049dfedcdb770a17d1d9aa94eb37571c2f55fedc8ffb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:32 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
5715
x-xss-protection
0
google-lineitem-id
5144421111
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138278274851
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.empr.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
Cookie set rt=ifr
bcp.crwdcntrl.net/5/c=14413/rand=714902447/pv=y/ver=1.4/int=%23OpR%2396858%23Total%20Site%20Traffic%20%3A%20www.empr.com/int=%23OpR%2396859%23www.empr.com%20%3A%20Site%20Section%20%3A%20home/int=%2... Frame 2D63
0
0
Document
General
Full URL
https://bcp.crwdcntrl.net/5/c=14413/rand=714902447/pv=y/ver=1.4/int=%23OpR%2396858%23Total%20Site%20Traffic%20%3A%20www.empr.com/int=%23OpR%2396859%23www.empr.com%20%3A%20Site%20Section%20%3A%20home/int=%23OpR%2396860%23www.empr.com%20%3A%20Site%20Section%20%3A%20home%20%20%3A%20news/int=%23OpR%2397492%23www.empr.com%20%3A%20Site%20Section%20%3A%20home%20%3A%20news%20%3A%20atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/med=%23OpR%2397539%23Article%20Tags%20%3A%20Oncology%2CRespiratory%20and%20Thoracic%20Cancers/rb=%7B%22url%22%3A%22https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653%22%7D/rt=ifr
Requested by
Host: tags.crwdcntrl.net
URL: https://tags.crwdcntrl.net/c/14413/cc.js?ver=1.4&ns=_cc14413
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.200.54.67 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-18-200-54-67.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash

Request headers

Host
bcp.crwdcntrl.net
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
Sec-Fetch-Site
cross-site
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Accept-Encoding
gzip, deflate, br
Cookie
_cc_dc=1; _cc_id=90eac7e3b74cfa126cc5d7b163f6f80c; _cc_cc="ACZ4nGNQsDRITUw2TzVOMjdJTks0NDJLTjZNMU8yNDNOM0uzMEhmAILY3omTGBAAAG7GC34%3D"; _cc_aud="ABR4nGNgYGCI7Z04iQEOABljAg4%3D"
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653

Response headers

Access-Control-Allow-Origin
*
Cache-Control
no-cache
Content-Encoding
gzip
Content-Type
text/html;charset=UTF-8
Date
Fri, 27 Sep 2019 04:35:32 GMT
Expires
0
P3P
CP=NOI DSP COR NID PSAa PSDa OUR UNI COM NAV
Pragma
no-cache
Set-Cookie
_cc_id=90eac7e3b74cfa126cc5d7b163f6f80c;Path=/;Domain=crwdcntrl.net;Expires=Tue, 23-Jun-2020 04:06:00 GMT;SameSite=None _cc_cc="ACZ4nGNQsDRITUw2TzVOMjdJTks0NDJLTjZNMU8yNDNOM0uzMEhmAILY3olT%2Fv3%2F%2F5%2BfAQZ4rs9sUWQ8W8Dwn5GRoXc6gn1qMoK9%2FE8hjPnmkyWM%2BWBqDyOMffn5HVkYe9VxdRjz8OI5LDD2BST2pVOP2GDs%2FcuPwrUCABZIQ8c%3D";Version=1;Path=/;Domain=crwdcntrl.net;Expires=Tue, 23-Jun-2020 04:06:00 GMT;Max-Age=23328000;SameSite=None _cc_aud="ABR4nGNgYGCI7Z04hQEGmBg4rtSCGBy3DwFJAE2tBRA%3D";Version=1;Path=/;Domain=crwdcntrl.net;Expires=Tue, 23-Jun-2020 04:06:00 GMT;Max-Age=23328000;SameSite=None
Vary
Accept-Encoding
X-Server
10.45.17.138
Content-Length
711
Connection
keep-alive
cs.js
sb.scorecardresearch.com/c2/21948019/
0
400 B
Script
General
Full URL
https://sb.scorecardresearch.com/c2/21948019/cs.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5XFK9V6
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.19.43.224 , Ascension Island, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a2-19-43-224.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:35:32 GMT
Content-Encoding
gzip
Last-Modified
Fri, 08 Apr 2011 23:11:26 GMT
ETag
"d41d8cd98f00b204e9800998ecf8427e:1349196464"
Vary
Accept-Encoding
Content-Type
application/x-javascript
Cache-Control
private, no-transform, max-age=259200
Connection
keep-alive
Content-Length
20
Expires
Mon, 30 Sep 2019 04:35:32 GMT
init-121b5si20pnxjymcwdz.js
api.b2c.com/api/
12 KB
5 KB
Script
General
Full URL
https://api.b2c.com/api/init-121b5si20pnxjymcwdz.js?isNHT=false
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5800:3282:b5ef:e766:4370 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
27ceaafaf5ba6ce304458663f1350033f91a9f68463b44fa12ef15655bdf634f

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:32 GMT
content-encoding
gzip
server
openresty
content-type
text/javascript
status
200
cache-control
no-cache, no-store, must-revalidate
expires
-1
collect
www.google-analytics.com/
35 B
133 B
Image
General
Full URL
https://www.google-analytics.com/collect?v=1&_v=j79&a=503328978&t=event&ni=1&_s=1&dl=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&ul=en-us&de=UTF-8&dt=Atezolizumab%20May%20Improve%20Survival%20for%20Some%20With%20Advanced%20Squamous%20NSCLC%20-%20MPR&sd=24-bit&sr=1600x1200&vp=1585x1200&je=0&ec=lytics_refresh&ea=undefined&_u=aGDAAAAjQ~&jid=&gjid=&cid=1601973801.1569558930&tid=UA-1290429-2&_gid=697230513.1569558930&gtm=2wg9i15XFK9V6&cd20=ga_med_nomycme%2Cga_med_nht_false%2Call%2Cga_med_known&cd21=&cd22=&cd23=&cd24=&cd25=&cd26=&cd27=&cd28=&cd29=&cd30=Normal%20(74%20segments%20found)&z=23283339
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
8337212354871836e6763a41e615916c89bac5b3f1f0adf60ba43c7c806e1015
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Thu, 22 Aug 2019 05:40:43 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
age
3106489
status
200
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
35
expires
Mon, 01 Jan 1990 00:00:00 GMT
up
insight.adsrvr.org/track/ Frame BEC1
0
0
Document
General
Full URL
https://insight.adsrvr.org/track/up?adv=wxli9bh&ref=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&upid=7fhq4wn&upv=1.1.0
Requested by
Host: js.adsrvr.org
URL: https://js.adsrvr.org/up_loader.1.1.0.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.248.255.146 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-34-248-255-146.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash

Request headers

:method
GET
:authority
insight.adsrvr.org
:scheme
https
:path
/track/up?adv=wxli9bh&ref=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&upid=7fhq4wn&upv=1.1.0
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
accept-encoding
gzip, deflate, br
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653

Response headers

status
200
date
Fri, 27 Sep 2019 04:35:32 GMT
content-type
text/html
cache-control
private,no-cache, must-revalidate
pragma
no-cache
x-aspnet-version
4.0.30319
p3p
CP="NOI DSP COR CUR ADMo DEVo PSAo PSDo OUR SAMo BUS UNI NAV"
collect
www.google-analytics.com/
35 B
93 B
Image
General
Full URL
https://www.google-analytics.com/collect?v=1&_v=j79&a=503328978&t=event&ni=1&_s=1&dl=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&ul=en-us&de=UTF-8&dt=Atezolizumab%20May%20Improve%20Survival%20for%20Some%20With%20Advanced%20Squamous%20NSCLC%20-%20MPR&sd=24-bit&sr=1600x1200&vp=1585x1200&je=0&ec=Scroll%20Depth&ea=%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F&el=25%25&ev=25&_u=aGDAAAAjQ~&jid=&gjid=&cid=1601973801.1569558930&tid=UA-1290429-2&_gid=697230513.1569558930&gtm=2wg9i15XFK9V6&z=47741025
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
8337212354871836e6763a41e615916c89bac5b3f1f0adf60ba43c7c806e1015
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Thu, 22 Aug 2019 05:40:43 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
age
3106489
status
200
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
35
expires
Mon, 01 Jan 1990 00:00:00 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame 209C
0
75 B
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjst5oHdsyxWdeAImnpRdEUAx9Q82VCfkEUQlnmUWYdbAfjkDxhz4PM8UoyY9XA5bHvp0uOp5Tn3m-_0Xk1rRr9Q7vSurg7waojIx16ZfVUucEkrEy93-kd0HiNn7zX6lMyTElUb433ccfuueMDbqOx6kRB9jWvweTgpZHMZxGoUjDLjAoYR8VYgAZhrPHTr8EuLhdYhcxev2gx9BPVRRuZBt5n_1mo5p3cH81K77KsDDAKF5lwEAFjoLSNYCEOrzfJiZuegNy0mA-rIkbnrAux_9RTA&sig=Cg0ArKJSzKuaOvEJRTf4EAE&adurl=
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.162 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s11-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 27 Sep 2019 04:35:32 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
0
x-xss-protection
0
window_focus.js
tpc.googlesyndication.com/pagead/js/r20190924/r20110914/client/ Frame 209C
2 KB
1 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20190924/r20110914/client/window_focus.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81e::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
d31b12baad65082a7d404da9971cc9fed871e35f29a5893f815f468f1050491f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 24 Sep 2019 13:57:32 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
225480
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
content-disposition
attachment; filename="f.txt"
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
1044
x-xss-protection
0
server
cafe
etag
16885093947315342629
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Tue, 08 Oct 2019 13:57:32 GMT
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame 209C
78 KB
29 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:816::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
6182dfae0694d2f06ce0ba9e18b21af30bdc62b4878767761059e6f03cba08e5
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:32 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1569237451959804"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
29692
x-xss-protection
0
expires
Fri, 27 Sep 2019 04:35:32 GMT
l
www.google.com/ads/measurement/ Frame 209C
0
0
Image
General
Full URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaRhFf8A-BclgUthQ4nAnslaiSI3qQVhyp6HKpZfhObzO4yDnDHbDIrag7XSPo6q607IlXu0R0uRatkqFvGzyKhN2Bu6Qg
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:820::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

init-132dn9au2z77uqg0m5w.js
api.b2c.com/api/ Frame 209C
13 KB
5 KB
Script
General
Full URL
https://api.b2c.com/api/init-132dn9au2z77uqg0m5w.js?AdUnitID_TopLevel=71146705&AdUnitID=21776212071&AdvertiserID=27496345&OrderID=415436905&LineItemID=5144421111&CreativeID=138278274851&CPN=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&sid=News
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091901.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5800:3282:b5ef:e766:4370 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
d720a46aa392008329dab97f3954f33c6da1c8a37a07ddb9fb49548ad52b5267

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:32 GMT
content-encoding
gzip
server
openresty
content-type
text/javascript
status
200
cache-control
no-cache, no-store, must-revalidate
expires
-1
15638570741095414737
tpc.googlesyndication.com/simgad/ Frame 209C
30 KB
30 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/15638570741095414737
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81e::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
892ff0b3166742d839aeb9027057d0bd3f0e9af48d70cbfa44f22952f9c1fcf0
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Wed, 28 Aug 2019 04:12:41 GMT
x-content-type-options
nosniff
age
2593371
x-dns-prefetch-control
off
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
30632
x-xss-protection
0
last-modified
Wed, 07 Aug 2019 16:56:48 GMT
server
sffe
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Thu, 27 Aug 2020 04:12:41 GMT
ads
securepubads.g.doubleclick.net/gampad/
20 KB
6 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=3816467843477988&correlator=3548141125121021&output=ldjh&impl=fif&adsid=NT&eid=21064387%2C21064592&vrg=2019091901&guci=1.2.0.0.2.2.0.0&plat=1%3A32776%2C2%3A16809992%2C8%3A134250504&sc=1&sfv=1-0-35&ecs=20190927&iu=%2F5745%2Fmpr_us%2Fhome%2Fnews%2Fbox_1&sz=300x250%7C300x600&scp=pos%3Dbox_1%26LyticsSegments%3Dga_med_nomycme%2Cga_med_nht_false%2Cmycme_rheum_survey_audience%2Cmycme_4638_audience%2Conc_town_wall_audience%2Con_town_wall_audience_use_this%2Con_town_wall_audience_use_this_no_gastro%2C3_day_visitors_neuro_ca_empr%2Cblackfriday_notunknown%2Cactivity_5126_audience%2Cmycme_endofyearsale_noanonymous_nosdc%2Caudience_for_mlk_sale%2Cnot_unknown_5770%2Cmycme_activity_5762%2Call%2Csmt_new%2Cly_reporting_from_email%2Cly_reporting_has_visited_web%2Cly_reporting_multi_session_visitor%2Cly_reporting_last_visit_within_day%2Cly_reporting_last_visit_within_week%2Cly_reporting_last_visit_within_month%2Cly_reporting_last_visit_within_3_months%2Cly_known_email%2Cly_repeat_visitor%2Cly_international_visitor%2Cly_uses_desktop%2Cly_from_email%2Cknown%2Call_time_visitors%2Cmycme_allergy_all_except_4797_completes%2Cmycme_hiv_all_except_4670_completes%2Cmycme_internal_med_all_except_4670_completes%2Cmycme_allergy_all_except_4744_completes%2Cmycme_psychiatry_all_except_4812_completes%2Cmycme_cardiology_all_except_cardiology_pas%2Cmycme_dermatology_all_except_4831_completes%2Cmycme_pediatrics_all_except_4354_completes%2Cmycme_acc_next_activity_promo_no_4523%2Cmycme_acc_next_activity_promo_no_4524%2Cmycme_acc_next_activity_promo_no_4525%2Cmycme_acc_next_activity_promo_no_4526%2Cmycme_acc_next_activity_promo_no_4593%2Cmycme_acc_next_activity_promo_no_4595%2Cmycme_acc_next_activity_promo_no_4710%2Cmycme_acc_next_activity_promo_no_4804%2Cmycme_acc_next_activity_promo_no_4834%2Cmycme_acc_next_activity_promo_no_4800%2Cmycme_acc_next_activity_promo_no_4792%2Cmycme_acc_next_activity_promo_no_4511%2Cmycme_acc_next_activity_promo_no_4529%2Cmycme_acc_next_activity_promo_no_4558%2Cmycme_acc_next_activity_promo_no_4634%2Cmycme_impact_next_activity_promo_no_4740%2Cmycme_impact_next_activity_promo_no_4757%2Cmycme_impact_next_activity_promo_no_4842%2Cmycme_impact_next_activity_promo_no_4816%2Cmycme_impact_next_activity_promo_no_4897%2Cmycme_impact_next_activity_promo_no_4727%2Cmycme_impact_next_activity_promo_no_4755%2Cmycme_impact_next_activity_promo_no_4791%2Cmycme_impact_next_activity_promo_no_47911%2Cmycme_impact_next_activity_promo_no_4826%2Cmycme_impact_next_activity_promo_no_4815%2Cce_excluding_mpr_print_subscribers%2Cce_excluding_ca_print_subscribers%2Cga_med_known%2Cnace_conversations_in_onc_ona%2Cmycme_homepage_ibs_town_wall_%2Cmycme_ddw_nash%2Cmycme_cll_may_16%2Cemailops060619%2Cmycme_activity_5841_2%2Cmycme_pediatrics_activity_5591%26amid%3D7ae510fe18e7431582eb749cfc8567497d75868fa53d079af4ef35f92eebbf33%26atype%3DMPR_Drug_News%26author%3DSteve%2520Duffy%26block%3DHMN_Abilify_Reserve_107385%2CHMN_Nasal_Glucagon_2019%2CHMN_Rexulti_2019%2CHMN_Sanofi_2019%2CHMN_Tecfidera_2019%2Cmpr_basaglar042616%2CTest%26browser%3DChrome%252074%26cat%3DOncology%2CRespiratory_and_Thoracic_Cancers%26comp%3D%26cpn%3Dpcp_md%252Cfp_md%252Cpcp_all%252Charvonitbg%252Cepclusalistb_jan2019%252Cepclusa_april_2019%26eid%3D4765f0213a10614f6c52b4556676d479ec4f181705feaedbccdcef78c850b74a%26env%3Dlive%26isnht%3Dfalse%26pagetype%3Dpost%26postID%3D124119%26sid%3DNews%26sponsor%3D%26spr%3D448%26ssp%3D%26styleid%3D%26subid%3D0%26usrc%3Dhaymarket%26lid%3D5144421111&eri=1&cust_params=pagetype%3Dpost%26sponsor%3D%26comp%3D%26author%3DSteve%2520Duffy%26postID%3D124119%26env%3Dlive%26sid%3DNews%26styleid%3D%26cat%3DOncology%252CRespiratory_and_Thoracic_Cancers%26atype%3DMPR_Drug_News%26block%3DHMN_Abilify_Reserve_107385%252CHMN_Nasal_Glucagon_2019%252CHMN_Rexulti_2019%252CHMN_Sanofi_2019%252CHMN_Tecfidera_2019%252Cmpr_basaglar042616%252CTest%26isnht%3Dfalse%26browser%3DChrome%252074%26subid%3D0%26usrc%3Dhaymarket%26eid%3D4765f0213a10614f6c52b4556676d479ec4f181705feaedbccdcef78c850b74a%26amid%3D7ae510fe18e7431582eb749cfc8567497d75868fa53d079af4ef35f92eebbf33%26spr%3D448%26ssp%3D%26cpn%3Dpcp_md%252Cfp_md%252Cpcp_all%252Charvonitbg%252Cepclusalistb_jan2019%252Cepclusa_april_2019%26LyticsSegments%3Dga_med_nomycme%252Cga_med_nht_false%252Cmycme_rheum_survey_audience%252Cmycme_4638_audience%252Conc_town_wall_audience%252Con_town_wall_audience_use_this%252Con_town_wall_audience_use_this_no_gastro%252C3_day_visitors_neuro_ca_empr%252Cblackfriday_notunknown%252Cactivity_5126_audience%252Cmycme_endofyearsale_noanonymous_nosdc%252Caudience_for_mlk_sale%252Cnot_unknown_5770%252Cmycme_activity_5762%252Call%252Csmt_new%252Cly_reporting_from_email%252Cly_reporting_has_visited_web%252Cly_reporting_multi_session_visitor%252Cly_reporting_last_visit_within_day%252Cly_reporting_last_visit_within_week%252Cly_reporting_last_visit_within_month%252Cly_reporting_last_visit_within_3_months%252Cly_known_email%252Cly_repeat_visitor%252Cly_international_visitor%252Cly_uses_desktop%252Cly_from_email%252Cknown%252Call_time_visitors%252Cmycme_allergy_all_except_4797_completes%252Cmycme_hiv_all_except_4670_completes%252Cmycme_internal_med_all_except_4670_completes%252Cmycme_allergy_all_except_4744_completes%252Cmycme_psychiatry_all_except_4812_completes%252Cmycme_cardiology_all_except_cardiology_pas%252Cmycme_dermatology_all_except_4831_completes%252Cmycme_pediatrics_all_except_4354_completes%252Cmycme_acc_next_activity_promo_no_4523%252Cmycme_acc_next_activity_promo_no_4524%252Cmycme_acc_next_activity_promo_no_4525%252Cmycme_acc_next_activity_promo_no_4526%252Cmycme_acc_next_activity_promo_no_4593%252Cmycme_acc_next_activity_promo_no_4595%252Cmycme_acc_next_activity_promo_no_4710%252Cmycme_acc_next_activity_promo_no_4804%252Cmycme_acc_next_activity_promo_no_4834%252Cmycme_acc_next_activity_promo_no_4800%252Cmycme_acc_next_activity_promo_no_4792%252Cmycme_acc_next_activity_promo_no_4511%252Cmycme_acc_next_activity_promo_no_4529%252Cmycme_acc_next_activity_promo_no_4558%252Cmycme_acc_next_activity_promo_no_4634%252Cmycme_impact_next_activity_promo_no_4740%252Cmycme_impact_next_activity_promo_no_4757%252Cmycme_impact_next_activity_promo_no_4842%252Cmycme_impact_next_activity_promo_no_4816%252Cmycme_impact_next_activity_promo_no_4897%252Cmycme_impact_next_activity_promo_no_4727%252Cmycme_impact_next_activity_promo_no_4755%252Cmycme_impact_next_activity_promo_no_4791%252Cmycme_impact_next_activity_promo_no_47911%252Cmycme_impact_next_activity_promo_no_4826%252Cmycme_impact_next_activity_promo_no_4815%252Cce_excluding_mpr_print_subscribers%252Cce_excluding_ca_print_subscribers%252Cga_med_known%252Cnace_conversations_in_onc_ona%252Cmycme_homepage_ibs_town_wall_%252Cmycme_ddw_nash%252Cmycme_cll_may_16%252Cemailops060619%252Cmycme_activity_5841_2%252Cmycme_pediatrics_activity_5591&cookie=ID%3D8ef9adabcaf64527%3AT%3D1569558931%3AS%3DALNI_MaQyj8MLoiFlNqv9mhW5yXDAnK6zA&cookie_enabled=1&bc=31&abxe=1&lmt=1569558932&dt=1569558932492&dlt=1569558929880&idt=697&frm=20&biw=1585&bih=1200&oid=3&adx=1053&ady=305&adk=204078694&uci=3&ifi=3&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&dssz=82&icsg=609129441787908&mso=67108864&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=300x250&msz=300x250&psts=Ci8I2d-oP-gB9qLXlIMEggIVsbmAD9G59iGBw_Yh8e3PNLfIz49R0QKSwJJcgI7Tjg%2CCjAI98WGlRPoAaOOnJCDBIICFbG5gA_RufYhgcP2IfHtzzTnwNqPUdECx1LF5FAGpbY&ga_vid=1601973801.1569558930&ga_sid=1569558932&ga_hid=503328978&fws=516&ohw=1585
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019091901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.162 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s11-in-f2.1e100.net
Software
cafe /
Resource Hash
eca760eaa6d98b1cd3a0d88d1b83b9312a67c82101158c08e02614a674c550b1
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:32 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
5693
x-xss-protection
0
google-lineitem-id
132783265
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
116494027225
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.empr.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
truncated
/ Frame 209C
213 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
6cf577b17f127e2a7210e9a0bb3517183bbb2a83613f21557000a3ea7e59f3dc

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
report
ads.spotible.com/creative/aiv6/
43 B
191 B
Image
General
Full URL
https://ads.spotible.com/creative/aiv6/report?,1569558932,773001;UNIQUE_USER_GLOBAL!0,1,0;UNIQUE_USER_DAILY!0,1,0;UNIQUE_USER_HOURLY!0,1,0;IMPRESSION!0,1,0!2,1,0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.205.176.240 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-205-176-240.compute-1.amazonaws.com
Software
/
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:35:32 GMT
Cache-Control
no-store
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
view
securepubads.g.doubleclick.net/pcs/
0
57 B
Image
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjstcYOtKegVwOEyobvOskrNuxYiZw7RdZibAIB-7bNqBUD-FxCunaDPVdb1WLNWlG-lW32ud42jtWLbCdzAWshOTf2Wzx4yZW9Ypg4RXDDTYthrAO2Xk14DybAJQ4Y75hwUPMWDgUcVxBnMnHXfn2OyRtdbM3461_LzPfq0e6UygwMm_-sEIlFvdCpN_yiGZ04vZziE0V47OTjiZ54LzlzihYG9kp3cUc5NxDhQGhE_P3rtSKm48wszfEhXk90MbwTFB_FSHCrG4Mn8EPINoy1YgDhWOT9iMCqnqPuufKYaecsayujWW9wUUw0nRJg&sai=AMfl-YRaRGV_5TdjkHNHwapYaA5GtzK-UzcQQTEcno7olfsSU7vTrMvzv-hkSMwgp8MCvTTWbtLPwzY4QbPf5HjKnf0-OjbJIT4SnR8PK0ebrw&sig=Cg0ArKJSzI38B79Z5xyqEAE&urlfix=1&adurl=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.162 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s11-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 27 Sep 2019 04:35:32 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
0
x-xss-protection
0
view
securepubads.g.doubleclick.net/pcs/ Frame C36C
0
57 B
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsto6BuMHOcfML0MxscZnlae9FCkEZNtZCVINwl8s6hp_xb2FfAeI7L2zWb6b-537nCijmgn78try3dyuyNserPYwKpai1mHB1lRebgi8dxtSGJesLBHm5zcwFlf8nbbvo_a1_Kk-gu2kCnF7tgpwnxM24SZ1OcYWNiKZ-8lp5xn45CYhNqLFGr901n5W4FhkYN_aEUGwPp4Lyc2scEn7MGX8-1Ct-WESYOd8TVFyoQBtzjA7X-8ATiV_0uSJVV6pMt2Xs2ecbHz&sig=Cg0ArKJSzIhyrQN-mFThEAE&adurl=
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.162 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s11-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 27 Sep 2019 04:35:32 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
0
x-xss-protection
0
window_focus.js
tpc.googlesyndication.com/pagead/js/r20190924/r20110914/client/ Frame C36C
2 KB
1 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20190924/r20110914/client/window_focus.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81e::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
d31b12baad65082a7d404da9971cc9fed871e35f29a5893f815f468f1050491f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 24 Sep 2019 13:57:32 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
225480
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
content-disposition
attachment; filename="f.txt"
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
1044
x-xss-protection
0
server
cafe
etag
16885093947315342629
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Tue, 08 Oct 2019 13:57:32 GMT
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame C36C
78 KB
29 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:816::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
6182dfae0694d2f06ce0ba9e18b21af30bdc62b4878767761059e6f03cba08e5
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:32 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1569237451959804"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
29692
x-xss-protection
0
expires
Fri, 27 Sep 2019 04:35:32 GMT
l
www.google.com/ads/measurement/ Frame C36C
0
0
Image
General
Full URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaS97j-ptl6-RWiPUfRVfpyHQbac-2vlCfLlt0x9O5jXoFdSLvR0Y64RqNbyEqx5gOq2JfcXs6HzmWKrpnrOs8gw1oLhJg
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:820::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

init-132dn9au2z77uqg0m5w.js
api.b2c.com/api/ Frame C36C
12 KB
5 KB
Script
General
Full URL
https://api.b2c.com/api/init-132dn9au2z77uqg0m5w.js?AdUnitID_TopLevel=71146705&AdUnitID=21776031401&AdvertiserID=27496345&OrderID=415436905&LineItemID=132783265&CreativeID=116494027225&CPN=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&sid=News
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091901.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5800:3282:b5ef:e766:4370 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
94cf02886e8215927276c48bab819789add376443782748917b49f0bc10bb837

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:32 GMT
content-encoding
gzip
server
openresty
content-type
text/javascript
status
200
cache-control
no-cache, no-store, must-revalidate
expires
-1
14655538721910231531
tpc.googlesyndication.com/simgad/ Frame C36C
86 KB
86 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/14655538721910231531
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81e::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
308e0a77d88613aa857a9af4e20cdba521e03f8b48d29ce4d170b1e5e275360a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:32 GMT
x-content-type-options
nosniff
last-modified
Thu, 02 Feb 2017 14:20:33 GMT
server
sffe
status
200
x-dns-prefetch-control
off
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
87630
x-xss-protection
0
expires
Sat, 26 Sep 2020 04:35:32 GMT
ads
securepubads.g.doubleclick.net/gampad/
20 KB
6 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=3816467843477988&correlator=3548141125121021&output=ldjh&impl=fif&adsid=NT&eid=21064387%2C21064592&vrg=2019091901&guci=1.2.0.0.2.2.0.0&plat=1%3A32776%2C2%3A16809992%2C8%3A134250504&sc=1&sfv=1-0-35&ecs=20190927&iu=%2F5745%2Fmpr_us%2Fhome%2Fnews%2Fbox_2&sz=300x250&scp=pos%3Dbox_2%26LyticsSegments%3Dga_med_nomycme%2Cga_med_nht_false%2Cmycme_rheum_survey_audience%2Cmycme_4638_audience%2Conc_town_wall_audience%2Con_town_wall_audience_use_this%2Con_town_wall_audience_use_this_no_gastro%2C3_day_visitors_neuro_ca_empr%2Cblackfriday_notunknown%2Cactivity_5126_audience%2Cmycme_endofyearsale_noanonymous_nosdc%2Caudience_for_mlk_sale%2Cnot_unknown_5770%2Cmycme_activity_5762%2Call%2Csmt_new%2Cly_reporting_from_email%2Cly_reporting_has_visited_web%2Cly_reporting_multi_session_visitor%2Cly_reporting_last_visit_within_day%2Cly_reporting_last_visit_within_week%2Cly_reporting_last_visit_within_month%2Cly_reporting_last_visit_within_3_months%2Cly_known_email%2Cly_repeat_visitor%2Cly_international_visitor%2Cly_uses_desktop%2Cly_from_email%2Cknown%2Call_time_visitors%2Cmycme_allergy_all_except_4797_completes%2Cmycme_hiv_all_except_4670_completes%2Cmycme_internal_med_all_except_4670_completes%2Cmycme_allergy_all_except_4744_completes%2Cmycme_psychiatry_all_except_4812_completes%2Cmycme_cardiology_all_except_cardiology_pas%2Cmycme_dermatology_all_except_4831_completes%2Cmycme_pediatrics_all_except_4354_completes%2Cmycme_acc_next_activity_promo_no_4523%2Cmycme_acc_next_activity_promo_no_4524%2Cmycme_acc_next_activity_promo_no_4525%2Cmycme_acc_next_activity_promo_no_4526%2Cmycme_acc_next_activity_promo_no_4593%2Cmycme_acc_next_activity_promo_no_4595%2Cmycme_acc_next_activity_promo_no_4710%2Cmycme_acc_next_activity_promo_no_4804%2Cmycme_acc_next_activity_promo_no_4834%2Cmycme_acc_next_activity_promo_no_4800%2Cmycme_acc_next_activity_promo_no_4792%2Cmycme_acc_next_activity_promo_no_4511%2Cmycme_acc_next_activity_promo_no_4529%2Cmycme_acc_next_activity_promo_no_4558%2Cmycme_acc_next_activity_promo_no_4634%2Cmycme_impact_next_activity_promo_no_4740%2Cmycme_impact_next_activity_promo_no_4757%2Cmycme_impact_next_activity_promo_no_4842%2Cmycme_impact_next_activity_promo_no_4816%2Cmycme_impact_next_activity_promo_no_4897%2Cmycme_impact_next_activity_promo_no_4727%2Cmycme_impact_next_activity_promo_no_4755%2Cmycme_impact_next_activity_promo_no_4791%2Cmycme_impact_next_activity_promo_no_47911%2Cmycme_impact_next_activity_promo_no_4826%2Cmycme_impact_next_activity_promo_no_4815%2Cce_excluding_mpr_print_subscribers%2Cce_excluding_ca_print_subscribers%2Cga_med_known%2Cnace_conversations_in_onc_ona%2Cmycme_homepage_ibs_town_wall_%2Cmycme_ddw_nash%2Cmycme_cll_may_16%2Cemailops060619%2Cmycme_activity_5841_2%2Cmycme_pediatrics_activity_5591%26amid%3D7ae510fe18e7431582eb749cfc8567497d75868fa53d079af4ef35f92eebbf33%26atype%3DMPR_Drug_News%26author%3DSteve%2520Duffy%26block%3DHMN_Abilify_Reserve_107385%2CHMN_Nasal_Glucagon_2019%2CHMN_Rexulti_2019%2CHMN_Sanofi_2019%2CHMN_Tecfidera_2019%2Cmpr_basaglar042616%2CTest%26browser%3DChrome%252074%26cat%3DOncology%2CRespiratory_and_Thoracic_Cancers%26comp%3D%26cpn%3Dpcp_md%252Cfp_md%252Cpcp_all%252Charvonitbg%252Cepclusalistb_jan2019%252Cepclusa_april_2019%26eid%3D4765f0213a10614f6c52b4556676d479ec4f181705feaedbccdcef78c850b74a%26env%3Dlive%26isnht%3Dfalse%26pagetype%3Dpost%26postID%3D124119%26sid%3DNews%26sponsor%3D%26spr%3D448%26ssp%3D%26styleid%3D%26subid%3D0%26usrc%3Dhaymarket%26lid%3D5144421111%2C132783265&eri=1&cust_params=pagetype%3Dpost%26sponsor%3D%26comp%3D%26author%3DSteve%2520Duffy%26postID%3D124119%26env%3Dlive%26sid%3DNews%26styleid%3D%26cat%3DOncology%252CRespiratory_and_Thoracic_Cancers%26atype%3DMPR_Drug_News%26block%3DHMN_Abilify_Reserve_107385%252CHMN_Nasal_Glucagon_2019%252CHMN_Rexulti_2019%252CHMN_Sanofi_2019%252CHMN_Tecfidera_2019%252Cmpr_basaglar042616%252CTest%26isnht%3Dfalse%26browser%3DChrome%252074%26subid%3D0%26usrc%3Dhaymarket%26eid%3D4765f0213a10614f6c52b4556676d479ec4f181705feaedbccdcef78c850b74a%26amid%3D7ae510fe18e7431582eb749cfc8567497d75868fa53d079af4ef35f92eebbf33%26spr%3D448%26ssp%3D%26cpn%3Dpcp_md%252Cfp_md%252Cpcp_all%252Charvonitbg%252Cepclusalistb_jan2019%252Cepclusa_april_2019%26LyticsSegments%3Dga_med_nomycme%252Cga_med_nht_false%252Cmycme_rheum_survey_audience%252Cmycme_4638_audience%252Conc_town_wall_audience%252Con_town_wall_audience_use_this%252Con_town_wall_audience_use_this_no_gastro%252C3_day_visitors_neuro_ca_empr%252Cblackfriday_notunknown%252Cactivity_5126_audience%252Cmycme_endofyearsale_noanonymous_nosdc%252Caudience_for_mlk_sale%252Cnot_unknown_5770%252Cmycme_activity_5762%252Call%252Csmt_new%252Cly_reporting_from_email%252Cly_reporting_has_visited_web%252Cly_reporting_multi_session_visitor%252Cly_reporting_last_visit_within_day%252Cly_reporting_last_visit_within_week%252Cly_reporting_last_visit_within_month%252Cly_reporting_last_visit_within_3_months%252Cly_known_email%252Cly_repeat_visitor%252Cly_international_visitor%252Cly_uses_desktop%252Cly_from_email%252Cknown%252Call_time_visitors%252Cmycme_allergy_all_except_4797_completes%252Cmycme_hiv_all_except_4670_completes%252Cmycme_internal_med_all_except_4670_completes%252Cmycme_allergy_all_except_4744_completes%252Cmycme_psychiatry_all_except_4812_completes%252Cmycme_cardiology_all_except_cardiology_pas%252Cmycme_dermatology_all_except_4831_completes%252Cmycme_pediatrics_all_except_4354_completes%252Cmycme_acc_next_activity_promo_no_4523%252Cmycme_acc_next_activity_promo_no_4524%252Cmycme_acc_next_activity_promo_no_4525%252Cmycme_acc_next_activity_promo_no_4526%252Cmycme_acc_next_activity_promo_no_4593%252Cmycme_acc_next_activity_promo_no_4595%252Cmycme_acc_next_activity_promo_no_4710%252Cmycme_acc_next_activity_promo_no_4804%252Cmycme_acc_next_activity_promo_no_4834%252Cmycme_acc_next_activity_promo_no_4800%252Cmycme_acc_next_activity_promo_no_4792%252Cmycme_acc_next_activity_promo_no_4511%252Cmycme_acc_next_activity_promo_no_4529%252Cmycme_acc_next_activity_promo_no_4558%252Cmycme_acc_next_activity_promo_no_4634%252Cmycme_impact_next_activity_promo_no_4740%252Cmycme_impact_next_activity_promo_no_4757%252Cmycme_impact_next_activity_promo_no_4842%252Cmycme_impact_next_activity_promo_no_4816%252Cmycme_impact_next_activity_promo_no_4897%252Cmycme_impact_next_activity_promo_no_4727%252Cmycme_impact_next_activity_promo_no_4755%252Cmycme_impact_next_activity_promo_no_4791%252Cmycme_impact_next_activity_promo_no_47911%252Cmycme_impact_next_activity_promo_no_4826%252Cmycme_impact_next_activity_promo_no_4815%252Cce_excluding_mpr_print_subscribers%252Cce_excluding_ca_print_subscribers%252Cga_med_known%252Cnace_conversations_in_onc_ona%252Cmycme_homepage_ibs_town_wall_%252Cmycme_ddw_nash%252Cmycme_cll_may_16%252Cemailops060619%252Cmycme_activity_5841_2%252Cmycme_pediatrics_activity_5591&cookie=ID%3D8ef9adabcaf64527%3AT%3D1569558931%3AS%3DALNI_MaQyj8MLoiFlNqv9mhW5yXDAnK6zA&cookie_enabled=1&bc=31&abxe=1&lmt=1569558932&dt=1569558932715&dlt=1569558929880&idt=697&frm=20&biw=1585&bih=1200&oid=3&adx=1053&ady=1176&adk=3917873969&uci=4&ifi=4&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fatezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&dssz=82&icsg=609129441787908&mso=67108864&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=300x283&msz=300x250&psts=Ci8IobmoP-gB2ZPX_LEDggIVsbmAD9G59iGBw_Yh8e3PNKm9z49R0QKY2Zg3gEj9Yw%2CCi8I2d-oP-gB9qLXlIMEggIVsbmAD9G59iGBw_Yh8e3PNLfIz49R0QKSwJJcgI7Tjg%2CCjAI98WGlRPoAaOOnJCDBIICFbG5gA_RufYhgcP2IfHtzzTnwNqPUdECx1LF5FAGpbY&ga_vid=1601973801.1569558930&ga_sid=1569558932&ga_hid=503328978&fws=516&ohw=1585
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019091901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.162 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s11-in-f2.1e100.net
Software
cafe /
Resource Hash
ea435e335b80cec0680feac205710447f5a1cecf7af3304346bd4f84efb673af
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:32 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
5692
x-xss-protection
0
google-lineitem-id
132783265
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138231809754
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.empr.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
truncated
/ Frame C36C
214 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
ae97be9789cfeb75923e6846ca36cf057da96578b7360dc7ba445b4b0f94dfd0

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
/
adtrackapi.haymarketmedia.com/adverttracking/
2 B
366 B
XHR
General
Full URL
https://adtrackapi.haymarketmedia.com/adverttracking/
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-adtracking-js/prod/adtracking.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:20bb:5400:16:bc48:4dc0:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-type
application/json

Response headers

date
Fri, 27 Sep 2019 04:35:33 GMT
via
1.1 63db28734e1b9429c04087abd41a1692.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA56
x-amzn-requestid
c18e8e04-76f0-44cc-9604-71f3bb3627cc
status
200
x-cache
Miss from cloudfront
content-type
application/json
access-control-allow-origin
*
x-amzn-trace-id
Root=1-5d8d9195-376c4061c8771dd06e7e4fcf;Sampled=0
x-amz-apigw-id
AqOvVFiqIAMFoIw=
content-length
2
x-amz-cf-id
J-xRAf0_RscWZ7pzGoaqAMCEILZqSb8cvJi_ag9ZUBgZeSW3VbX4qQ==
view
securepubads.g.doubleclick.net/pcs/ Frame 3F23
0
57 B
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsv9JYOTnuL2Z4_-OEx9uPzKPQyZ8OkNbTXTkk0mRQQGNJjZo2zDk_5iZzGjz5VFv64HBBYerDR1IWIhxwm7-e101qSkHhFPVB--ge--E0dgyYnhxTHLAxpKMrLfh8O345qFABEwLF_YR4CiTLpnUCJoP0YRsHIIawR-tw9EMTawctZX-YZXgMoy-gHe87S0Fs_r-CJPS8e8o6xQsbLCPiRQ--zHXTobUKohDdF3Cwq011foa-g8sRxIeUaLNJqCU9tkzB2IfYQC&sig=Cg0ArKJSzPLcfP3ijgOwEAE&adurl=
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.162 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s11-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 27 Sep 2019 04:35:32 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
0
x-xss-protection
0
window_focus.js
tpc.googlesyndication.com/pagead/js/r20190924/r20110914/client/ Frame 3F23
2 KB
1 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20190924/r20110914/client/window_focus.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81e::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
d31b12baad65082a7d404da9971cc9fed871e35f29a5893f815f468f1050491f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 24 Sep 2019 13:57:32 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
225480
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
content-disposition
attachment; filename="f.txt"
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
1044
x-xss-protection
0
server
cafe
etag
16885093947315342629
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Tue, 08 Oct 2019 13:57:32 GMT
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame 3F23
78 KB
29 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:816::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
6182dfae0694d2f06ce0ba9e18b21af30bdc62b4878767761059e6f03cba08e5
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:35:32 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1569237451959804"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
29692
x-xss-protection
0
expires
Fri, 27 Sep 2019 04:35:32 GMT
l
www.google.com/ads/measurement/ Frame 3F23
0
0
Image
General
Full URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaT5KDvwwUiCiBAouKRCRFe4SuiNDH7llaposzYv_Oxu7TtUN8Dyz42MOaVkMAjC_6IkM8rL6zlJbwr2LeSwfdrhz_2jJA
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:820::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

init-132dn9au2z77uqg0m5w.js
api.b2c.com/api/ Frame 3F23
12 KB
5 KB
Script
General
Full URL
https://api.b2c.com/api/init-132dn9au2z77uqg0m5w.js?AdUnitID_TopLevel=71146705&AdUnitID=21776031404&AdvertiserID=27496345&OrderID=415436905&LineItemID=132783265&CreativeID=138231809754&CPN=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&sid=News
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091901.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5800:3282:b5ef:e766:4370 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
20a92b466756d6736c034b6165b411633db4d9e8c92ec14957d34ce4a5475c5d

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:32 GMT
content-encoding
gzip
server
openresty
content-type
text/javascript
status
200
cache-control
no-cache, no-store, must-revalidate
expires
-1
16030660017714012110
tpc.googlesyndication.com/simgad/ Frame 3F23
48 KB
48 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/16030660017714012110
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81e::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
4daa8b467725da84b7f12beba99f81c390ddfdffa7bda838aed65663f266941c
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 20 Sep 2019 15:31:30 GMT
x-content-type-options
nosniff
age
565442
x-dns-prefetch-control
off
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
49437
x-xss-protection
0
last-modified
Thu, 02 Feb 2017 14:35:44 GMT
server
sffe
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Sat, 19 Sep 2020 15:31:30 GMT
truncated
/ Frame 3F23
213 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
b9647f9e3a760d1e82d0e24c3d86ae5e52890e9ed5ad875baf7884d21086e714

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
ad.gif
api-54-203-125-28.b2c.com/api/ Frame 209C
43 B
233 B
Image
General
Full URL
https://api-54-203-125-28.b2c.com/api/ad.gif
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5802:b89c:c3ee:ab7e:71f1 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:35:33 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
/
adtrackapi.haymarketmedia.com/adverttracking/
2 B
364 B
XHR
General
Full URL
https://adtrackapi.haymarketmedia.com/adverttracking/
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-adtracking-js/prod/adtracking.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:20bb:5400:16:bc48:4dc0:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-type
application/json

Response headers

date
Fri, 27 Sep 2019 04:35:33 GMT
via
1.1 63db28734e1b9429c04087abd41a1692.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA56
x-amzn-requestid
ab5ca6e2-7dcf-4690-b622-b8efee6d7170
status
200
x-cache
Miss from cloudfront
content-type
application/json
access-control-allow-origin
*
x-amzn-trace-id
Root=1-5d8d9195-f72a5c450da30af204d5674e;Sampled=0
x-amz-apigw-id
AqOvVHAJIAMFs9g=
content-length
2
x-amz-cf-id
uT-V4UvBY774Gbv0rWwP1kT3PvyUbWSeKOyrS_xgRixBQ7reM20lYA==
ad.gif
api-54-245-184-141.b2c.com/api/
43 B
233 B
Image
General
Full URL
https://api-54-245-184-141.b2c.com/api/ad.gif
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5800:23c6:3b85:d7f5:6913 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:35:33 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
ad.gif
api-35-166-13-162.b2c.com/api/ Frame C36C
43 B
233 B
Image
General
Full URL
https://api-35-166-13-162.b2c.com/api/ad.gif
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5800:18fd:5331:bb62:1421 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:35:33 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
ad.gif
api-34-219-221-191.b2c.com/api/ Frame 3F23
43 B
233 B
Image
General
Full URL
https://api-34-219-221-191.b2c.com/api/ad.gif
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5802:dbb0:2341:5b61:3e04 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:35:33 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
4
api-54-203-125-28.b2c.com/api/ Frame 209C
Redirect Chain
  • https://api-54-203-125-28.b2c.com/api/x?lTqdDOoZhzUwKMFp$dXJsJDAkaHR0cHM6Ly93d3cuZW1wci5jb20vaG9tZS9uZXdzL2F0ZXpvbGl6dW1hYi1tYXktaW1wcm92ZS1zdXJ2aXZhbC1mb3Itc29tZS13aXRoLWFkdmFuY2VkLXNxdWFtb3VzLW5z...
  • https://api-54-203-125-28.b2c.com:444/api/4?lTqdDOoZhzUwKMFp
43 B
441 B
XHR
General
Full URL
https://api-54-203-125-28.b2c.com:444/api/4?lTqdDOoZhzUwKMFp
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.203.125.28 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-54-203-125-28.us-west-2.compute.amazonaws.com
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 27 Sep 2019 04:35:34 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
image/gif
Access-Control-Allow-Origin
null
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
43
Expires
-1

Redirect headers

Date
Fri, 27 Sep 2019 04:35:33 GMT
Server
openresty
Location
https://api-54-203-125-28.b2c.com:444/api/4?lTqdDOoZhzUwKMFp
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/html
Access-Control-Allow-Origin
https://www.empr.com
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
142
/
adtrackapi.haymarketmedia.com/adverttracking/
2 B
364 B
XHR
General
Full URL
https://adtrackapi.haymarketmedia.com/adverttracking/
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-adtracking-js/prod/adtracking.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:20bb:5400:16:bc48:4dc0:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-type
application/json

Response headers

date
Fri, 27 Sep 2019 04:35:33 GMT
via
1.1 63db28734e1b9429c04087abd41a1692.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA56
x-amzn-requestid
9314cae3-b10a-49a5-9ef5-2a2f89612a7b
status
200
x-cache
Miss from cloudfront
content-type
application/json
access-control-allow-origin
*
x-amzn-trace-id
Root=1-5d8d9195-ad71e7117a624161f6d59463;Sampled=0
x-amz-apigw-id
AqOvaH-1oAMFY0Q=
content-length
2
x-amz-cf-id
EbH1vnSdsxlVF0IvKt7P1pHBS8WSz3N1Z7fBze-3I6MNe87NWOqvpg==
4
api-54-245-184-141.b2c.com/api/
Redirect Chain
  • https://api-54-245-184-141.b2c.com/api/x?nmvGW6zwFAyOY7Gj$dXJsJDAkaHR0cHM6Ly93d3cuZW1wci5jb20vaG9tZS9uZXdzL2F0ZXpvbGl6dW1hYi1tYXktaW1wcm92ZS1zdXJ2aXZhbC1mb3Itc29tZS13aXRoLWFkdmFuY2VkLXNxdWFtb3VzLW5...
  • https://api-54-245-184-141.b2c.com:444/api/4?nmvGW6zwFAyOY7Gj
43 B
441 B
XHR
General
Full URL
https://api-54-245-184-141.b2c.com:444/api/4?nmvGW6zwFAyOY7Gj
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.245.184.141 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-54-245-184-141.us-west-2.compute.amazonaws.com
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 27 Sep 2019 04:35:34 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
image/gif
Access-Control-Allow-Origin
null
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
43
Expires
-1

Redirect headers

Date
Fri, 27 Sep 2019 04:35:33 GMT
Server
openresty
Location
https://api-54-245-184-141.b2c.com:444/api/4?nmvGW6zwFAyOY7Gj
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/html
Access-Control-Allow-Origin
https://www.empr.com
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
142
4
api-35-166-13-162.b2c.com/api/ Frame C36C
Redirect Chain
  • https://api-35-166-13-162.b2c.com/api/x?cAdUZQMT5wFwWu5Y$dXJsJDAkaHR0cHM6Ly93d3cuZW1wci5jb20vaG9tZS9uZXdzL2F0ZXpvbGl6dW1hYi1tYXktaW1wcm92ZS1zdXJ2aXZhbC1mb3Itc29tZS13aXRoLWFkdmFuY2VkLXNxdWFtb3VzLW5z...
  • https://api-35-166-13-162.b2c.com:444/api/4?cAdUZQMT5wFwWu5Y
43 B
441 B
XHR
General
Full URL
https://api-35-166-13-162.b2c.com:444/api/4?cAdUZQMT5wFwWu5Y
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.166.13.162 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-35-166-13-162.us-west-2.compute.amazonaws.com
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 27 Sep 2019 04:35:34 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
image/gif
Access-Control-Allow-Origin
null
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
43
Expires
-1

Redirect headers

Date
Fri, 27 Sep 2019 04:35:33 GMT
Server
openresty
Location
https://api-35-166-13-162.b2c.com:444/api/4?cAdUZQMT5wFwWu5Y
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/html
Access-Control-Allow-Origin
https://www.empr.com
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
142
4
api-34-219-221-191.b2c.com/api/ Frame 3F23
Redirect Chain
  • https://api-34-219-221-191.b2c.com/api/x?xX0Lj6s33Hw3Bheo$dXJsJDAkaHR0cHM6Ly93d3cuZW1wci5jb20vaG9tZS9uZXdzL2F0ZXpvbGl6dW1hYi1tYXktaW1wcm92ZS1zdXJ2aXZhbC1mb3Itc29tZS13aXRoLWFkdmFuY2VkLXNxdWFtb3VzLW5...
  • https://api-34-219-221-191.b2c.com:444/api/4?xX0Lj6s33Hw3Bheo
43 B
441 B
XHR
General
Full URL
https://api-34-219-221-191.b2c.com:444/api/4?xX0Lj6s33Hw3Bheo
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.219.221.191 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-34-219-221-191.us-west-2.compute.amazonaws.com
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 27 Sep 2019 04:35:34 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
image/gif
Access-Control-Allow-Origin
null
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
43
Expires
-1

Redirect headers

Date
Fri, 27 Sep 2019 04:35:33 GMT
Server
openresty
Location
https://api-34-219-221-191.b2c.com:444/api/4?xX0Lj6s33Hw3Bheo
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/html
Access-Control-Allow-Origin
https://www.empr.com
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
142
x
api-54-203-125-28.b2c.com/api/ Frame 209C
0
382 B
Other
General
Full URL
https://api-54-203-125-28.b2c.com/api/x?lTqdDOoZhzUwKMFp$YWRibG9jayQ1MzYkMA
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5802:b89c:c3ee:ab7e:71f1 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Pragma
no-cache
Date
Fri, 27 Sep 2019 04:35:33 GMT
Server
openresty
Transfer-Encoding
chunked
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/plain
Access-Control-Allow-Origin
https://www.empr.com
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Expires
-1
activeview
pagead2.googlesyndication.com/pcs/ Frame 209C
42 B
274 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjst5BC0dQ1lDiAJwor1FmDv0ACAKU_kMeH9RFh3qbE9PPzV5LJ9DqrzwyB43-RZoi_QQ_KVkvLv9UpJiyBturCyg1DMVrq4w-HZOJr9lKDI&sig=Cg0ArKJSzGE3NEi-ZoWmEAE&adk=2785330797&tt=1118&bs=1585%2C1200&mtos=1077,1077,1077,1077,1077&tos=1077,0,0,0,0&p=140,429,230,1157&mcvt=1077&rs=3&ht=0&tfs=818&tls=1895&mc=1&lte=1&bas=0&bac=0&met=no&avms=nio&niot_obs=765&niot_cbk=778&md=2&lm=2&rst=1569558932488&rpt=27&isd=0&msd=0&oseid=3&xdi=0&uup=1&ps=1585%2C4159&ss=1600%2C1200&pt=778&bin=1&deb=1-1-4-8-19-10-53-18-0-0-0&tvt=1889&r=v&id=osdim&vs=4&za&uc=11&upc=1&tgt=DIV&cl=1&cec=1&clc=1&cac=1&cd=728x90&itpl=3&v=20190923
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:816::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:33 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
status
200
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
no-cache, must-revalidate
content-type
image/gif
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
x
api-54-245-184-141.b2c.com/api/
0
382 B
Other
General
Full URL
https://api-54-245-184-141.b2c.com/api/x?nmvGW6zwFAyOY7Gj$YWRibG9jayQ1MjgkMA
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5800:23c6:3b85:d7f5:6913 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Pragma
no-cache
Date
Fri, 27 Sep 2019 04:35:33 GMT
Server
openresty
Transfer-Encoding
chunked
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/plain
Access-Control-Allow-Origin
https://www.empr.com
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Expires
-1
x
api-35-166-13-162.b2c.com/api/ Frame C36C
0
382 B
Other
General
Full URL
https://api-35-166-13-162.b2c.com/api/x?cAdUZQMT5wFwWu5Y$YWRibG9jayQ1MzIkMA
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5800:18fd:5331:bb62:1421 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Pragma
no-cache
Date
Fri, 27 Sep 2019 04:35:33 GMT
Server
openresty
Transfer-Encoding
chunked
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/plain
Access-Control-Allow-Origin
https://www.empr.com
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Expires
-1
x
api-34-219-221-191.b2c.com/api/ Frame 3F23
0
382 B
Other
General
Full URL
https://api-34-219-221-191.b2c.com/api/x?xX0Lj6s33Hw3Bheo$YWRibG9jayQ1MzYkMA
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5802:dbb0:2341:5b61:3e04 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Pragma
no-cache
Date
Fri, 27 Sep 2019 04:35:33 GMT
Server
openresty
Transfer-Encoding
chunked
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/plain
Access-Control-Allow-Origin
https://www.empr.com
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Expires
-1
activeview
pagead2.googlesyndication.com/pcs/ Frame C36C
42 B
110 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjss02aeZ8czUPIW32ITBP65V0ATEAel7ygT_Zrh_3pd5N_VVqKKHG6F7ELKssL7swcAQE6ZWeGdte-wakWzr3HV03swVen9a1vq8VZ0BxLU&sig=Cg0ArKJSzC9CQ_wQO_OsEAE&adk=204078694&tt=1523&bs=1585%2C1200&mtos=1077,1077,1077,1077,1077&tos=1077,0,0,0,0&p=305,1053,905,1353&mcvt=1077&rs=3&ht=0&tfs=1223&tls=2300&mc=1&lte=1&bas=0&bac=0&met=no&avms=nio&niot_obs=988&niot_cbk=999&md=2&lm=2&rst=1569558932710&rpt=142&isd=0&msd=0&oseid=3&xdi=0&uup=1&ps=1585%2C4159&ss=1600%2C1200&pt=778&bin=1&deb=1-1-4-10-23-10-71-22-0-0-0&tvt=2294&r=v&id=osdim&vs=4&za&uc=13&upc=11&tgt=DIV&cl=1&cec=1&clc=1&cac=1&cd=300x600&itpl=3&v=20190923
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:816::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:35:34 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
status
200
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
no-cache, must-revalidate
content-type
image/gif
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
close_button2.png
cdn1.spotible.com/hashed/74483a4bff0849849588dbf32a396fe9/
1 KB
2 KB
Image
General
Full URL
https://cdn1.spotible.com/hashed/74483a4bff0849849588dbf32a396fe9/close_button2.png
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.214.7 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-214-7.fra53.r.cloudfront.net
Software
/
Resource Hash
f42e34b205a7c2ac4a0997e0b1eb2627e76ee8ae15ac7a15b05954827e186dd9

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 17 Sep 2019 08:54:47 GMT
via
1.1 80d90c7955dda88e3912960ead8e99d6.cloudfront.net (CloudFront)
age
236890
etag
"74483a4bff0849849588dbf32a396fe9"
x-cache
Hit from cloudfront
status
200
cache-control
public, max-age=604800
x-amz-cf-pop
FRA53-C1
accept-ranges
bytes
content-length
1429
x-amz-cf-id
M_1KSQ5PhKoTlipKwtroOnxNZHaae6vL6oFOLDMybP7DX13dMfKhBw==
report
ads.spotible.com/creative/aiv6/
43 B
191 B
Image
General
Full URL
https://ads.spotible.com/creative/aiv6/report?,1569558932,773003;IMPRESSION!4,1,0!5,1,0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.205.176.240 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-205-176-240.compute-1.amazonaws.com
Software
/
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/atezolizumab-may-improve-survival-for-some-with-advanced-squamous-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:35:36 GMT
Cache-Control
no-store
Connection
keep-alive
Content-Length
43
Content-Type
image/gif

Verdicts & Comments Add Verdict or Comment

200 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

object| onformdata object| onpointerrawupdate number| pamEnabled object| hmAds object| dataLayer object| $ function| jQuery function| cookie object| _cc14413 object| LOTCC object| Digest function| UtilityMove object| core object| __core-js_shared__ object| global object| System function| asap function| Observable function| setImmediate function| clearImmediate object| regeneratorRuntime boolean| _babelPolyfill object| googletag object| ggeac object| closure_memoize_cache_ object| googleToken object| googleIMState object| google_js_reporting_queue function| processGoogleToken object| google_tag_manager string| GoogleAnalyticsObject function| ga string| adTrackProxyPath string| advertTrackingApiUrl boolean| trackImpressionsViewable object| clickedAd boolean| isOverIFrame object| dfpRequests function| waitFor function| DataLayerExist function| AdSlotsRegistered function| TrackPassbackImpression function| TrackImpression function| TrackImpressionViewable function| AdClick function| checkDuplicateImpression function| callApi function| AmazonWebService function| createAdTrackingMessage function| getAJAXObject function| trackAdvert function| xdTrackAdvert function| getRenderedAd function| EventType function| getPageDetails function| getPageName function| getSection1 function| getPageType function| getDevice function| getValueFromTargets function| getPageTypeId function| getBrowser function| getUser function| getDfpTimestamp function| getCookies function| getTimeStamp function| ProcessMouseOut function| ProcessMouseOver function| processIFrameClick function| getDfpUrlFor function| getDfpUrls function| logAdvertRequested object| dataLayerService function| hmHeaderLoginState object| dfpAdSlots object| mapping object| adSlotsConfig object| allowedSlots string| hmHomeUrl string| hmAccountUrl object| hmRegisteredAds boolean| hmAdsLazyload number| hmAdsActiveRefresh boolean| hmAdsCommentsHouse boolean| hmDmdAimEnabled boolean| hmProclivityEnabled boolean| hmAdsActiveRefreshAll boolean| hmAdsBoxReposition boolean| hmAdsLytics object| adSlots number| adDebug object| hmProclivity string| cpn object| haymarketCustomEvents string| redirect object| google_tag_data object| gaplugins object| gaGlobal object| gaData object| epas function| maropostInitTracking string| name_funnel function| _132350 string| name_funnel1 function| _13235 object| data object| ids object| epasAPI object| hm_localize object| hm_gated object| date function| isStorageSupported function| truncateItem function| storeData function| removeData function| retrieveData function| readStorage function| getExpiration object| CE2 string| __INDIVIDUAL_ONE_VERSION_ev-store_ENFORCE_SINGLETON undefined| __INDIVIDUAL_ONE_VERSION_ev-store object| TenUp object| liosetup object| jstag object| hmAuthNoncePromise function| disqus_config object| hmRegisterPrompt function| hmSetLyticsData object| adblockDetector object| pageVars object| wp function| hmOpenRegisterPrompt object| AIM object| _ml object| google_optimize function| webpackJsonp function| __jstag_onload undefined| initObj string| ly_cid object| _atrk_opts function| fbq function| _fbq function| retry function| isIE10OrLater function| detectPrivateMode undefined| google_measure_js_timing boolean| google_noFetch number| __google_ad_urls_id object| ns_ function| atrk boolean| _atrk_fired object| lio string| set_domain function| domain_name function| deleteMaroClickScriptTag function| maroRecordClick function| anchor_event_add function| maroRecordTime function| maroTrackInit object| _0x4777 function| _0x5be4 object| optimizely object| pathfora function| HMIRegistration object| ssoLogin object| ssoRegister function| ttd_dom_ready function| TTDUniversalPixelApi number| google_unique_id object| google_reactive_ads_global_state function| Goog_AdSense_getAdAdapterInstance function| Goog_AdSense_OsdAdapter object| __google_ad_urls object| ampInaboxIframes object| ampInaboxPendingMessages boolean| google_osd_loaded boolean| google_onload_fired function| Goog_Osd_UnloadAdBlock function| Goog_Osd_UpdateElementToMeasure function| google_osd_amcb object| prontoTags object| ProntoCE object| ProntoDOMEvents object| gtm string| string1 string| string2 string| string3 string| string4 string| string5 string| string6 string| string7 string| string8 string| string9 string| string10 number| lySegmentCounter string| result string| key function| checkForCPNSegments function| logit function| __$PP

37 Cookies

Domain/Path Name / Value
www.medtargetsystem.com/ Name: DMDSESSID
Value: 9ba74aem1dmpubvj1klbsjb4b6
.empr.com/ Name: __gads
Value: ID=8ef9adabcaf64527:T=1569558931:S=ALNI_MaQyj8MLoiFlNqv9mhW5yXDAnK6zA
www.empr.com/ Name: _sess
Value: 48a98256-b793-404a-a267-b663edb51788.42d335cf-097c-487f-b86f-d16df8e6a46c.1569558930.2
www.empr.com/ Name: register-pages
Value: 1
www.empr.com/ Name: PathforaTest_d32aacecfe87458780ba0a5b22e84019
Value: 0.913931361036336
www.empr.com/ Name: PathforaTest_853e3ee5e01881b83ab49fe8c2eae359
Value: 0.24803866966284382
www.empr.com/ Name: PathforaTest_845520b7c2ad6c7b2d753bf3b76b1546
Value: 0.23315999172381208
www.empr.com/ Name: PathforaPageView
Value: 1
www.empr.com/ Name: dmd-48a98256-b793-404a-a267-b663edb51788
Value: e30=
www.empr.com/ Name: dmd-vid
Value: 42d335cf-097c-487f-b86f-d16df8e6a46c
www.empr.com/ Name: dmd-ahk
Value: 8be3b5a83b
.empr.com/ Name: seerid
Value: eba40efa5985b991eb795147de5cdecd
.empr.com/ Name: __auc
Value: 7ffcae4d16d7100a4e3c57557a2
.empr.com/ Name: _maro_contact_id
Value: BAhpA6UmIw==--7a2ae91d148709d3a8aade4e018a13ff525399d3
.empr.com/ Name: __asc
Value: 7ffcae4d16d7100a4e3c57557a2
.www.empr.com/ Name: seerid
Value: eba40efa5985b991eb795147de5cdecd
www.empr.com/ Name: _ccmaid
Value: 5978151501699125277
.empr.com/ Name: _maro_campaign_id
Value: BAhpA9oMAQ==--13a721e567250d382d80a7d4545534371e8c2ba4
www.empr.com/ Name: _ccmsi
Value: 1569558930614_jmolk9dk9|1569558930614
www.empr.com/ Name: hmUsrc
Value: haymarket
www.empr.com/ Name: shadowAccount
Value: true
.empr.com/ Name: _maro_account_id
Value: BAhpAisF--37e0a5dc91bbd179df584d1ded7f2656371a9960
www.empr.com/ Name: dmd-sid
Value: 48a98256-b793-404a-a267-b663edb51788
www.empr.com/ Name: hmSsoCheck
Value: true
.www.empr.com/ Name: seerses
Value: e
.empr.com/ Name: seerses
Value: e
www.empr.com/ Name: PathforaTest_33a33bdd982117e2cd8a1be673315252
Value: 0.8195045301110053
www.empr.com/ Name: globalAct
Value: 0
.empr.com/ Name: _ga
Value: GA1.2.1601973801.1569558930
www.empr.com/ Name: globalActData
Value: {%22subscriber%22:{%22firstName%22:%22Thao%22%2C%22lastName%22:%22Nguyen%22%2C%22email%22:%22nguyentt@sutterhealth.org%22%2C%22displayName%22:%22Thao%20Nguyen%22%2C%22subscriberId%22:0}%2C%22medicalData%22:{%22npiNumber%22:1619909975%2C%22hashedNpiNumber%22:%227ae510fe18e7431582eb749cfc8567497d75868fa53d079af4ef35f92eebbf33%22%2C%22profession%22:{%22id%22:448%2C%22name%22:%22Physician%22}%2C%22subscriberTopics%22:[]}%2C%22publicationId%22:0%2C%22address%22:{%22city%22:%22SAN%20JOSE%22%2C%22stateCode%22:%22CA%22%2C%22postalCode%22:%2295112%22}%2C%22newsLetters%22:[]%2C%22optInMyCmeEmails%22:false%2C%22optInHmiEmails%22:false%2C%22optInThirdPartyEmails%22:false%2C%22optOutRelevantWorkEmails%22:false%2C%22optInScreenedWorkEmails%22:false%2C%22optOutScreenedWorkEmails%22:false%2C%22sendEmailConfirmation%22:false}
.empr.com/ Name: _gat_UA-1290429-2
Value: 1
.empr.com/ Name: _fbp
Value: fb.1.1569558930609.1359657798
.empr.com/ Name: _gid
Value: GA1.2.697230513.1569558930
www.empr.com/ Name: spinfo
Value: spem=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1
www.empr.com/ Name: hmNpiId
Value: 1619909975
www.empr.com/ Name: PathforaTest_48455487baba85f52d70e65e52b8f2d2
Value: 0.1870585953041819
www.empr.com/ Name: adcpn2
Value: pcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019

84 Console Messages

Source Level URL
Text
console-api log URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/jquery/jquery-migrate.min.js?ver=1.4.1(Line 2)
Message:
JQMIGRATE: Migrate is installed, version 1.4.1
console-api log URL: https://s3.amazonaws.com/haymarket-adtracking-js/prod/adtracking.js(Line 540)
Message:
interactive
console-api log (Line 2)
Message:
DMD AIM data:{}
console-api log URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1567085297(Line 1)
Message:
[ABD] start beginTest
console-api log URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1567085297(Line 1)
Message:
[ABD] adding bait node to DOM
console-api log URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1567085297(Line 1)
Message:
[ABD] start beginTest
console-api log URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1567085297(Line 1)
Message:
[ABD] adding bait node to DOM
console-api log (Line 8)
Message:
logit -ga_med_nomycme
console-api log (Line 8)
Message:
logit -ga_med_nht_false
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_rheum_survey_audience)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_4638_audience)
console-api log (Line 6)
Message:
checkForCPNSegments(onc_town_wall_audience)
console-api log (Line 6)
Message:
checkForCPNSegments(on_town_wall_audience_use_this)
console-api log (Line 6)
Message:
checkForCPNSegments(on_town_wall_audience_use_this_no_gastro)
console-api log (Line 6)
Message:
checkForCPNSegments(3_day_visitors_neuro_ca_empr)
console-api log (Line 6)
Message:
checkForCPNSegments(blackfriday_notunknown)
console-api log (Line 6)
Message:
checkForCPNSegments(activity_5126_audience)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_endofyearsale_noanonymous_nosdc)
console-api log (Line 6)
Message:
checkForCPNSegments(audience_for_mlk_sale)
console-api log (Line 6)
Message:
checkForCPNSegments(not_unknown_5770)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_activity_5762)
console-api log (Line 8)
Message:
logit -all
console-api log (Line 6)
Message:
checkForCPNSegments(all)
console-api log (Line 6)
Message:
checkForCPNSegments(smt_new)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_reporting_from_email)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_reporting_has_visited_web)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_reporting_multi_session_visitor)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_reporting_last_visit_within_day)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_reporting_last_visit_within_week)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_reporting_last_visit_within_month)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_reporting_last_visit_within_3_months)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_known_email)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_repeat_visitor)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_international_visitor)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_uses_desktop)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_from_email)
console-api log (Line 6)
Message:
checkForCPNSegments(known)
console-api log (Line 6)
Message:
checkForCPNSegments(all_time_visitors)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_allergy_all_except_4797_completes)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_hiv_all_except_4670_completes)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_internal_med_all_except_4670_completes)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_allergy_all_except_4744_completes)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_psychiatry_all_except_4812_completes)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_cardiology_all_except_cardiology_pas)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_dermatology_all_except_4831_completes)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_pediatrics_all_except_4354_completes)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4523)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4524)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4525)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4526)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4593)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4595)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4710)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4804)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4834)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4800)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4792)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4511)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4529)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4558)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4634)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4740)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4757)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4842)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4816)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4897)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4727)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4755)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4791)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_47911)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4826)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4815)
console-api log (Line 6)
Message:
checkForCPNSegments(ce_excluding_mpr_print_subscribers)
console-api log (Line 6)
Message:
checkForCPNSegments(ce_excluding_ca_print_subscribers)
console-api log (Line 8)
Message:
logit -ga_med_known
console-api log (Line 6)
Message:
checkForCPNSegments(nace_conversations_in_onc_ona)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_homepage_ibs_town_wall_)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_ddw_nash)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_cll_may_16)
console-api log (Line 6)
Message:
checkForCPNSegments(emailops060619)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_activity_5841_2)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_pediatrics_activity_5591)
console-api log (Line 5)
Message:
OK
console-api log URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1567085297(Line 1)
Message:
[ABD] exiting test loop - value: false

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
accounts.haymarketmedia.com
ads.spotible.com
adservice.google.com
adservice.google.de
adtrackapi.haymarketmedia.com
api-34-219-221-191.b2c.com
api-35-166-13-162.b2c.com
api-54-203-125-28.b2c.com
api-54-245-184-141.b2c.com
api.b2c.com
api.lytics.io
bcp.crwdcntrl.net
c.lytics.io
cdn1.spotible.com
certify.alexametrics.com
connect.facebook.net
content.maropost.com
d31qbv1cthcecs.cloudfront.net
fonts.googleapis.com
fonts.gstatic.com
idsync.rlcdn.com
in.ml314.com
insight.adsrvr.org
js.adsrvr.org
link.email.empr.com
ml314.com
mpct1.maropost.com
mt.sitomobile.com
pagead2.googlesyndication.com
pixel.mathtag.com
pixel.tapad.com
ps.eyeota.net
s3.amazonaws.com
sb.scorecardresearch.com
script.crazyegg.com
securepubads.g.doubleclick.net
sp.sitomobile.com
stats.g.doubleclick.net
subapi.haymarketmedia.com
sync.crwdcntrl.net
tags.bluekai.com
tags.crwdcntrl.net
tpc.googlesyndication.com
www.empr.com
www.facebook.com
www.google-analytics.com
www.google.com
www.google.de
www.googletagmanager.com
www.googletagservices.com
www.medtargetsystem.com
www.pulmonologyadvisor.com
www.thecardiologyadvisor.com
104.111.241.32
143.204.207.113
143.204.214.122
143.204.214.38
143.204.214.7
172.217.16.162
18.195.251.148
18.200.54.67
2.18.233.201
2.19.43.224
2600:1f14:e96:5800:18fd:5331:bb62:1421
2600:1f14:e96:5800:23c6:3b85:d7f5:6913
2600:1f14:e96:5800:3282:b5ef:e766:4370
2600:1f14:e96:5802:b89c:c3ee:ab7e:71f1
2600:1f14:e96:5802:dbb0:2341:5b61:3e04
2600:9000:20bb:5400:16:bc48:4dc0:93a1
2600:9000:20bb:7a00:1b:fadc:b780:93a1
2606:4700:20::6819:5365
2606:4700::6813:9408
2a00:1450:4001:80b::2003
2a00:1450:4001:80b::200e
2a00:1450:4001:814::2008
2a00:1450:4001:816::2002
2a00:1450:4001:817::200a
2a00:1450:4001:81d::2003
2a00:1450:4001:81e::2001
2a00:1450:4001:820::2004
2a00:1450:400c:c08::9d
2a03:2880:f01c:8012:face:b00c:0:3
2a03:2880:f11c:8083:face:b00c:0:25de
3.211.28.224
34.202.10.50
34.205.176.240
34.219.221.191
34.225.50.222
34.248.158.173
34.248.255.146
35.166.13.162
35.172.78.117
35.174.96.0
35.190.72.21
35.227.192.113
35.227.248.159
35.238.92.4
52.1.219.33
52.206.48.92
52.216.161.101
54.203.125.28
54.245.184.141
93.184.220.113
94.31.29.64
036d841b132c14046e26d8f2da1bc634c6ad34885ed1295660694a91c98933a6
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
04fd413245ae05c0ec3f793814266315a74f2107767c3614b34ed89764663795
10d8d42d73a02ddb877101e72fbfa15a0ec820224d97cedee4cf92d571be5caa
128ac90fcfc2f8612b7d97447b302b0c8a5e8187bab2eba836c7fe609de5057b
138ea615cc7a69000251588011c04ded37150346b21476ad46c16913b9bba80c
14d88b3a27f0e6de034f86ad42d6411081e9467daf754147f2f16bcb20782177
15153958bd4482bc5c553cf705694509d008fe238f00bb1a92a347d4dabbadc5
169b598c2a86576823e1068924ba6325c973d3250c9464ff3ea0e0fcbd73cf01
19aa6c614f72f6bb67cb17a6169ca551686c2bab5475293c95880f5f32cd830e
1c0e0ca6ba3ee267ba14d39184efb68c958717fc6e58b528b700502c0aea5170
1db21d816296e6939ba1f42962496e4134ae2b0081e26970864c40c6d02bb1df
1e5207491267777bd65a4bd10fc7289e9b2dc5eee7deec16e5893db15a3ce353
206a40b0d9084415064c358a1a381b3a05b27de806b4e62ffefb1b7be2da3bd0
207775987f53f3b91160546806345706ec562f294cb076637004e36d81ef221b
20a92b466756d6736c034b6165b411633db4d9e8c92ec14957d34ce4a5475c5d
2152557cac69e2bd7d6debef5037a9f554f9209cc305b8141b3329acb10c42b7
218087ed3854e672a6627b47c86b3a97e1dad722daa9f509fe522b33b01302a2
2673f6b0416b9a9f7488ee96f384f5badfa04acb14499c92ae52e394b7572f1f
27ceaafaf5ba6ce304458663f1350033f91a9f68463b44fa12ef15655bdf634f
2a3c8fc442100be71fa62aecfe6c6db82d0074d9b5b982940fb96dc402afb703
2b9d553068a82437949fb7f332ecf746c87fb1a8abedf7dc231a6026030f5c38
2ccc2d6a6ce64b8e30228624183547c2456f8d9597ca456d147f47e95f4fe443
2d407ec30530520d2ba4a86a5bf4c00d8060ceb0fea21b796ab71b12e1016fd8
2e497e5231e532fad481d8b7874822e1808d2ba6432a2f8436e57ccfdcdc2685
2fb1365733c0309e4d51b57b5c7aacdf0a028d1b59f8ccfe7bffa405bb5c491b
2fb7e78ece3fe64f8f94c1dda266f0aa6708ef5c01e787440f8f96f54344945c
308e0a77d88613aa857a9af4e20cdba521e03f8b48d29ce4d170b1e5e275360a
33fb5a762c31a731746d28a872769d3ef5ea3a2702ec4d0b7e0a7f9c9147bcc3
33fe4fe8214760f15a5fdd753b5c396ee5b916e5d6f66f79d4765ed260706723
3463d937369067ba4b7700dd056500a6d9d28fed29addce4e3bce87a0970a348
3831ce65c84a69356a031077168510933920dd685df14ca4b8c14e9579b54afc
397486cc51c9de9801c4edd9fb26b4ff81b25b770528ef43cd5ebebb6c541b13
3b8eec5229515f9e95a68b635aba1d27d7d91f2e1b726302c53124fe18cefd20
3ed3de3fd0fabc795d8b96ada205998944ff3157366f20b70d5d10b099b63120
4215e6200c04a4874f3d23c78af23fcd22b5bc3bc916237fd95c108aaae38735
43a5ba666207ae3718ce7fe6b4015c58043b4ac4dfdacae285d5d8574d80fdf6
44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a
47bc305eb82af2bd196db29a335a223c0ab8cf72534dd5378460bfb59d104116
48eb8b500ae6a38617b5738d2b3faec481922a7782246e31d2755c034a45cd5d
4901c9453014d8e210b2f62189f68c2d7964543517e1fc8447924de7d542058a
4b3c190f1fd1a6c15ba3202a789424a7fbfb9e6b3fc0a96af1e712d456fc9fd4
4b8fe5c3d0e5ef7a6582185cbf5c535b5d369c8df1da98c03ed69833e55f474d
4bd7ab38b940371c161b19f0cf34bdfdeaac480eda86b13c29591ed01ed67c36
4d3e9dbf75d761b4fc344b3be601971eb517ce533c7ce46e093539e03349616e
4daa8b467725da84b7f12beba99f81c390ddfdffa7bda838aed65663f266941c
4e501c17d8c5779bf86d7be7f64a8743c9286dc9ec478fbf0acebb84632f26a2
4eef9cbbcb01ac2538e54c45514c0560e686abf17070adfba489fd1b3b86455a
538eeb4c52038047bc8e54debcaf7891fbf3422f735fd0f483fd7b4d3c84f3d5
58aa5964d6f5dc68b2180e943ea63b6031c0ba83e44d9815e724b10f2f615f9f
59173f786dd1f3802f7ab26fd339aac4099dc10c6cb54a6a92213e6af277592a
5a546cfcdf18d9f64acea85800d8ce7348338fa4ccaaed237041bdc4bb12737e
5b2ad74d53081be605e9eccddb55b222611a4cd93a283651d43fa299c0e9c670
5fbf2db66ae1d2af5ac41e878a9fe20ed5574bd073ada8c03ef2b2f7f9efea5d
6003829935cc8575fbf4e925dace1c877be37ef8a64db4e4d36ba9cccb81ced8
6182dfae0694d2f06ce0ba9e18b21af30bdc62b4878767761059e6f03cba08e5
6258dbe6dbce7a7de872ad56d9ceea8354f5d37626e66201ec29b2717a95e949
635994bacaaafcf5296ca204df7739d714b94ad861f7156c0d3e98d5353de747
6463301e10c71f76fc14bb977dfa9097b5633ed4a3ee4119abccf2ead9aa9e29
65af014c9562d3ef38dbb4638bef464aa19d2c5899e1872b6ec96da9046168e5
65f72bc49f7e243cf332df6eb265d987e4c6e997e7aecd813ceace591f805071
693d39f8b27d78f2a570672b862512cb8e3dee72e8f641cf95ada2d81bac720b
6944e75951f2e7bf00121eea502e7d952a833e811e13a1f28fb077df6af721f3
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992
6bc323bb55caf9db36461181e8ecdc648456d6d1f28bce914c6d716cee9835ce
6cf577b17f127e2a7210e9a0bb3517183bbb2a83613f21557000a3ea7e59f3dc
6f288f48917269872aabf9f5f79383b1fff2974f0ae1fbf30bd65636489e69ad
719a7e9a6d7b5858bb3e6f52044f7e3314d8e831a50558e7fde876c23b41abd7
734fd0ea8fd9ef5774133ec8229454a33210c6a4b6eb70ab2d3cdc85426ab1d3
7a1eaf913cf2579fc6b89d3a474cc9def653fa4d36702569d75b54fce2502519
7bb8bc9d113519cbd812363c3376a39d24f1dba2d12b48ad2fd8a833e5287f31
7d655e8cd62ba58d86b3bc9c8e1e04a76506a4dfc852c3b3813deb0aef284548
7df3d9fe132da0dc751d222fd597ad501748a6f6a6e30ae9f9f510515ded1887
7e98e381189d908e1981b6e535bcdd7f3edceafdb0e7095f3e04292e8aac6a0c
803e3ba42413340bcc0c185e1b5f40bfcc115ed3a52832ffcdf7827cbf239be0
808e5dda9ebf9cae0ae42a7f53c8c335e6f2951724c8a58c15658d0fdd49b61f
822847109c3aaf484affe599900514bcf4167ceda17fcca7a97b691d780dae25
8337212354871836e6763a41e615916c89bac5b3f1f0adf60ba43c7c806e1015
8461c8b27e1ab73d3b920835dc71668152c013ee563c97fbbc53ee8c32b09038
8617f3b621a7fe14ab36ef607fda9909163c458e72f24f0836fb0158a5e31f83
866e74600600f8647c979414828f3538d646101dc8504de84c2ed00e30460811
8689484e31c0c85e3e074f0b59348974f5de4b2eec412e388e2ea32924a41478
8744ced6470d0961297be478b4f7e25cbb8a1638af4724a7b288ed9e9d79281a
892ff0b3166742d839aeb9027057d0bd3f0e9af48d70cbfa44f22952f9c1fcf0
89fe0ee6020314794fc2cfeacf3d10c31050cfe56f8ebddf1ed0a33fbe941fa7
8a846df9c01f4d8d8b6e82c6e505069104280430b3b05d94a13a5b99d7c854aa
8bb87b6a883fd75428afe9c39a568eea8415cb06565b55f77483dcfedf440290
8e0da2e2d764c1a202d33dd39287784df8ac6bc20c7401ea14f2d62001292856
90451ba3e82cd9db02f0ca76bd45d0ab5ef7e90a49da4215903cb7f08471e2e7
916b46685de3064525220ba828d946e60ab332f5e65c62d7df5fe9877f9c54b2
92f43f03582b5fa6ab35f37ba18f5e9b532fe6105c262a7ad0879bd1b3a565c7
92fca55833f48b4289ac8f1cedd48752b580fce4ec4b5d81670b8193d6e51b54
93c4a8cc5d4782ed85c9a7661ce68d1e7e7e6d4a91a57219f649f77564617460
94cf02886e8215927276c48bab819789add376443782748917b49f0bc10bb837
9baad10e85c5be8d5697086479983b6b477197103bf8f0f11817b1bdfb9a7451
9c9401c3de840fa118289641c41b6125ca5825612d110a20584d2ba32036a1cf
a29b20518a3bb583278ebb330cba43e072795b7009b39f3479819d00f0833064
a46294826b4b30760616049dfedcdb770a17d1d9aa94eb37571c2f55fedc8ffb
a54d3bff6a0eee0fd36bfdb96e571636fca0fde8e8524daf3ea38fcbe3a834c8
aab6776d26273b51bcb25e1058f3ef503b39ac1e5219dbaa6f20927c140669c0
abb1dd7905b3797711e15609800d43cabead4c0358dc0030a1932a20e82a37d7
acc5e3a4ec186ddd04bf3dc78cc2b00b5664aca1214c6c9460285400cce759f6
ad16911f49d3e72d789bfe438841576129e86d69f42bcaddf489d3523ed69951
ad9d820f1802abd0f80d4e260c43cd6c92d643c926732a00296821182ae3f9c7
ae97be9789cfeb75923e6846ca36cf057da96578b7360dc7ba445b4b0f94dfd0
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b
b3c617e4ee00489d6fb85a53bd88cb1e1f5e71ae5244c54a7fea6b6e7d9921ad
b4e9e9bef19c34422f55a7fdb9d10c4db5e39cff24b8c98a0be0e09b2ee6ac2b
b92a2e8779df445c71f7253608ef7526db31a5cfda1130a0df33c5e2f554f344
b9647f9e3a760d1e82d0e24c3d86ae5e52890e9ed5ad875baf7884d21086e714
b98f9a9b49eef5d104e6d3d91907fa226b8b04b7d60364e6a32fbecf50bfaceb
bb4c48e63332f312f4d1945747e9e319247d26592eec54e38fe75eff833eb130
be6beaacd90961241ca111e54c0953bc476a844a264e5afade4792a75c78c540
c68d891f07355e5d0807b4a4f18ac8f16f6e9088277be3134c7efa570022ab2d
c77635c1d346c5471d294f59d0c4ef11f71c21f94e82087cbd99984c9aaa3cda
cb02a588c74d4f4d1220ad2c949acad7308a47b5d81420d649cc4a189ea44b1d
cb391edd0de3ef3afb6e8960e8609017ccd3f39fd009219154d79dd9bae6b7cb
ce647423705101407941c5ea90afc23dff9181046d16b62b2b1433d048144bfa
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda
cffef365e4b53f1a6e9d33a7d42c0d1542b573360f774069589240f75f0e84f1
d0e4a6372d6fb5ffe9505dbe9e94aee8f1b9b96ec8e5e20684cce8b4c5a88fa7
d0e90581c7b707bcad9f78f9b066371e6b1377d993ff03cbdee7193d6068ac78
d31b12baad65082a7d404da9971cc9fed871e35f29a5893f815f468f1050491f
d4bcb251006ecf5b401b479c59b7c07234d028ebf9e5d1d8ed4614eee91b3d72
d720a46aa392008329dab97f3954f33c6da1c8a37a07ddb9fb49548ad52b5267
d9593473fc4d73446eac1a620bb1bbe590fc80d61d8909484dfee64ae522b787
dbb67c620eaabf6679a314db18d3ae43037aef71ab27422e6feec08ee987cc0a
dc33184388cdcf8d8744da89db61d1633ff8219cc2a82f5c16758ff51a6ef531
de21751600a5bbe5eede21f33cc022383a3583c34c2d72384fe95fd771e8a8b5
de709acbe98dba4f2f3fc3204a09a5add553a366b33501d54f78b5f263775785
de9d3fd0eb948bd294477d0eda60a73b85caff1794803530d0463193a113da98
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
e828282e92509efc0f7bc57888382c5816bd403e0abbb685eda5c4372cc7daa5
ea435e335b80cec0680feac205710447f5a1cecf7af3304346bd4f84efb673af
eca760eaa6d98b1cd3a0d88d1b83b9312a67c82101158c08e02614a674c550b1
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
ef4b924da9d8dd8119518323f50bcb8f0a3953228b9995ea6398e4e56209aefe
f0341fe392815f4fedec6d94398334b176ce2fb0eafebc391a82afcb3cc5fef0
f1e3884dae2f0ddd32795c0c1ac83e9f9a8c7dce35dbd784bdc3c9872196bb1c
f42e34b205a7c2ac4a0997e0b1eb2627e76ee8ae15ac7a15b05954827e186dd9
f4eef8263281c0b26486637831251059757bc3fdc4c3a48045a8ef8646b36e8f